MolProbity logo
When finished, you should .

All-Atom
Contacts
Clashscore, all atoms:6.3 90th percentile* (N=1784, all resolutions)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers181.37% Goal: <0.3%
Favored rotamers121392.38% Goal: >98%
Ramachandran outliers171.15% Goal: <0.05%
Ramachandran favored136092.02% Goal: >98%
MolProbity score^1.9479th percentile* (N=27675, 0Å - 99Å)
Cβ deviations >0.25Å231.65% Goal: 0
Bad bonds:12 / 120850.10% Goal: 0%
Bad angles:132 / 163300.81% Goal: <0.1%
Peptide Omegas Cis Prolines: 0 / 45 0.00% Expected: ≤1 per chain, or ≤5%
In the two column results, the left column gives the raw count, right column gives the percentage.
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst. For clashscore the comparative set of structures was selected in 2004, for MolProbity score in 2006.
^ MolProbity score combines the clashscore, rotamer, and Ramachandran evaluations into a single score, normalized to be on the same scale as X-ray resolution.

#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 1 MET4.3--Favored (29.8%) ttt
chi angles: 180.1,178.7,169.1
0.06Å- OUTLIER(S)
worst is CG-SD-CE: 4.3 σ
-
A 2 GLN4.26-Favored (14.9%)
General / -97.3,159.5
Favored (59%) mm-40
chi angles: 288.4,289.8,340.4
0.12Å---
A 3 ARG4.62-Favored (5.71%)
General / -100.0,175.6
Favored (19%) ptt90
chi angles: 59.3,157.2,173.4,100.8
0.12Å- OUTLIER(S)
worst is C-N-CA: 4.4 σ
-
A 4 SER4.35-Favored (63.05%)
Pre-Pro / -78.4,163.2
Favored (31.3%) p
chi angles: 77.2
0.33Å- OUTLIER(S)
worst is C-CA-CB: 5.3 σ
-
A 5 PRO273.44-Favored (64.44%)
Trans-Pro / -64.4,-18.9
Favored (2.5%) Cg_endo
chi angles: 6.9,336.1,32.1
0.22Å---
A 6 LEU257.19-Favored (30.48%)
General / -88.4,121.2
Allowed (0.9%) tt
chi angles: 208.5,160.9
0.02Å---
A 7 GLU262.2-Favored (34.12%)
General / -73.6,158.8
Allowed (1.2%) pp20
chi angles: 71.4,85.8,42.7
0.06Å---
A 8 LYS274.87-Favored (9.92%)
General / -133.4,174.9
Favored (58.2%) pttt
chi angles: 59.3,182.3,182.1,180.6
0.02Å---
A 9 ALA296.36-Favored (31.81%)
General / -160.8,161.1
-0.03Å---
A 10 SER289.89-Favored (11.83%)
General / -114.0,166.2
Favored (31.4%) t
chi angles: 183.5
0.03Å---
A 11 VAL269.66-Favored (42.96%)
Ile or Val / -56.0,-36.0
Favored (24.9%) m
chi angles: 295.4
0.09Å---
A 12 VAL277.65-Favored (9.2%)
Ile or Val / -75.7,-56.2
Favored (68%) t
chi angles: 179
0.03Å---
A 13 SER262.84-Favored (66.79%)
General / -55.2,-37.1
Favored (7.6%) p
chi angles: 49.4
0.01Å---
A 14 LYS291.99-Favored (80.46%)
General / -67.1,-35.7
Favored (75.4%) tttt
chi angles: 192.5,169.3,184.4,175.3
0.01Å---
A 15 LEU258.12-Favored (13.15%)
General / -75.3,-51.5
Favored (26%) tp
chi angles: 186.2,54.4
0.01Å---
A 16 PHE265.85-Favored (55.9%)
General / -84.1,-11.9
Favored (61.9%) m-80
chi angles: 290.5,291.7
0.04Å---
A 17 PHE282.43-Allowed (0.55%)
General / 58.6,72.1
Favored (86%) m-80
chi angles: 300.7,281.9
0.08Å- OUTLIER(S)
worst is CA-CB-CG: 5.3 σ
-
A 18 SER267.35-Favored (71.86%)
General / -70.6,-41.7
Favored (21.7%) p
chi angles: 79.3
0.03Å---
A 19 TRP288.75-Favored (3.27%)
General / -55.0,-17.0
Favored (24%) p90
chi angles: 62.5,79.8
0.08Å---
A 20 THR314.46-Favored (74.1%)
General / -59.4,-35.6
Favored (22.3%) p
chi angles: 51.2
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 21 ARG327.67-Favored (96.47%)
Pre-Pro / -60.0,-44.3
Favored (85.1%) mtt-85
chi angles: 286.1,184.6,172.2,283.1
0.11Å---
A 22 PRO270.71-Favored (18.32%)
Trans-Pro / -54.7,-49.0
Favored (79.9%) Cg_exo
chi angles: 329.1,29.3,344.2
0.04Å---
A 23 ILE301.37-Favored (27.75%)
Ile or Val / -74.5,-31.4
Favored (35.3%) pt
chi angles: 63.8,166.4
0.14Å---
A 24 LEU301.75-Favored (81.12%)
General / -67.7,-42.9
Favored (6.9%) mp
chi angles: 270.1,54.5
0.07Å---
A 25 ARG327.67-Favored (96.25%)
General / -61.9,-40.7
Favored (83.9%) ttt180
chi angles: 184.5,177.9,176.3,181.4
0.01Å---
A 26 LYS317.46-Favored (72.42%)
General / -67.9,-46.1
Favored (8.8%) tptm
chi angles: 188,67.3,170,284.5
0.02Å---
A 27 GLY307.41-Favored (79.16%)
Glycine / -69.4,-41.0
-----
A 28 TYR292.14-Favored (90.03%)
General / -65.0,-38.2
Favored (56.4%) t80
chi angles: 189.3,81.7
0.01Å---
A 29 ARG327.67-Allowed (0.42%)
General / -73.2,-69.5
Favored (34.6%) ttt90
chi angles: 176.9,173.7,159.9,76
0.03Å---
A 30 GLN327.67-Favored (21.94%)
General / -114.7,158.3
Favored (39.2%) tt0
chi angles: 194.4,167.9,25.9
0.03Å---
A 31 ARG327.67-Favored (44.6%)
General / -69.6,131.4
Favored (44.8%) ttt-90
chi angles: 191.6,181.9,169.5,283
0.01Å---
A 32 LEU314.98-Favored (25.4%)
General / -77.5,164.4
Favored (69.9%) mt
chi angles: 300.4,171.7
0.01Å---
A 33 GLU318.99-Favored (46.38%)
General / -138.9,150.8
Favored (7.4%) tp30
chi angles: 197.8,73.4,52.7
0.04Å---
A 34 LEU323.6-Favored (83.52%)
General / -59.9,-38.9
Favored (33.3%) tp
chi angles: 187.1,62.3
0.01Å---
A 35 SER303.34-Favored (64.22%)
General / -69.9,-26.5
Favored (23.7%) m
chi angles: 304.1
0.01Å---
A 36 ASP290.16-Favored (72.91%)
General / -65.1,-31.6
Favored (6.3%) t70
chi angles: 198.8,278
0.03Å---
A 37 ILE288.51-Favored (27.23%)
Ile or Val / -71.5,135.8
Favored (63.7%) mt
chi angles: 296.4,161
0.04Å---
A 38 TYR327.67-Favored (17.94%)
General / -83.2,167.2
Favored (42.3%) p90
chi angles: 64.2,83.9
0.11Å---
A 39 GLN307.15-Favored (11.45%)
General / -74.6,172.8
Favored (80.8%) mt0
chi angles: 295.2,178.2,3.3
0.03Å---
A 40 ILE271.93-Favored (57.55%)
Pre-Pro / -85.1,151.7
Favored (7.2%) mt
chi angles: 314,163.2
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 41 PRO277.34-Favored (84.49%)
Trans-Pro / -62.3,151.1
Favored (98.7%) Cg_exo
chi angles: 332.2,35.5,331.2
0.04Å---
A 42 SER288.42-Favored (64.49%)
General / -65.7,-17.3
Favored (10.7%) t
chi angles: 189.9
0.03Å---
A 43 VAL309.89-Favored (68.64%)
Ile or Val / -69.8,-47.7
Favored (93.8%) t
chi angles: 174.7
0.04Å---
A 44 ASP315.62-Favored (6.96%)
General / -82.9,90.5
Allowed (1.5%) m-30
chi angles: 293.9,34.6
0.02Å---
A 45 SER290.57-Favored (16.4%)
General / -151.3,135.1
Favored (49.4%) m
chi angles: 291.2
0.02Å---
A 46 ALA276.17-Favored (55.87%)
General / -52.5,-36.8
-0.03Å---
A 47 ASP272.65-Favored (89.94%)
General / -59.5,-41.5
Favored (55.9%) m-30
chi angles: 295.3,301.6
0.01Å---
A 48 ASN284.48-Favored (28.03%)
General / -72.2,-50.4
Favored (4%) m-40
chi angles: 289.3,253.2
0.04Å---
A 49 LEU272.96-Favored (67.72%)
General / -68.2,-29.0
Favored (6.7%) mp
chi angles: 272.8,51.8
0.09Å---
A 50 SER286.3-Favored (41.28%)
General / -73.2,-47.7
Favored (46.6%) t
chi angles: 180
0.10Å---
A 51 GLU307.48-Favored (91.72%)
General / -62.2,-39.1
Favored (45.4%) tt0
chi angles: 192.4,180.6,322.7
0.01Å---
A 52 LYS327.67-Favored (72.26%)
General / -67.2,-47.0
Favored (18.4%) mtpp
chi angles: 291.6,180.8,79.1,68.9
0.04Å---
A 53 LEU301.18-Favored (69.32%)
General / -71.1,-32.7
Favored (12.3%) mt
chi angles: 293.2,192.2
0.04Å---
A 54 GLU327.67-Favored (64.55%)
General / -58.5,-52.7
Favored (45.1%) tt0
chi angles: 186.7,171.1,33.6
0.03Å---
A 55 ARG327.67-Favored (93.99%)
General / -65.0,-39.8
Favored (18.7%) ptp-170
chi angles: 66.2,177.3,66.4,180.3
0.08Å---
A 56 GLU293.15-Favored (85.95%)
General / -63.0,-46.8
Favored (9.3%) mm-30
chi angles: 289.9,274.9,27
0.02Å---
A 57 TRP294.99-Favored (83.93%)
General / -66.9,-37.2
Favored (75%) t-100
chi angles: 178.5,254.3
0.08Å---
A 58 ASP327.67-Favored (64.07%)
General / -62.7,-52.2
Favored (21.9%) t0
chi angles: 182.1,39.6
0.02Å---
A 59 ARG327.67-Favored (69.72%)
General / -68.2,-30.6
Favored (9.4%) ptp90
chi angles: 69.2,168,51.6,78.2
0.09Å---
A 60 GLU301.180.51Å
HG3 with A 72 ALA HB2
Favored (72.42%)
General / -71.1,-38.4
Favored (52.1%) mm-30
chi angles: 283.4,293.5,304.6
0.11Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 61 LEU301.94-Favored (95.9%)
General / -64.6,-40.7
Favored (3.6%) tt
chi angles: 189.7,140.3
0.03Å---
A 62 ALA277.95-Favored (62.37%)
General / -73.1,-28.6
-0.04Å---
A 63 SER276.93-Allowed (0.31%)
General / -78.6,-73.8
Favored (18.5%) p
chi angles: 52.6
0.05Å---
A 64 LYS273.25-Favored (23.27%)
General / -75.6,166.6
Allowed (1%) mptp
chi angles: 281.2,76.4,163.1,57.7
0.03Å---
A 65 LYS327.67-Favored (14.81%)
General / -75.5,-50.7
Favored (82.3%) tttt
chi angles: 189.9,176,177.1,181.1
0.02Å---
A 66 ASN303.59-Favored (31.49%)
Pre-Pro / -115.2,92.4
Favored (39.5%) m110
chi angles: 298,129.2
0.02Å---
A 67 PRO286.12-Favored (6.12%)
Trans-Pro / -79.2,124.7
Favored (76.9%) Cg_endo
chi angles: 28.3,332,16.2
0.03Å---
A 68 LYS314.69-Favored (34.71%)
General / -84.6,130.7
Favored (94.2%) mttt
chi angles: 298.9,182.1,179.5,181.2
0.03Å---
A 69 LEU315.92-Favored (65.84%)
General / -73.4,-35.5
Favored (2.6%) tt
chi angles: 193.6,141.3
0.01Å---
A 70 ILE304.36-Favored (82.69%)
Ile or Val / -62.0,-39.2
Allowed (1.4%) mp
chi angles: 304.8,113.4
0.04Å---
A 71 ASN303.49-Favored (64.98%)
General / -61.7,-52.3
Favored (57.6%) t0
chi angles: 186.6,32.3
0.01Å---
A 72 ALA327.670.51Å
HB2 with A 60 GLU HG3
Favored (95.04%)
General / -64.4,-40.1
-0.02Å---
A 73 LEU327.67-Favored (95.02%)
General / -65.1,-41.4
Favored (30.4%) tp
chi angles: 187.4,63.8
0.01Å---
A 74 ARG327.67-Favored (60.23%)
General / -70.5,-47.5
Favored (32.4%) mmt180
chi angles: 284.3,281.7,180,181.3
0.04Å---
A 75 ARG327.67-Favored (65.8%)
General / -54.3,-38.3
Favored (29.5%) mmt180
chi angles: 283.9,288.6,180.1,197.4
0.14Å---
A 76 CYS302.6-Favored (76.63%)
General / -68.9,-42.6
Favored (13.6%) t
chi angles: 193.1
0.03Å---
A 77 PHE292.45-Favored (3.92%)
General / -117.6,37.4
Favored (86%) m-80
chi angles: 302.2,272.5
0.01Å---
A 78 PHE275.64-Favored (16.57%)
General / -87.6,-37.8
Favored (75.4%) t80
chi angles: 182.6,71.4
0.02Å---
A 79 TRP283.23-Favored (5.9%)
General / -77.6,-54.9
Favored (17.2%) t-100
chi angles: 203.5,245.8
0.04Å---
A 80 ARG327.67-Favored (69.97%)
General / -62.8,-28.4
Favored (58%) mmt-90
chi angles: 288,281,172.6,277.9
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 81 PHE276.16-Favored (90.75%)
General / -59.1,-45.5
Favored (89.7%) t80
chi angles: 179.2,76.5
0.02Å---
A 82 MET277.87-Favored (74.35%)
General / -70.5,-37.6
Favored (21.5%) mmt
chi angles: 292.2,283.6,172.8
0.03Å---
A 83 PHE286.51-Favored (87.15%)
General / -58.0,-45.3
Favored (57.6%) t80
chi angles: 188.5,77.3
0.02Å---
A 84 TYR285.51-Favored (76.11%)
General / -69.7,-40.6
Favored (32.2%) m-80
chi angles: 284.7,300.3
0.03Å---
A 85 GLY276.06-Favored (12.17%)
Glycine / -48.6,-54.9
-----
A 86 ILE292.27-Favored (29.56%)
Ile or Val / -54.5,-34.7
Allowed (0.9%) pp
chi angles: 59.5,101.3
0.12Å---
A 87 PHE311.51-Favored (69.83%)
General / -60.4,-30.9
Favored (61.8%) m-80
chi angles: 286.9,284.8
0.05Å---
A 88 LEU297.69-Favored (71.17%)
General / -68.2,-46.2
Favored (93.7%) mt
chi angles: 293.2,174.8
0.04Å---
A 89 TYR325.12-Favored (78.73%)
General / -61.5,-35.8
Favored (58.7%) t80
chi angles: 184.6,67.1
0.02Å---
A 90 LEU319.45-Favored (74.55%)
General / -65.7,-32.8
Favored (12.1%) tp
chi angles: 196,61
0.04Å---
A 91 GLY304.2-Favored (5.56%)
Glycine / -81.6,-49.1
-----
A 92 GLU327.67-Favored (68.05%)
General / -55.3,-38.0
Favored (17.5%) mm-30
chi angles: 289.4,277.6,19.2
0.04Å---
A 93 VAL299.45-Favored (84.66%)
Ile or Val / -67.5,-40.5
Favored (31.5%) m
chi angles: 297.7
0.10Å---
A 94 THR295.41-Favored (66.78%)
General / -65.2,-21.4
Favored (26.3%) p
chi angles: 52.1
0.09Å---
A 95 LYS327.670.53Å
O with A 98 GLN HG2
Favored (98.96%)
General / -61.4,-43.4
Favored (50.4%) mttp
chi angles: 293.4,184.5,181.2,73.9
0.03Å---
A 96 ALA327.67-Favored (60.97%)
General / -74.7,-28.7
-0.04Å---
A 97 VAL327.67-Favored (18.51%)
Ile or Val / -76.4,-29.0
Favored (84.3%) t
chi angles: 177.1
0.05Å---
A 98 GLN327.670.53Å
HG2 with A 95 LYS O
Favored (30.09%)
Pre-Pro / -59.7,-35.5
Favored (18.9%) pt0
chi angles: 69.1,180,54.4
0.18Å- OUTLIER(S)
worst is CA-C-N: 6.5 σ
-
A 99 PRO310.290.48Å
HD3 with A 98 GLN CG
Favored (45.22%)
Trans-Pro / -65.2,-14.5
Favored (40.7%) Cg_exo
chi angles: 338.3,29.8,332.5
0.15Å---
A 100 LEU327.67-Favored (65.51%)
General / -61.6,-52.2
Favored (5.5%) mp
chi angles: 276.6,71.5
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 101 LEU321.6-Favored (66.46%)
General / -64.8,-20.6
Favored (8%) mp
chi angles: 276.6,65.2
0.07Å---
A 102 LEU314.470.46Å
HD21 with A1134 THR HG22
Favored (69.15%)
General / -61.0,-51.5
Favored (49.9%) tp
chi angles: 173.4,59.8
0.01Å---
A 103 GLY310.79-Favored (36.44%)
Glycine / -50.4,-39.5
-----
A 104 ARG327.67-Favored (82.14%)
General / -68.3,-39.0
Favored (26.9%) mmt90
chi angles: 298,286.8,175.2,76.8
0.01Å---
A 105 ILE304.87-Favored (82.54%)
Ile or Val / -66.6,-38.9
Favored (16.7%) mm
chi angles: 297.2,287.6
0.06Å---
A 106 ILE327.67-Favored (75.49%)
Ile or Val / -70.8,-39.5
Allowed (1.1%) mp
chi angles: 279.5,61.9
0.10Å---
A 107 ALA289.74-Favored (65.33%)
General / -67.6,-19.9
-0.04Å---
A 108 SER289.02-Favored (73.84%)
General / -66.1,-47.6
Favored (46.7%) t
chi angles: 180.1
0.09Å---
A 109 TYR269.95-Favored (9.97%)
General / -86.7,73.7
Favored (97.4%) m-80
chi angles: 295,89.4
0.03Å---
A 110 ASP293.94-Favored (19.19%)
Pre-Pro / -144.2,142.0
Favored (28%) m-30
chi angles: 284.4,312.1
0.05Å---
A 111 PRO327.67-Allowed (1.14%)
Trans-Pro / -72.2,84.3
Favored (72.8%) Cg_endo
chi angles: 29.8,326.5,23.7
0.01Å---
A 112 ASP327.67-Allowed (0.83%)
General / -132.1,-62.8
Favored (68.1%) m-30
chi angles: 296.5,310.1
0.01Å---
A 113 ASN327.67-Favored (9.79%)
General / -129.7,174.3
Favored (89.1%) m-40
chi angles: 295.7,323.7
0.03Å---
A 114 LYS327.67-Allowed (1.16%)
General / -97.6,40.4
Favored (10%) pttm
chi angles: 63.6,171.4,198.2,303
0.06Å---
A 115 GLU327.67-Favored (44.33%)
General / -73.3,134.9
Favored (61%) mt-10
chi angles: 296.8,187,315.2
0.01Å---
A 116 GLU298.92-Favored (15.14%)
General / -85.2,168.0
Favored (20.1%) mp0
chi angles: 300.6,94.3,321.1
0.01Å---
A 117 ARG327.67-Favored (7.39%)
General / -47.9,-33.4
Favored (38.3%) ptt180
chi angles: 63.5,191.3,174.6,177.5
0.03Å---
A 118 SER327.67-Favored (3.82%)
General / -41.4,-50.4
Favored (69.3%) m
chi angles: 296.6
0.01Å---
A 119 ILE314.03-Favored (47.77%)
Ile or Val / -63.5,-29.6
Favored (5.5%) tt
chi angles: 204.2,173.9
0.11Å---
A 120 ALA293.98-Favored (2.51%)
General / -77.7,-60.1
-0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 121 ILE305.13-Favored (68.07%)
Ile or Val / -62.0,-35.4
Favored (9.2%) tp
chi angles: 196.8,67.5
0.12Å---
A 122 TYR327.67-Favored (69.3%)
General / -64.0,-27.7
Favored (18.2%) m-80
chi angles: 285.6,311.7
0.08Å---
A 123 LEU327.67-Favored (10.13%)
General / -84.6,-47.8
Favored (8.2%) mp
chi angles: 274.4,56.3
0.03Å---
A 124 GLY327.67-Favored (48.71%)
Glycine / -51.4,-41.7
-----
A 125 ILE327.67-Favored (84.37%)
Ile or Val / -62.5,-39.4
Favored (4.7%) tp
chi angles: 195,74.8
0.11Å---
A 126 GLY327.67-Favored (89.45%)
Glycine / -66.6,-44.6
-----
A 127 LEU327.67-Favored (86.89%)
General / -61.4,-38.4
Favored (2.6%) tt
chi angles: 180.8,135.2
0.03Å---
A 128 CYS314.25-Favored (90.27%)
General / -66.0,-39.5
Favored (67.4%) m
chi angles: 286.8
0.04Å---
A 129 LEU327.67-Favored (93.9%)
General / -64.5,-39.5
Favored (2.3%) tt
chi angles: 195.2,142.8
0.03Å---
A 130 LEU325.41-Favored (24.32%)
General / -49.8,-35.8
Allowed (0.7%) mm
chi angles: 257.1,292.5
0.08Å---
A 131 PHE296.460.46Å
CE1 with A1140 MET HE1
Favored (64.81%)
General / -68.1,-48.7
Favored (70%) m-80
chi angles: 291.4,288.7
0.10Å- OUTLIER(S)
worst is CA-CB-CG: 6.8 σ
-
A 132 ILE292.38-Favored (99.69%)
Ile or Val / -63.1,-44.8
Favored (63.9%) mt
chi angles: 294.7,160.3
0.06Å---
A 133 VAL313.51-Favored (81.74%)
Ile or Val / -65.7,-38.2
Favored (4.3%) p
chi angles: 72.3
0.13Å---
A 134 ARG318.82-Favored (78.81%)
General / -69.1,-38.1
Favored (10.1%) ttp-110
chi angles: 191.2,164.5,83.5,266.8
0.06Å---
A 135 THR292.39-Favored (83.04%)
General / -57.4,-46.8
Favored (26.9%) m
chi angles: 307.3
0.01Å---
A 136 LEU304.13-Favored (65.15%)
General / -70.6,-28.8
Favored (81.3%) mt
chi angles: 296.5,170.3
0.04Å---
A 137 LEU312.95-Favored (18.21%)
General / -69.5,-53.6
Allowed (0.9%) mp
chi angles: 256.5,50.2
0.06Å---
A 138 LEU299.19-Favored (17.71%)
General / -71.5,-52.5
Favored (69.8%) mt
chi angles: 295.9,167.6
0.03Å---
A 139 HIS308.14-Favored (9.55%)
Pre-Pro / -61.4,-32.0
Favored (51.1%) m-70
chi angles: 293.9,311.3
0.09Å---
A 140 PRO273.35-Favored (2.32%)
Trans-Pro / -70.4,-43.0
Favored (52.9%) Cg_exo
chi angles: 337,35.1,327.2
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 141 ALA284.78-Favored (79.52%)
General / -61.2,-36.3
-0.04Å---
A 142 ILE280.36-Favored (47.61%)
Ile or Val / -73.4,-36.0
Allowed (0.5%) tp
chi angles: 204.5,90.2
0.11Å---
A 143 PHE260.59-Favored (88.78%)
General / -66.6,-40.2
Favored (78.2%) t80
chi angles: 178.6,70.7
0.02Å---
A 144 GLY279.17-Favored (91.64%)
Glycine / -57.4,-40.2
-----
A 145 LEU287.76-Favored (83.06%)
General / -68.0,-39.8
Favored (37.2%) mt
chi angles: 295.2,162.9
0.04Å---
A 146 HIS327.67-Favored (98.75%)
General / -62.3,-41.7
Favored (41%) m90
chi angles: 285.2,95
0.03Å---
A 147 HIS327.67-Favored (80.94%)
General / -64.5,-35.4
Favored (22.6%) t-90
chi angles: 187.2,247.6
0.03Å---
A 148 ILE291.98-Favored (69.8%)
Ile or Val / -70.5,-37.4
Favored (48.8%) mt
chi angles: 295.7,157.9
0.08Å---
A 149 GLY279.61-Favored (20.55%)
Glycine / -48.5,-38.3
-----
A 150 MET267.97-Favored (86.04%)
General / -66.2,-43.7
Favored (17.4%) mmt
chi angles: 300.1,295.3,152.4
0.04Å---
A 151 GLN294.84-Favored (85.38%)
General / -62.5,-37.3
Favored (91.6%) mm-40
chi angles: 302.1,296.6,312
0.04Å---
A 152 MET327.67-Favored (68.29%)
General / -70.2,-44.6
Allowed (1.5%) mmp
chi angles: 298.1,268.3,88.5
0.02Å---
A 153 ARG327.67-Favored (15.46%)
General / -78.8,-48.1
Favored (44.6%) ttp-170
chi angles: 192.4,192.5,67.8,181.2
0.02Å---
A 154 ILE298.24-Favored (86.35%)
Ile or Val / -65.0,-39.6
Favored (51.6%) mt
chi angles: 295.7,158.4
0.05Å---
A 155 ALA277.15-Favored (95%)
General / -63.0,-39.5
-0.02Å---
A 156 MET327.67-Favored (78.26%)
General / -66.9,-45.4
Favored (81.7%) mtp
chi angles: 285.8,171.9,61.2
0.05Å---
A 157 PHE290.9-Favored (79.23%)
General / -64.3,-34.9
Favored (26.5%) m-80
chi angles: 294.6,313.1
0.04Å---
A 158 SER288.83-Favored (67.05%)
General / -72.6,-34.0
Favored (5.3%) t
chi angles: 195.2
0.02Å---
A 159 LEU293.58-Favored (23.52%)
General / -73.1,-50.3
Favored (2.2%) tt
chi angles: 200.1,152.5
0.04Å---
A 160 ILE284.38-Favored (42.48%)
Ile or Val / -61.5,-27.7
Allowed (1%) pp
chi angles: 63.1,100.8
0.12Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 161 TYR274.4-Favored (66.27%)
General / -59.5,-27.6
Favored (38.3%) t80
chi angles: 193.6,81.7
0.03Å---
A 162 LYS314.45-Favored (68.15%)
General / -69.4,-45.9
Favored (14.2%) mmtp
chi angles: 302.1,297.7,195.2,78.9
0.04Å---
A 163 LYS302.02-Favored (72.59%)
General / -66.3,-47.8
Favored (8.1%) tptt
chi angles: 198.2,77.5,201.7,193.7
0.04Å---
A 164 THR327.67-Favored (63.56%)
General / -56.7,-30.6
Favored (9.2%) t
chi angles: 192.8
0.10Å---
A 165 LEU297.24-Favored (64.67%)
General / -73.8,-38.2
Favored (59.7%) mt
chi angles: 295.7,166.1
0.02Å---
A 166 LYS311.67-Allowed (0.82%)
General / -101.7,55.6
Favored (86.7%) mttt
chi angles: 303.3,185.9,177,184.3
0.02Å---
A 167 LEU294.75-Favored (12.54%)
General / -97.1,164.4
Allowed (0.3%) mp
chi angles: 248,62.5
0.03Å---
A 168 SER292.93-Favored (21.62%)
General / -87.5,153.2
Favored (69.5%) m
chi angles: 294.9
0.02Å---
A 169 SER295.240.47Å
HB2 with A 474 GLU HG3
Favored (71.4%)
General / -67.0,-31.1
Favored (15.1%) t
chi angles: 188.3
0.01Å---
A 170 ARG327.67-Favored (56.83%)
General / -53.6,-33.9
Favored (69.2%) ttt180
chi angles: 191.8,169.1,179.7,179.2
0.01Å---
A 171 VAL309.66-Favored (42.48%)
Ile or Val / -75.4,-43.9
Favored (84.9%) t
chi angles: 177.2
0.04Å---
A 172 LEU307.29-Favored (65.42%)
General / -59.3,-26.9
Favored (2.3%) tt
chi angles: 189.4,136.4
0.06Å---
A 173 ASP324.39-Favored (76.63%)
General / -56.4,-41.6
Favored (25.4%) t0
chi angles: 185.5,41.5
0.02Å---
A 174 LYS318.15-Favored (19.23%)
General / -74.9,119.5
Favored (53.9%) mttp
chi angles: 294.5,187.4,174.1,65.7
0.03Å---
A 175 ILE286.24-Allowed (0.55%)
Ile or Val / -73.9,87.6
Favored (51.2%) mt
chi angles: 300.1,160.6
0.05Å---
A 176 SER282.44-Favored (6.5%)
General / -113.6,31.4
Favored (52.5%) p
chi angles: 56.7
0.03Å---
A 177 ILE291.72-Favored (41.85%)
Ile or Val / -74.4,-47.0
Favored (51%) mt
chi angles: 298.5,159.5
0.03Å---
A 178 GLY307.88-Favored (99.31%)
Glycine / -62.5,-43.2
-----
A 179 GLN327.67-Favored (72.49%)
General / -60.4,-33.4
Favored (50.7%) tt0
chi angles: 194,179.6,351
0.03Å---
A 180 LEU327.67-Favored (10.98%)
General / -73.6,-53.2
Allowed (1.2%) tt
chi angles: 208.8,168.9
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 181 VAL327.67-Favored (45.37%)
Ile or Val / -63.5,-28.6
Favored (25.8%) m
chi angles: 301.1
0.13Å---
A 182 SER327.67-Favored (75.86%)
General / -67.1,-45.9
Favored (15.8%) t
chi angles: 187.7
0.02Å---
A 183 LEU327.16-Favored (71.11%)
General / -56.8,-37.5
Allowed (0.8%) tt
chi angles: 170,159.8
0.07Å---
A 184 LEU326.52-Favored (8.62%)
General / -75.1,-53.6
Allowed (1.4%) tt
chi angles: 205.5,159.8
0.03Å---
A 185 SER327.67-Favored (74.14%)
General / -56.2,-40.4
Favored (15.9%) t
chi angles: 187.6
0.03Å---
A 186 ASN322.66-Favored (79.38%)
General / -68.1,-36.2
Favored (24.9%) p0
chi angles: 64,51.1
0.12Å---
A 187 ASN327.67-Favored (96.36%)
General / -60.6,-44.2
Favored (53.9%) t0
chi angles: 186.4,41.8
0.03Å---
A 188 LEU327.67-Favored (85.26%)
General / -61.2,-47.6
Allowed (2%) pp
chi angles: 61.3,95.2
0.09Å---
A 189 ASN327.67-Favored (69.62%)
General / -69.4,-45.3
Favored (57.5%) t0
chi angles: 191.7,24.3
0.02Å---
A 190 LYS327.67-Favored (80.36%)
General / -67.5,-36.1
Favored (8.7%) ptpt
chi angles: 67.3,175.4,65.5,167
0.07Å---
A 191 PHE296.23-Favored (16.92%)
General / -91.1,-30.1
Favored (20.4%) t80
chi angles: 189.3,53.5
0.04Å---
A 192 ASP267.55-Favored (4.25%)
General / -81.0,-56.2
Favored (2.5%) t0
chi angles: 207.8,312.3
0.02Å---
A 193 GLU291.5-Favored (72.8%)
General / -70.9,-39.3
Favored (29.5%) mt-10
chi angles: 296.9,163.2,37.1
0.03Å---
A 194 GLY285.32-Favored (56.51%)
Glycine / -68.6,-8.6
-----
A 195 LEU278.36-Favored (68.32%)
General / -63.4,-25.5
Favored (8.5%) tp
chi angles: 199.4,71
0.03Å---
A 196 ALA280.99-Favored (83.38%)
General / -66.3,-44.5
-0.02Å---
A 197 LEU278.47-Favored (59.8%)
General / -74.1,-21.7
Favored (53.5%) mt
chi angles: 300.2,169
0.02Å---
A 198 ALA273.58-Favored (63.9%)
General / -69.2,-23.3
-0.01Å---
A 199 HIS313.43-Favored (61.94%)
General / -72.2,-16.8
Favored (17.8%) t-90
chi angles: 197.6,262.7
0.03Å---
A 200 PHE303.92-Favored (15.77%)
General / -79.4,4.3
Favored (47.7%) m-80
chi angles: 301.5,299.8
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 201 VAL263.7-Favored (85.63%)
Ile or Val / -61.8,-40.1
Favored (71.5%) t
chi angles: 172.3
0.06Å---
A 202 TRP289.67-Favored (21.95%)
General / -98.4,-11.9
Favored (59.2%) p-90
chi angles: 72.5,272.1
0.05Å---
A 203 ILE274.25-Favored (28.93%)
Ile or Val / -75.0,-49.4
Favored (40.9%) mm
chi angles: 303.4,296.2
0.02Å---
A 204 ALA294.87-Favored (85.22%)
Pre-Pro / -61.8,-42.8
-0.10Å---
A 205 PRO310.02-Favored (58.53%)
Trans-Pro / -54.8,-43.5
Favored (71.6%) Cg_exo
chi angles: 328.8,33.5,337.8
0.04Å---
A 206 LEU327.67-Favored (66.93%)
General / -72.2,-32.6
Favored (95.7%) mt
chi angles: 296.9,176
0.02Å---
A 207 GLN327.67-Favored (48.02%)
General / -62.3,-53.9
Favored (24.2%) tp40
chi angles: 194.8,69.9,9.8
0.01Å---
A 208 VAL304.31-Favored (74.29%)
Ile or Val / -64.2,-35.6
Favored (7.5%) p
chi angles: 68.3
0.12Å---
A 209 ALA297.51-Favored (83.32%)
General / -64.1,-36.2
-0.03Å---
A 210 LEU290.71-Favored (52.42%)
General / -72.5,-47.0
Allowed (1.3%) tt
chi angles: 203.9,154.5
0.02Å---
A 211 LEU318.32-Favored (66.39%)
General / -61.4,-24.3
Favored (16.3%) mt
chi angles: 290.5,156.7
0.06Å---
A 212 MET325.07-Favored (87.27%)
General / -60.9,-47.2
Favored (27.7%) mtt
chi angles: 275.4,181.5,182.9
0.03Å---
A 213 GLY310.22-Favored (85.53%)
Glycine / -68.2,-36.5
-----
A 214 LEU323.13-Favored (81.42%)
General / -64.4,-35.6
Favored (64.4%) mt
chi angles: 293.5,165.4
0.03Å---
A 215 ILE302.8-Favored (4.66%)
Ile or Val / -75.4,105.8
Favored (20%) mm
chi angles: 296.7,288.9
0.01Å---
A 216 TRP327.67-Favored (52.31%)
General / -70.0,144.3
Favored (94.8%) m100
chi angles: 295.8,102.9
0.02Å---
A 217 GLU296.85-Favored (16.33%)
General / -63.4,-56.4
Allowed (1.1%) mt-10
chi angles: 295.2,136,42.3
0.02Å---
A 218 LEU327.67-Favored (5.16%)
General / 63.3,45.0
Favored (15%) mt
chi angles: 310.7,169.7
0.08Å---
A 219 LEU327.67-Favored (9.29%)
General / 62.0,17.7
Favored (2.7%) mp
chi angles: 293.6,70.6
0.11Å---
A 220 GLN327.67-Favored (40.98%)
General / -151.4,162.4
Favored (63.4%) mm-40
chi angles: 286.6,299.4,331.6
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 221 ALA327.67-Favored (9.67%)
General / -82.9,69.2
-0.03Å---
A 222 SER327.67-Favored (53.9%)
General / -74.3,-44.2
Favored (16.4%) p
chi angles: 52.1
0.02Å---
A 223 ALA327.67-Favored (75.42%)
General / -69.9,-40.9
-0.01Å---
A 224 PHE327.67-Favored (78.26%)
General / -69.2,-39.8
Favored (95.7%) m-80
chi angles: 294.8,278.4
0.04Å---
A 225 CYS327.67-Favored (74.77%)
General / -70.4,-38.6
Favored (10.5%) p
chi angles: 75.8
0.04Å---
A 226 GLY327.67-Favored (94.74%)
Glycine / -65.2,-43.9
-----
A 227 LEU327.67-Favored (72.52%)
General / -67.9,-46.1
Favored (50.6%) tp
chi angles: 183.6,60.7
0.01Å---
A 228 GLY327.67-Favored (45.58%)
Glycine / -55.5,-26.6
-----
A 229 PHE327.67-Favored (23.18%)
General / -69.9,-52.6
Favored (93.5%) t80
chi angles: 176.8,77.5
0.02Å---
A 230 LEU327.67-Favored (68.95%)
General / -68.7,-30.3
Favored (10%) tp
chi angles: 193,50.7
0.05Å---
A 231 ILE327.67-Favored (68.76%)
Ile or Val / -65.4,-34.2
Allowed (1.1%) pp
chi angles: 62.9,99.8
0.12Å---
A 232 VAL327.67-Favored (58.36%)
Ile or Val / -71.2,-35.5
Favored (90.2%) t
chi angles: 174.2
0.07Å---
A 233 LEU327.67-Favored (91.19%)
General / -64.9,-38.5
Favored (2.9%) tt
chi angles: 191.5,140.3
0.04Å---
A 234 ALA327.67-Favored (93.31%)
General / -65.1,-43.1
-0.02Å---
A 235 LEU327.67-Favored (82.35%)
General / -60.8,-37.5
Favored (49%) tp
chi angles: 184.1,62
0.01Å---
A 236 PHE327.67-Favored (95.51%)
General / -64.3,-43.2
Favored (41.7%) t80
chi angles: 192.7,83.6
0.01Å---
A 237 GLN327.67-Favored (98.26%)
General / -63.4,-40.8
Favored (72.3%) mt0
chi angles: 286.5,181.3,1.2
0.04Å---
A 238 ALA311.33-Favored (97.42%)
General / -62.7,-40.5
-0.02Å---
A 239 GLY327.67-Favored (93.8%)
Glycine / -63.0,-46.3
-----
A 240 LEU327.67-Favored (87.21%)
General / -64.5,-37.3
Favored (5.8%) mp
chi angles: 268.9,51.9
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 241 GLY327.67-Favored (78.42%)
Glycine / -62.8,-30.9
-----
A 242 ARG327.67-Favored (17.02%)
General / -69.1,-54.1
Favored (16%) tpt170
chi angles: 192.3,73.8,192.2,175.7
0.02Å---
A 243 MET308.3-Favored (66.1%)
General / -66.8,-23.9
Favored (19.2%) ptm
chi angles: 71.4,190.5,292.8
0.09Å---
A 244 MET300.55-Favored (71.44%)
General / -57.1,-37.0
Favored (52.2%) ttm
chi angles: 190.6,184.1,291
0.00Å---
A 245 MET276.4-Favored (71.64%)
General / -70.4,-33.6
Favored (22.8%) mmt
chi angles: 295.9,285.5,175.3
0.02Å---
A 246 LYS287.51-Favored (99.76%)
General / -62.3,-42.9
Favored (99.3%) mttt
chi angles: 294.4,176.8,182.1,178.1
0.03Å---
A 247 TYR290.18-Favored (79.17%)
General / -66.0,-34.9
Favored (51.3%) m-80
chi angles: 295.1,298.5
0.05Å---
A 248 ARG327.67-Favored (52.83%)
General / -68.6,-50.3
Favored (94.1%) mtt180
chi angles: 292.2,175.4,169.2,179.4
0.02Å---
A 249 ASP316.97-Favored (81.05%)
General / -59.6,-38.3
Favored (27.8%) t0
chi angles: 187.6,41.5
0.02Å---
A 250 GLN273.03-Favored (45.64%)
General / -72.4,-47.9
Favored (41%) tt0
chi angles: 193.6,178.5,312.1
0.01Å---
A 251 ARG326.88-Favored (66.52%)
General / -67.0,-25.8
Favored (51.5%) ttp80
chi angles: 185.9,160.5,55.1,77.2
0.03Å---
A 252 ALA274.11-Favored (53.25%)
General / -57.6,-23.9
-0.04Å---
A 253 GLY279.81-Favored (75.23%)
Glycine / -69.6,-41.5
-----
A 254 LYS299.76-Favored (55.99%)
General / -72.2,-46.5
Favored (46.7%) mttp
chi angles: 291.4,186.1,169.7,58.3
0.04Å---
A 255 ILE289.3-Favored (41.06%)
Ile or Val / -55.1,-37.0
Allowed (1%) pp
chi angles: 60,100.3
0.13Å---
A 256 SER295.64-Favored (84.81%)
General / -67.4,-41.5
Favored (33.1%) p
chi angles: 55.1
0.01Å---
A 257 GLU327.67-Favored (69.72%)
General / -66.0,-29.4
Favored (23.6%) tt0
chi angles: 194,171,40.1
0.03Å---
A 258 ARG327.67-Favored (42.84%)
General / -76.5,-42.7
Favored (44.6%) ttp-170
chi angles: 193.9,187.6,73.2,199.7
0.03Å- OUTLIER(S)
worst is C-N-CA: 4.0 σ
-
A 259 LEU264.37-Favored (82.33%)
General / -59.3,-39.2
Allowed (0.8%) tm
chi angles: 180,278.5
0.03Å---
A 260 VAL284.05-Favored (43.63%)
Ile or Val / -66.8,-28.6
Favored (17.6%) m
chi angles: 293.3
0.13Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 261 ILE277.13-Favored (36.77%)
Ile or Val / -76.2,-44.1
Favored (38.1%) mm
chi angles: 308.7,303.4
0.04Å---
A 262 THR272.16-Favored (78.28%)
General / -66.6,-34.6
Favored (37.8%) p
chi angles: 54.3
0.04Å---
A 263 SER276.76-Favored (93.1%)
General / -64.1,-44.1
Favored (92.8%) p
chi angles: 64.5
0.03Å---
A 264 GLU298.97-Favored (70.11%)
General / -69.3,-31.6
Favored (90.9%) mt-10
chi angles: 290.9,171.9,12.7
0.03Å---
A 265 MET327.67-Favored (24.85%)
General / -61.3,-56.0
Favored (23.9%) tpp
chi angles: 166,54,74.3
0.03Å---
A 266 ILE297.46-Favored (58.95%)
Ile or Val / -64.7,-32.7
Favored (33.9%) mm
chi angles: 295.9,294.6
0.10Å---
A 267 GLU298.58-Favored (75.36%)
General / -68.9,-43.3
Favored (52.4%) mm-30
chi angles: 292.8,288.3,311
0.03Å---
A 268 ASN308.7-Allowed (0.67%)
General / -113.8,59.3
Favored (40.5%) m-40
chi angles: 306.3,326.5
0.01Å---
A 269 ILE287.99-Favored (53.74%)
Ile or Val / -73.3,-38.5
Favored (58.9%) mt
chi angles: 298,160.8
0.02Å---
A 270 GLN327.67-Favored (75.13%)
General / -61.3,-34.4
Favored (23%) mt0
chi angles: 294.2,173,232.3
0.03Å---
A 271 SER283.62-Favored (69.8%)
General / -70.0,-44.3
Favored (82.7%) p
chi angles: 62.4
0.01Å---
A 272 VAL258.17-Favored (85.6%)
Ile or Val / -62.0,-40.0
Favored (53.6%) t
chi angles: 169.9
0.05Å---
A 273 LYS327.67-Favored (84.61%)
General / -64.9,-45.8
Favored (78.6%) mttt
chi angles: 287.9,171.4,171.9,167.4
0.02Å---
A 274 ALA285.76-Favored (62.49%)
General / -58.7,-53.1
-0.03Å---
A 275 TYR288.43-Favored (59.88%)
General / -74.1,-21.6
Favored (60.6%) m-80
chi angles: 294.5,294.9
0.04Å---
A 276 CYS298.7-Allowed (0.36%)
General / 67.4,70.6
Favored (37.9%) t
chi angles: 187.5
0.09Å---
A 277 TRP304.79-Allowed (1.21%)
General / -113.2,79.2
Favored (22.6%) m-10
chi angles: 293.6,320.5
0.00Å---
A 278 GLU277.62-Favored (4.33%)
General / -91.4,-53.5
Favored (48.1%) mm-30
chi angles: 307.2,304.2,320.7
0.01Å---
A 279 GLU308.57-Favored (56.59%)
General / -76.2,-21.3
Favored (89.8%) mt-10
chi angles: 296.9,178.1,11.1
0.02Å---
A 280 ALA286.36-Favored (58.42%)
General / -69.7,-48.9
-0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 281 MET289.14-Favored (24.98%)
General / -97.8,15.0
Favored (54%) mtp
chi angles: 303.3,191,69.7
0.06Å---
A 282 GLU289.88-Favored (5.32%)
General / -95.6,-49.6
Favored (61.1%) mt-10
chi angles: 283.1,172.9,24.1
0.01Å---
A 283 LYS327.67-Favored (90.53%)
General / -62.2,-38.8
Favored (97.9%) mttt
chi angles: 292.2,181,179.7,180.4
0.02Å---
A 284 MET291.77-Favored (85.31%)
General / -58.8,-47.3
Favored (27.6%) ttt
chi angles: 190.6,171.5,176.9
0.01Å---
A 285 ILE278.54-Favored (56.57%)
Ile or Val / -71.6,-47.6
Favored (35.6%) mm
chi angles: 299.4,294.3
0.03Å---
A 286 GLU321.54-Favored (68.44%)
General / -64.3,-26.4
Favored (15.8%) tt0
chi angles: 194.4,161.5,33.3
0.09Å---
A 287 ASN317.43-Favored (80.53%)
General / -68.7,-39.3
Favored (65%) m-40
chi angles: 285.6,311.1
0.04Å---
A 288 LEU277.2-Favored (77.68%)
General / -65.1,-34.1
Favored (4.5%) mp
chi angles: 266.4,68.5
0.07Å---
A 289 ARG327.67-Favored (71.52%)
General / -66.9,-47.6
Favored (28.6%) mmm-85
chi angles: 294.7,306.7,311.9,260.9
0.03Å---
A 290 GLN327.67-Favored (71.53%)
General / -54.5,-43.1
Favored (52.9%) tt0
chi angles: 180,182.7,331.4
0.10Å---
A 291 THR260.99-Favored (60.6%)
General / -66.1,-51.2
Allowed (1.5%) m
chi angles: 319.5
0.01Å---
A 292 GLU266.7-Favored (80.29%)
General / -57.0,-42.3
Favored (31.4%) tt0
chi angles: 188.8,174.9,299
0.02Å---
A 293 LEU268.13-Favored (76.45%)
General / -55.5,-44.4
Allowed (1%) mm
chi angles: 273.3,305.6
0.04Å---
A 294 LYS301.8-Favored (72.19%)
General / -63.2,-31.1
Favored (4.9%) ttmt
chi angles: 194.1,154.2,279.3,164.6
0.03Å---
A 295 LEU254.47-Favored (26.06%)
General / -76.1,-47.1
Allowed (0.6%) tt
chi angles: 210.7,161.2
0.02Å---
A 296 THR257.6-Favored (50.63%)
General / -52.2,-36.0
Favored (15.8%) m
chi angles: 310
0.03Å---
A 297 ARG327.67-Favored (95.81%)
General / -62.2,-44.8
Favored (59.6%) mtt-85
chi angles: 290.2,176.7,201.1,284.6
0.02Å---
A 298 LYS316.03-Favored (71.38%)
General / -65.3,-30.5
Favored (48%) mtmt
chi angles: 293.8,198.6,293.3,183.6
0.05Å---
A 299 ALA300.26-Favored (76.71%)
General / -66.4,-33.9
-0.02Å---
A 300 ALA313.63-Favored (31.72%)
General / -77.0,-44.3
-0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 301 TYR290.46-Favored (82.63%)
General / -57.2,-43.1
Favored (30%) m-80
chi angles: 288.8,306.8
0.05Å---
A 302 VAL285.63-Favored (81.12%)
Ile or Val / -62.8,-38.2
Favored (31.5%) m
chi angles: 297
0.11Å---
A 303 ARG327.67-Favored (85.29%)
General / -66.0,-37.1
Favored (34.6%) tpt90
chi angles: 190.1,70.9,176.3,77.3
0.02Å---
A 304 TYR293.52-Favored (97.12%)
General / -63.2,-43.8
Favored (80.2%) t80
chi angles: 182,85.2
0.04Å---
A 305 PHE296.54-Favored (99.25%)
General / -61.5,-43.2
Favored (33.2%) m-80
chi angles: 282.8,296.4
0.04Å---
A 306 ASN287.87-Favored (87.94%)
General / -58.7,-46.1
Favored (11.9%) t0
chi angles: 203.3,333.2
0.02Å---
A 307 SER293.8-Favored (10.34%)
General / -69.9,-55.2
Favored (71.3%) m
chi angles: 295.2
0.02Å---
A 308 SER314.89-Favored (72.42%)
General / -58.2,-36.0
Favored (81.4%) p
chi angles: 61.8
0.04Å---
A 309 ALA306.07-Favored (69.59%)
General / -54.5,-41.4
-0.02Å---
A 310 PHE288.57-Favored (99.55%)
General / -62.2,-42.7
Favored (61.5%) t80
chi angles: 188,81.1
0.02Å---
A 311 PHE271.96-Favored (65.35%)
General / -72.9,-40.5
Favored (91.1%) m-80
chi angles: 298.6,282.6
0.03Å---
A 312 PHE293.79-Favored (71.37%)
General / -70.6,-33.7
Favored (14.6%) m-80
chi angles: 273.5,290.5
0.07Å---
A 313 SER294.21-Favored (48.36%)
General / -49.8,-43.2
Favored (40.8%) t
chi angles: 175.2
0.03Å---
A 314 GLY311.12-Favored (3.01%)
Glycine / -42.5,-38.5
-----
A 315 PHE312.18-Favored (10.62%)
General / -74.6,-52.9
Favored (90.3%) t80
chi angles: 178,75.8
0.01Å---
A 316 PHE305.65-Favored (88.36%)
General / -60.0,-46.8
Favored (77.7%) m-80
chi angles: 290.1,281.5
0.03Å---
A 317 VAL324.73-Favored (64.91%)
Ile or Val / -60.7,-35.6
Favored (5.6%) p
chi angles: 69.5
0.10Å---
A 318 VAL278.760.40Å
HG11 with A 340 ILE HD13
Favored (10.96%)
Ile or Val / -85.9,-53.2
Favored (37.3%) t
chi angles: 184
0.04Å---
A 319 PHE312.66-Favored (59.42%)
General / -51.8,-39.9
Favored (64.9%) t80
chi angles: 187.1,79.3
0.04Å---
A 320 LEU293.12-Favored (76.95%)
General / -64.6,-33.9
Favored (4.3%) tt
chi angles: 186.4,139.8
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 321 SER305.88-Favored (21.72%)
General / -86.8,-30.3
Favored (68.5%) p
chi angles: 58.7
0.04Å---
A 322 VAL296.55-Favored (42.47%)
Ile or Val / -72.7,-49.2
Favored (59.6%) t
chi angles: 170.7
0.05Å---
A 323 LEU304.03-Favored (40.52%)
Pre-Pro / -55.7,-36.0
Favored (18.8%) tp
chi angles: 191.6,64.4
0.10Å---
A 324 PRO266.78-Favored (15.77%)
Trans-Pro / -49.6,-27.9
Favored (31.7%) Cg_exo
chi angles: 326.6,29.8,345.9
0.03Å---
A 325 TYR283.05-Favored (72.27%)
General / -65.3,-31.2
Favored (13.2%) t80
chi angles: 184.3,42.9
0.03Å---
A 326 ALA281.81-Favored (61.76%)
General / -69.3,-12.6
-0.04Å---
A 327 LEU298.94-Favored (72.29%)
General / -56.9,-38.1
Favored (28.8%) tp
chi angles: 188.3,62.3
0.03Å---
A 328 ILE293.01-Allowed (0.2%)
Ile or Val / -107.7,43.7
Favored (4.8%) mm
chi angles: 320.4,298.8
0.06Å---
A 329 LYS281.21-Favored (3.54%)
General / 42.4,44.8
Favored (47.8%) mttm
chi angles: 302.1,191.8,178.5,296.7
0.09Å---
A 330 GLY262.25-Favored (2.21%)
Glycine / -71.9,107.5
-----
A 331 ILE258-Favored (52.51%)
Ile or Val / -129.4,121.1
Favored (11%) tt
chi angles: 179.8,162.4
0.08Å---
A 332 ILE237.22-Favored (4.75%)
Ile or Val / -161.3,146.4
Favored (22.5%) tt
chi angles: 190.7,166.6
0.06Å---
A 333 LEU290.39-Favored (11.38%)
General / -94.3,-37.6
Favored (33.3%) tp
chi angles: 187,61.7
0.01Å---
A 334 ARG327.67-Favored (63.59%)
General / -70.8,-46.1
Favored (2.9%) tmm160
chi angles: 183.7,253.7,288,184.6
0.03Å---
A 335 LYS327.67-Favored (62.16%)
General / -71.3,-24.8
Favored (31.6%) tttt
chi angles: 198.8,164.8,184.3,158.5
0.03Å---
A 336 ILE327.67-Favored (28.65%)
Ile or Val / -70.7,-26.7
Allowed (0.7%) pp
chi angles: 66.4,103.7
0.12Å---
A 337 PHE321.52-Favored (8%)
General / -69.5,-56.2
Favored (51.3%) m-80
chi angles: 287.8,293.2
0.03Å---
A 338 THR327.67-Favored (68.23%)
General / -57.5,-33.6
Favored (10.6%) t
chi angles: 188.6
0.12Å---
A 339 THR320.37-Favored (68.97%)
General / -60.8,-28.6
Favored (16.7%) p
chi angles: 48.9
0.04Å---
A 340 ILE296.30.40Å
HD13 with A 318 VAL HG11
Favored (54.19%)
Ile or Val / -66.5,-51.7
Favored (24%) mm
chi angles: 305.1,292.7
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 341 SER310.11-Favored (68.35%)
General / -64.0,-26.0
Favored (2.8%) p
chi angles: 43.6
0.05Å---
A 342 PHE327.67-Favored (33.26%)
General / -75.5,-46.3
Favored (39.6%) m-80
chi angles: 287.6,298.3
0.14Å- OUTLIER(S)
worst is CA-CB-CG: 4.2 σ
-
A 343 CYS323.26-Favored (80.24%)
General / -68.4,-41.5
Favored (8.6%) t
chi angles: 195.7
0.06Å---
A 344 ILE287.74-Favored (52.12%)
Ile or Val / -58.9,-34.3
Allowed (1%) mp
chi angles: 273.2,60.1
0.14Å---
A 345 VAL301.3-Favored (84.47%)
Ile or Val / -68.3,-42.6
Favored (94.7%) t
chi angles: 174.8
0.05Å---
A 346 LEU290.58-Favored (98.49%)
General / -60.8,-42.9
Allowed (0.6%) tm
chi angles: 179.9,274.5
0.02Å---
A 347 ARG327.67-Favored (96.49%)
General / -63.8,-43.4
Favored (5.6%) ttp-170
chi angles: 184.3,205.8,65.5,152.4
0.03Å---
A 348 MET302.87-Favored (75.63%)
General / -56.9,-40.2
Favored (43.8%) tpp
chi angles: 188.4,74.6,73.7
0.02Å---
A 349 ALA294.78-Favored (6.38%)
General / -73.1,-55.5
-0.02Å---
A 350 VAL291.57-Favored (35.59%)
Ile or Val / -76.1,-38.9
Favored (3.5%) p
chi angles: 73.3
0.11Å---
A 351 THR317.08-Favored (14.75%)
General / -80.1,-47.4
Favored (2.7%) m
chi angles: 316.6
0.02Å---
A 352 ARG327.67-Favored (3.45%)
General / -109.8,-46.8
Favored (36.3%) ttt180
chi angles: 201,166.4,189.7,174
0.02Å---
A 353 GLN322.42-Favored (52.99%)
General / -74.1,-44.6
Favored (37.7%) tt0
chi angles: 194.2,169,315.7
0.04Å---
A 354 PHE286.76-Favored (23.39%)
Pre-Pro / -69.5,-43.6
Favored (82.7%) t80
chi angles: 181.6,74.5
0.10Å---
A 355 PRO277.12-Favored (77.32%)
Trans-Pro / -54.6,-33.0
Favored (89.3%) Cg_exo
chi angles: 329.8,37.4,330.7
0.03Å---
A 356 TRP296.92-Favored (90.55%)
General / -64.5,-38.3
Favored (54.2%) m-10
chi angles: 292.7,338.4
0.04Å---
A 357 ALA259.55-Favored (88.33%)
General / -64.6,-37.7
-0.03Å---
A 358 VAL260.51-Favored (74.84%)
Ile or Val / -71.1,-40.1
Favored (99.2%) t
chi angles: 175.4
0.04Å---
A 359 GLN283.4-Favored (47.54%)
General / -62.6,-53.9
Favored (5.7%) tp-100
chi angles: 175,52.1,223.6
0.01Å---
A 360 THR275.74-Favored (79.38%)
General / -65.7,-35.0
Favored (8.7%) t
chi angles: 193
0.11Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 361 TRP267.33-Favored (71.8%)
General / -63.8,-49.7
Favored (2.3%) m100
chi angles: 264.3,72.1
0.03Å---
A 362 TYR269.18-Favored (94.18%)
General / -63.1,-44.9
Favored (82.3%) t80
chi angles: 182.6,75.5
0.07Å---
A 363 ASP297.51-Favored (90.17%)
General / -66.1,-41.7
Favored (25.9%) t70
chi angles: 189,46.7
0.01Å---
A 364 SER288.47-Favored (17.35%)
General / -74.0,-51.0
Favored (43.5%) t
chi angles: 180.8
0.01Å---
A 365 LEU297.16-Favored (79.85%)
General / -57.6,-40.7
Favored (25.7%) tp
chi angles: 189.3,62.1
0.02Å---
A 366 GLY307.08-Favored (95.38%)
Glycine / -62.0,-38.0
-----
A 367 ALA308.94-Favored (77.98%)
General / -69.3,-37.7
-0.03Å---
A 368 ILE315-Favored (72.51%)
Ile or Val / -67.0,-34.9
Favored (53.7%) mt
chi angles: 297.4,159.4
0.04Å---
A 369 ASN308.11-Favored (71.26%)
General / -71.1,-40.8
Favored (7.2%) t0
chi angles: 207.8,326.2
0.03Å---
A 370 LYS306.34-Favored (71.95%)
General / -57.8,-50.8
Favored (30.9%) ttmt
chi angles: 188.4,179.7,284.8,187.4
0.02Å---
A 371 ILE293.99-Favored (57.28%)
Ile or Val / -67.4,-32.5
Allowed (1%) pp
chi angles: 65.6,99.8
0.11Å---
A 372 GLN327.67-Favored (84.24%)
General / -64.0,-36.5
Favored (55.3%) tt0
chi angles: 182.2,183.9,342.4
0.02Å---
A 373 ASP327.67-Favored (97.82%)
General / -63.8,-41.7
Favored (26%) t0
chi angles: 186.6,42.7
0.01Å---
A 374 PHE322.07-Favored (69.17%)
General / -70.2,-31.7
Favored (75.4%) t80
chi angles: 184.7,80.3
0.01Å---
A 375 LEU281.65-Favored (86.21%)
General / -66.7,-42.7
Allowed (2%) tt
chi angles: 197.4,145.7
0.03Å---
A 376 GLN310.89-Favored (7.44%)
General / -85.0,85.9
Favored (34.3%) tt0
chi angles: 187.8,161.7,43.9
0.04Å---
A 377 LYS327.33-Favored (16.5%)
General / -135.1,170.0
Favored (35.9%) mttm
chi angles: 277.9,183.5,170.7,284.6
0.01Å---
A 378 GLN327.67-Favored (31.7%)
General / -72.8,127.2
Favored (2.9%) mp-120
chi angles: 277.9,71,235.8
0.03Å---
A 379 GLU303.74-Favored (24.31%)
General / -108.3,152.7
Favored (10.5%) pm20
chi angles: 61,262.1,46.7
0.05Å---
A 380 TYR271.46-Favored (13.18%)
General / -77.5,111.3
Favored (8.1%) t80
chi angles: 162.1,59.2
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 381 LYS314.19-Favored (19.39%)
General / -86.0,110.3
Favored (26.2%) ttmt
chi angles: 184.2,169.8,280.9,185.5
0.02Å---
A 382 THR298.91-Favored (6.74%)
General / -66.6,115.7
Favored (12.2%) t
chi angles: 187.9
0.10Å---
A 383 LEU301.75-Favored (28.37%)
General / -75.8,162.2
Allowed (0.9%) pt
chi angles: 85.5,179.2
0.06Å---
A 384 GLU277.55-Favored (19.09%)
General / -88.0,156.8
Favored (9.4%) pm20
chi angles: 57.4,260.5,46.4
0.06Å---
A 385 TYR277.5-Allowed (1.37%)
General / -144.0,40.2
Favored (23%) p90
chi angles: 49.2,269.7
0.04Å---
A 386 ASN327.67-Favored (22.9%)
General / -108.3,16.8
Favored (28.3%) p0
chi angles: 65.5,323.5
0.03Å---
A 387 LEU257.19-Favored (26.93%)
General / -78.5,161.7
Favored (60.2%) mt
chi angles: 302.3,172
0.01Å---
A 388 THR270.22-Favored (12.41%)
General / -73.8,171.9
Favored (62.3%) p
chi angles: 57.7
0.01Å---
A 389 THR280.61-Allowed (0.32%)
General / 77.7,-40.4
Favored (2.4%) m
chi angles: 317.4
0.14Å---
A 390 THR287.95-Favored (10.45%)
General / 60.2,46.4
Favored (43.9%) p
chi angles: 66.9
0.14Å---
A 391 GLU303.18-Favored (53.86%)
General / -123.6,134.2
Favored (13.1%) tt0
chi angles: 171.3,158.5,42.9
0.04Å---
A 392 VAL303.2-Allowed (1.65%)
Ile or Val / -79.1,93.6
Favored (85.4%) t
chi angles: 177.3
0.05Å---
A 393 VAL313.31-Favored (39.77%)
Ile or Val / -95.4,132.3
Favored (70.5%) t
chi angles: 178.7
0.01Å---
A 394 MET322.26-Favored (49.05%)
General / -135.5,148.0
Favored (24.1%) mtt
chi angles: 279.5,193.9,175.7
0.03Å---
A 395 GLU308.96-Favored (4.5%)
General / -146.9,109.2
Favored (16.9%) mt-10
chi angles: 280.5,193.5,55.1
0.02Å---
A 396 ASN327.67-Favored (14.11%)
General / 60.3,43.0
Favored (45.9%) m-40
chi angles: 309.5,314.6
0.07Å---
A 397 VAL322.02-Favored (27.46%)
Ile or Val / -77.9,119.8
Favored (62.6%) t
chi angles: 179.6
0.02Å---
A 398 THR327.670.66Å
CG2 with A 439 PRO HB2
Favored (31.48%)
General / -148.5,149.3
Favored (13.4%) m
chi angles: 311.3
0.02Å---
A 399 ALA327.670.42Å
HB2 with A 477 PRO HA
Favored (7.16%)
General / -152.8,-178.9
-0.04Å---
A 400 PHE316.05-Favored (48.08%)
General / -124.9,149.0
Favored (14.4%) m-80
chi angles: 273.3,286.4
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 401 TRP289.06-Favored (19.78%)
General / -76.7,-48.1
Favored (10%) t60
chi angles: 191.1,62
0.00Å---
A 402 GLU278.040.40Å
O with A 403 GLU HB2
Favored (3.39%)
General / -134.1,2.9
Favored (9.4%) pt0
chi angles: 55.5,175.3,36.5
0.01Å---
A 403 GLU5.930.40Å
HB2 with A 402 GLU O
Allowed (0.83%)
General / 59.4,-117.0
Favored (23.5%) mt-10
chi angles: 299.1,162.9,40.8
0.09Å---
A 404 GLY6.52-Allowed (1.76%)
Glycine / -141.8,121.0
-----
A 405 PHE7.14-Favored (25.43%)
General / -143.4,134.3
Favored (33.5%) p90
chi angles: 74.2,275.5
0.13Å---
A 406 GLY6.93-Favored (31.94%)
Glycine / 175.5,-162.5
-----
A 407 GLU7.31-Favored (47.39%)
General / -72.8,144.9
Favored (95.4%) mt-10
chi angles: 294.2,180,7.1
0.12Å---
A 408 LEU8.75-Favored (6.02%)
General / -96.1,176.6
Favored (4.5%) mp
chi angles: 284.6,74.9
0.16Å- OUTLIER(S)
worst is C-N-CA: 5.0 σ
-
A 409 PHE9.14-Favored (48.38%)
General / -72.6,142.4
Favored (4.5%) p90
chi angles: 39.7,79.6
0.09Å---
A 410 GLU8.78-Favored (2.42%)
General / -72.8,98.5
Favored (91.8%) tt0
chi angles: 184.5,180,354.6
0.07Å---
A 411 LYS8.810.41Å
HG3 with A 412 ALA H
Favored (3.06%)
General / -170.8,179.8
OUTLIER (0%)
chi angles: 204.4,72.6,76.9,277.9
0.10Å---
A 412 ALA9.140.41Å
H with A 411 LYS HG3
Favored (48.88%)
General / -102.0,127.4
-0.11Å---
A 413 LYS9.23-Favored (77.37%)
General / -67.9,-34.8
Favored (8.3%) tptt
chi angles: 198.1,66.2,191.4,155.5
0.12Å---
A 414 GLN9.45-Allowed (1.63%)
General / -58.1,112.8
Favored (77.9%) mt0
chi angles: 295.2,180.1,9.9
0.10Å---
A 415 ASN9.56-Favored (2.17%)
General / 54.3,63.4
Favored (50.4%) t0
chi angles: 186,63.2
0.15Å- OUTLIER(S)
worst is CA-CB-CG: 4.3 σ
-
A 416 ASN10.02-Favored (20.66%)
General / -111.6,157.2
OUTLIER (0.1%)
chi angles: 69.1,122.1
0.12Å---
A 417 ASN9.96-Favored (10.84%)
General / -70.4,116.5
Favored (66.9%) m-40
chi angles: 295.7,349.9
0.05Å- OUTLIER(S)
worst is CA-CB-CG: 7.6 σ
-
A 418 ASN10.28-Favored (44.32%)
General / -70.8,131.8
Favored (77%) m-40
chi angles: 282.7,349.9
0.12Å- OUTLIER(S)
worst is CA-CB-CG: 8.0 σ
-
A 419 ARG10.11-Favored (11.28%)
General / -63.5,120.2
Favored (37.3%) mmt-90
chi angles: 310.7,301.2,189,259.9
0.04Å---
A 420 LYS9.6-Favored (82.46%)
General / -68.2,-39.5
Favored (23.8%) mmtm
chi angles: 302.6,304.2,174.2,302.4
0.09Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 421 THR9.480.42Å
HG22 with A 422 SER N
Favored (20.7%)
General / -100.2,152.1
Favored (81.8%) m
chi angles: 302.3
0.06Å---
A 422 SER9.410.42Å
N with A 421 THR HG22
Favored (54.33%)
General / -65.8,135.1
Favored (67.7%) m
chi angles: 296.8
0.09Å---
A 423 ASN9.91-Favored (2.18%)
General / -126.2,-170.3
Favored (14.2%) m110
chi angles: 310,105.9
0.08Å- OUTLIER(S)
worst is CA-CB-CG: 7.7 σ
-
A 424 GLY10.05-Favored (12.25%)
Glycine / 107.0,145.3
-----
A 425 ASP10.09-Favored (81.1%)
General / -66.7,-44.7
Favored (40.5%) m-30
chi angles: 293.5,1.9
0.12Å---
A 426 ASP10.25-Favored (46.71%)
General / -71.6,148.3
Favored (61.4%) m-30
chi angles: 293.9,356.1
0.07Å- OUTLIER(S)
worst is CA-CB-CG: 5.0 σ
-
A 427 SER10.07-Favored (15.77%)
General / -162.1,172.5
Favored (70.4%) m
chi angles: 295
0.07Å---
A 428 LEU9.97-Favored (51.53%)
General / -116.8,138.4
Favored (13.1%) tp
chi angles: 195.5,64.3
0.09Å---
A 429 PHE9.3-Favored (19.66%)
General / -100.0,152.9
Favored (30.5%) m-80
chi angles: 277.8,270.2
0.09Å---
A 430 PHE9.14-Favored (34.87%)
General / -93.8,135.7
Favored (49.3%) t80
chi angles: 190.4,77
0.12Å- OUTLIER(S)
worst is CA-CB-CG: 8.2 σ
-
A 431 SER8.340.46Å
O with A 432 ASN HB2
Favored (2.58%)
General / -102.6,85.4
Favored (18.3%) t
chi angles: 169.6
0.16Å---
A 432 ASN7.430.46Å
HB2 with A 431 SER O
OUTLIER (0)%)
General / 162.0,128.0
Allowed (1.6%) t0
chi angles: 177.6,95.2
0.15Å---
A 433 PHE70.55Å
O with A 675 ALA HB2
Favored (52.1%)
General / -105.2,126.5
Favored (15.2%) t80
chi angles: 200.5,79.3
0.06Å- OUTLIER(S)
worst is CA-CB-CG: 4.7 σ
-
A 434 SER7.45-Allowed (0.06%)
General / -174.7,-154.9
Favored (65%) m
chi angles: 297.3
0.14Å---
A 435 LEU7.550.43Å
N with A 435 LEU HD12
Favored (14.44%)
General / -68.5,120.4
Allowed (1.8%) mp
chi angles: 295.6,67
0.12Å---
A 436 LEU7.24-Favored (32.31%)
General / -79.8,146.4
Allowed (1.1%) mm
chi angles: 290.6,306.7
0.14Å---
A 437 GLY6.92-Favored (30.33%)
Glycine / -96.5,-154.6
-----
A 438 THR6.53-OUTLIER (0.02)%)
Pre-Pro / -151.5,-53.9
Favored (88.5%) m
chi angles: 301.3
0.17Å- OUTLIER(S)
worst is CA-C-N: 5.4 σ
-
A 439 PRO267.70.66Å
HB2 with A 398 THR CG2
Favored (23.68%)
Trans-Pro / -78.8,166.2
Favored (16.4%) Cg_endo
chi angles: 17.9,331.3,29.1
0.29Å- OUTLIER(S)
worst is C-N-CA: 5.1 σ
-
A 440 VAL254.54-Favored (8.37%)
Ile or Val / -85.6,-34.2
Favored (2.2%) p
chi angles: 76.2
0.10Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 441 LEU259.69-Favored (3.58%)
General / -140.2,99.1
Favored (65.5%) mt
chi angles: 292.6,180.1
0.20Å---
A 442 LYS318.94-Favored (21.22%)
General / -105.8,153.9
Favored (43%) tttp
chi angles: 193.2,173.9,170.8,66.1
0.02Å---
A 443 ASP270.12-Allowed (0.96%)
General / 61.5,65.4
Favored (20.7%) t70
chi angles: 195.6,48.8
0.08Å---
A 444 ILE318.89-Favored (45.48%)
Ile or Val / -115.8,114.2
Favored (26.7%) mm
chi angles: 311.4,300.1
0.03Å---
A 445 ASN296.45-Favored (5.39%)
General / -156.9,124.4
Favored (6.5%) t0
chi angles: 201.8,295.7
0.01Å---
A 446 PHE294.98-Favored (18.88%)
General / -158.1,146.4
Favored (38.2%) p90
chi angles: 54.2,270.6
0.01Å---
A 447 LYS327.67-Favored (4.51%)
General / -133.1,99.2
Favored (97.5%) mttt
chi angles: 296.4,182.4,180,179.4
0.02Å---
A 448 ILE297.290.47Å
HD11 with A 454 LEU HD22
Favored (45.63%)
Ile or Val / -96.9,120.0
Favored (18.2%) mt
chi angles: 308.6,160.9
0.03Å---
A 449 GLU288.34-Favored (33.9%)
General / -78.1,149.2
Favored (73.3%) mt-10
chi angles: 298.8,184.4,328.8
0.03Å---
A 450 ARG327.67-Allowed (1.16%)
General / -63.7,107.3
Favored (7.6%) mtm180
chi angles: 286.3,221.1,302.7,172.2
0.04Å---
A 451 GLY293.98-Allowed (0.93%)
Glycine / 138.6,-47.4
-----
A 452 GLN327.67-Favored (30.96%)
General / -77.6,156.2
Favored (9.2%) mt0
chi angles: 284.6,194.5,125.2
0.07Å---
A 453 LEU266.98-Favored (42.39%)
General / -107.5,139.2
Favored (9.6%) tp
chi angles: 177.2,78
0.08Å---
A 454 LEU321.760.47Å
HD22 with A 448 ILE HD11
Favored (51.55%)
General / -106.3,125.9
Favored (32.1%) tp
chi angles: 178,53.2
0.02Å---
A 455 ALA307.72-Favored (39.76%)
General / -101.7,120.1
-0.03Å---
A 456 VAL327.67-Favored (54.5%)
Ile or Val / -113.4,134.9
Favored (37.9%) t
chi angles: 183.9
0.03Å---
A 457 ALA327.67-Favored (41.36%)
General / -154.9,161.7
-0.02Å---
A 458 GLY327.67-Favored (32.66%)
Glycine / 158.6,-162.8
-----
A 459 SER327.67-Favored (40.12%)
General / -76.5,138.3
Favored (36.7%) p
chi angles: 55.5
0.01Å---
A 460 THR327.67-Favored (54.07%)
General / -69.4,139.4
Favored (8.9%) t
chi angles: 191.6
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 461 GLY327.67-Favored (69.05%)
Glycine / 70.3,41.1
-----
A 462 ALA327.67-Favored (5.11%)
General / -130.7,19.7
-0.03Å---
A 463 GLY327.67-Favored (8.85%)
Glycine / 109.2,18.9
-----
A 464 LYS327.67-Favored (68.03%)
General / -66.5,-49.0
OUTLIER (0%)
chi angles: 290,292.6,111.8,274.1
0.09Å---
A 465 THR327.67-Favored (69.94%)
General / -71.2,-41.8
Favored (57.7%) m
chi angles: 303.7
0.07Å---
A 466 SER327.67-Favored (67.81%)
General / -65.5,-26.2
Favored (66.8%) m
chi angles: 297
0.08Å---
A 467 LEU327.390.43Å
O with A 470 VAL HG22
Favored (90.43%)
General / -64.2,-44.9
Favored (49.4%) tp
chi angles: 181.1,65.7
0.07Å---
A 468 LEU327.670.78Å
HD23 with A 570 LEU HB3
Favored (69.86%)
General / -70.7,-32.5
Favored (3.7%) mp
chi angles: 290.6,73.3
0.11Å---
A 469 MET327.670.44Å
HA with A 472 MET HE2
Favored (84.84%)
General / -64.5,-36.6
Favored (91.1%) mtp
chi angles: 294,183.1,71.6
0.08Å---
A 470 VAL315.220.43Å
HG22 with A 467 LEU O
Favored (50.39%)
Ile or Val / -67.2,-30.7
Favored (28.5%) m
chi angles: 300
0.14Å---
A 471 ILE327.67-Favored (98.55%)
Ile or Val / -63.7,-45.0
Favored (81%) mt
chi angles: 299.7,169
0.07Å---
A 472 MET322.370.44Å
HE2 with A 469 MET HA
Favored (81.74%)
General / -63.6,-35.8
Favored (70.4%) mtm
chi angles: 291.8,180.5,296.2
0.08Å---
A 473 GLY311.55-Favored (55.32%)
Glycine / 100.8,-0.6
-----
A 474 GLU313.850.47Å
HG3 with A 169 SER HB2
Favored (72.23%)
General / -66.1,-48.0
Favored (14.8%) tp30
chi angles: 194.2,58.5,52.7
0.06Å---
A 475 LEU308.130.40Å
HG with A 469 MET HE2
Favored (15.99%)
General / -103.9,105.7
Favored (40.8%) mt
chi angles: 289,180.2
0.12Å---
A 476 GLU299.82-Favored (89.74%)
Pre-Pro / -72.6,147.7
Favored (65.8%) mt-10
chi angles: 298.4,184.9,320.2
0.01Å---
A 477 PRO288.790.42Å
HA with A 399 ALA HB2
Favored (21.6%)
Trans-Pro / -78.0,144.8
Favored (51.6%) Cg_endo
chi angles: 32.9,324.6,23.7
0.06Å---
A 478 SER272.6-Favored (71.91%)
General / -71.3,-37.6
Favored (87.1%) p
chi angles: 69.6
0.01Å---
A 479 GLU270.13-Favored (40.38%)
General / -155.8,160.5
Favored (8.3%) pt0
chi angles: 55.2,169.8,22.5
0.04Å---
A 480 GLY261.52-Favored (20.52%)
Glycine / 129.9,-170.9
-----
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 481 LYS311.24-Favored (18.5%)
General / -137.8,122.3
Favored (92.9%) mttt
chi angles: 296.3,179.5,187,173.6
0.03Å---
A 482 ILE286.52-Favored (74.6%)
Ile or Val / -118.7,125.7
Favored (63.5%) mt
chi angles: 303.7,170.1
0.09Å---
A 483 LYS282.88-Favored (2.37%)
General / -137.3,88.7
Favored (87.7%) mttt
chi angles: 283.8,187.3,175.7,184.2
0.00Å---
A 484 HIS327.67-Favored (53.59%)
General / -124.9,136.3
Favored (56.8%) p-80
chi angles: 68.1,278.8
0.04Å---
A 485 SER327.67-Favored (15.87%)
General / -130.9,169.4
Favored (18.8%) p
chi angles: 52.6
0.02Å---
A 486 GLY327.67-Favored (30.87%)
Glycine / 96.3,155.7
-----
A 487 ARG327.67-Favored (56.71%)
General / -67.7,139.7
Favored (46.3%) ttm170
chi angles: 191.4,176.2,292.5,179.3
0.02Å---
A 488 ILE280.39-Favored (34.08%)
Ile or Val / -107.9,138.5
Favored (26.2%) mt
chi angles: 305.5,159.5
0.04Å---
A 489 SER288.47-Favored (45.97%)
General / -134.8,140.5
Favored (9%) t
chi angles: 191.9
0.01Å---
A 490 PHE294.13-Favored (51.19%)
General / -128.4,144.9
Favored (85.8%) t80
chi angles: 178.5,73.8
0.07Å---
A 491 CYS311.94-Favored (24.97%)
General / -125.8,118.2
Favored (58.6%) t
chi angles: 182.5
0.03Å---
A 492 SER317.09-Favored (18.94%)
General / -87.0,159.5
Favored (10.2%) t
chi angles: 190.7
0.01Å---
A 493 GLN327.67-Favored (21.67%)
General / -71.9,-51.6
Favored (4.3%) tt0
chi angles: 186.3,186.5,144.9
0.05Å---
A 494 PHE276.030.61Å
HE2 with A 734 ARG HD3
Favored (57.89%)
General / -64.7,137.6
Favored (48.9%) m-80
chi angles: 282.2,88.8
0.03Å---
A 495 SER301.18-Favored (15.44%)
General / -76.7,114.4
Favored (50.8%) p
chi angles: 56.5
0.02Å---
A 496 TRP305.73-Favored (26.56%)
General / -106.6,113.2
Favored (11.4%) t-100
chi angles: 165.1,232.9
0.02Å---
A 497 ILE301.97-Favored (19.64%)
Ile or Val / -134.5,115.3
Favored (24.5%) mm
chi angles: 302.1,291.5
0.03Å---
A 498 MET327.67-Favored (20.32%)
Pre-Pro / -78.5,169.5
Favored (4.1%) ptt
chi angles: 77.4,203.8,177.8
0.02Å---
A 499 PRO327.67-Favored (31%)
Trans-Pro / -65.9,132.7
Favored (52%) Cg_exo
chi angles: 336.7,34.3,328.6
0.04Å---
A 500 GLY325.01-Favored (22.09%)
Glycine / 128.6,-163.2
-----
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 501 THR316.39-Favored (28.08%)
General / -78.9,158.2
Favored (67.6%) p
chi angles: 58.6
0.01Å---
A 502 ILE327.67-Favored (39.16%)
Ile or Val / -66.3,-26.9
Allowed (0.9%) pp
chi angles: 65.2,100.9
0.09Å---
A 503 LYS318.51-Favored (86.33%)
General / -57.9,-45.4
Favored (23.9%) mmmt
chi angles: 293.4,293.8,298.2,196
0.03Å---
A 504 GLU327.67-Favored (83.57%)
General / -62.2,-37.0
Favored (55.9%) mm-30
chi angles: 292.7,288.7,312.6
0.03Å---
A 505 ASN302.11-Favored (84.67%)
General / -67.3,-38.2
Favored (68.4%) m-40
chi angles: 287.4,309.4
0.04Å---
A 506 ILE325.21-Favored (37.42%)
Ile or Val / -74.7,-47.8
Favored (46.7%) mt
chi angles: 298,158.3
0.06Å---
A 507 ILE297.340.47Å
HG13 with A 508 PHE H
Favored (6.43%)
Ile or Val / -73.3,-57.7
Favored (40.8%) pt
chi angles: 61.1,168.3
0.20Å---
A 508 PHE277.450.47Å
H with A 507 ILE HG13
Allowed (0.1%)
General / 44.6,75.9
Favored (10.4%) t80
chi angles: 199.6,61.3
0.07Å---
A 509 GLY301.15-Allowed (0.74%)
Glycine / 100.2,-59.0
-----
A 510 VAL327.67-Favored (6.19%)
Ile or Val / -77.1,149.6
Favored (49.1%) t
chi angles: 181.6
0.04Å---
A 511 SER327.67-Favored (19.84%)
General / -66.3,162.6
Favored (61.4%) p
chi angles: 57.9
0.02Å---
A 512 TYR322.37-Favored (31.93%)
General / -78.1,127.2
Favored (47.9%) t80
chi angles: 189.3,70.6
0.01Å---
A 513 ASP316.07-Favored (6.71%)
General / -131.2,103.8
Favored (69.6%) m-30
chi angles: 294.6,314.7
0.03Å---
A 514 GLU313.08-Favored (94.32%)
General / -65.2,-41.7
Favored (31%) tt0
chi angles: 192.5,170,32.9
0.03Å---
A 515 TYR279.38-Favored (88.26%)
General / -66.3,-38.7
Favored (27.7%) t80
chi angles: 196.1,79.4
0.02Å---
A 516 ARG327.67-Favored (69.16%)
General / -72.0,-39.3
Favored (81.6%) mtt180
chi angles: 296.6,194.9,173.7,183.4
0.02Å---
A 517 TYR310.74-Favored (74.93%)
General / -59.8,-35.6
Favored (41.3%) t80
chi angles: 191.6,270.6
0.01Å---
A 518 ARG327.67-Favored (96.98%)
General / -64.1,-42.3
Favored (75%) ttt180
chi angles: 191.2,179.1,177.9,181.6
0.01Å---
A 519 SER327.67-Favored (74.23%)
General / -70.5,-37.9
Favored (81.7%) p
chi angles: 62
0.04Å---
A 520 VAL327.67-Favored (78.94%)
Ile or Val / -65.5,-49.3
Favored (52.4%) t
chi angles: 169.7
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 521 ILE327.67-Favored (77.02%)
Ile or Val / -66.4,-36.3
Favored (2.2%) tp
chi angles: 202.9,80
0.14Å---
A 522 LYS327.67-Favored (97.68%)
General / -63.8,-42.1
Favored (49.4%) tttp
chi angles: 176.9,177.1,168.6,64.5
0.01Å---
A 523 ALA327.67-Favored (34.34%)
General / -66.1,-53.7
-0.02Å---
A 524 CYS327.67-Favored (59.88%)
General / -74.6,-20.6
Favored (13.5%) p
chi angles: 73.5
0.06Å---
A 525 GLN327.67-Allowed (1.03%)
General / 61.8,64.3
Favored (52.9%) mt0
chi angles: 303,189.7,344.8
0.09Å---
A 526 LEU327.67-Favored (13.76%)
General / -105.2,-19.6
Favored (3.7%) mp
chi angles: 261,58.1
0.04Å---
A 527 GLU316.79-Favored (13.93%)
General / -48.8,-35.1
Favored (14.2%) pt0
chi angles: 63.7,180.2,31.9
0.07Å---
A 528 GLU327.67-Favored (86.98%)
General / -65.0,-45.1
Favored (69.6%) mt-10
chi angles: 293.8,188.7,328.9
0.02Å---
A 529 ASP327.67-Favored (68.68%)
General / -69.2,-30.5
Favored (74.3%) m-30
chi angles: 297.5,316.5
0.03Å---
A 530 ILE327.67-Favored (69.48%)
Ile or Val / -70.6,-46.5
Favored (77.6%) mt
chi angles: 293.4,162.1
0.05Å---
A 531 SER327.67-Favored (65.84%)
General / -59.1,-27.7
Favored (97%) p
chi angles: 63.5
0.06Å---
A 532 LYS327.67-Favored (88.65%)
General / -61.8,-38.6
Favored (88.3%) mttt
chi angles: 290.6,168.9,185.7,175.5
0.03Å---
A 533 PHE327.670.64Å
CE1 with A 773 MET HG2
Favored (10.68%)
General / -85.0,68.8
Favored (68.9%) m-80
chi angles: 301.6,290.3
0.01Å---
A 534 ALA327.67-Favored (25.54%)
General / -50.9,-33.7
-0.06Å---
A 535 GLU327.67-Allowed (1.24%)
General / -70.8,-62.8
Favored (40.1%) tt0
chi angles: 188.8,170,33.2
0.03Å---
A 536 LYS327.67-Favored (6.73%)
General / -167.7,152.4
Favored (2.5%) tppp
chi angles: 189.4,61.2,69.4,64
0.01Å---
A 537 ASP320.89-Favored (4.87%)
General / -91.7,64.4
Favored (36.5%) p0
chi angles: 56.8,349.9
0.09Å---
A 538 ASN304.36-Favored (2.03%)
General / -125.6,48.6
Favored (81.9%) m-40
chi angles: 298.7,326.6
0.02Å---
A 539 ILE281.68-Favored (30.22%)
Ile or Val / -74.9,123.3
Favored (18.2%) tt
chi angles: 193.8,171
0.10Å---
A 540 VAL320.720.41Å
HG11 with A 766 ARG HG3
Allowed (1.68%)
Ile or Val / -79.9,92.0
Favored (63.2%) t
chi angles: 179.6
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 541 LEU327.67-Favored (24.68%)
General / -77.1,165.4
Favored (49.2%) mt
chi angles: 300.5,168.6
0.03Å---
A 542 GLY327.67-Favored (6.36%)
Glycine / -125.7,-145.1
-----
A 543 GLU327.67-Favored (40.96%)
General / -75.5,132.8
Favored (2.6%) tm-30
chi angles: 189.8,267.6,301.6
0.01Å---
A 544 GLY327.67-Favored (2.45%)
Glycine / 84.3,-74.8
-----
A 545 GLY327.67-Allowed (0.65%)
Glycine / 107.8,68.3
-----
A 546 ILE327.670.46Å
HG21 with A 762 GLN HE21
Favored (29.66%)
Ile or Val / -70.1,-26.4
Favored (30.9%) pt
chi angles: 61.8,164.3
0.11Å---
A 547 THR327.67-Favored (4.95%)
General / -72.3,-56.8
Favored (42.6%) p
chi angles: 55
0.02Å---
A 548 LEU327.67-Favored (35.46%)
General / -76.0,155.0
Favored (82.2%) mt
chi angles: 300.7,175.9
0.01Å---
A 549 SER321.65-Favored (32.02%)
General / -78.1,153.7
Favored (60.4%) p
chi angles: 57.8
0.01Å---
A 550 GLY312.32-Favored (57.85%)
Glycine / -56.4,-29.9
-----
A 551 GLY327.67-Favored (47.36%)
Glycine / -67.8,-49.7
-----
A 552 GLN327.67-Favored (73.21%)
General / -59.8,-34.5
Favored (50.2%) mt0
chi angles: 280.9,189,48.4
0.06Å---
A 553 ARG327.67-Favored (93.14%)
General / -65.2,-39.7
Favored (79.4%) mtm-85
chi angles: 298.6,202.7,300.6,282
0.03Å---
A 554 ALA327.67-Favored (78.67%)
General / -68.0,-35.7
-0.03Å---
A 555 ARG327.67-Favored (90.6%)
General / -65.9,-39.5
Favored (74.1%) mtt90
chi angles: 290,187.2,176.9,77.6
0.03Å---
A 556 ILE327.67-Favored (84.8%)
Ile or Val / -66.8,-40.0
Favored (37.9%) mt
chi angles: 292.7,155.6
0.06Å---
A 557 SER327.67-Favored (96.84%)
General / -61.4,-44.6
Favored (30.7%) m
chi angles: 302.9
0.01Å---
A 558 LEU327.67-Favored (95.13%)
General / -64.7,-42.8
Favored (43.6%) tp
chi angles: 185,61.4
0.01Å---
A 559 ALA320.39-Favored (94.75%)
General / -60.8,-45.4
-0.02Å---
A 560 ARG327.67-Favored (99.58%)
General / -62.6,-43.1
Favored (48.3%) ttp80
chi angles: 175,180,46.4,90.2
0.10Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 561 ALA320.92-Favored (75.12%)
General / -66.2,-47.0
-0.08Å---
A 562 VAL325.440.53Å
HG21 with A 594 LEU CD2
Favored (40.11%)
Ile or Val / -71.8,-31.1
Favored (8.7%) p
chi angles: 65.5
0.12Å---
A 563 TYR277.79-Favored (77.44%)
General / -56.6,-48.5
Favored (88.9%) t80
chi angles: 179.6,76.5
0.03Å---
A 564 LYS304.34-Favored (42.14%)
General / -74.0,148.3
Favored (75%) tttt
chi angles: 190.7,174.4,170.9,184.6
0.01Å---
A 565 ASP299.56-Favored (35.35%)
General / -81.4,132.8
Favored (20.6%) t70
chi angles: 181.6,46.2
0.03Å---
A 566 ALA311.18-Favored (13.16%)
General / -162.5,149.1
-0.02Å---
A 567 ASP294.95-Favored (40.25%)
General / -82.0,-19.5
Favored (74.7%) m-30
chi angles: 297.3,321.8
0.02Å---
A 568 LEU296.52-Favored (23.14%)
General / -135.0,123.3
Favored (12.6%) tp
chi angles: 193.5,71.5
0.02Å---
A 569 TYR281.73-Favored (52.52%)
General / -112.0,124.5
Favored (90.1%) m-80
chi angles: 293.8,281
0.15Å---
A 570 LEU311.50.78Å
HB3 with A 468 LEU HD23
Favored (54.7%)
General / -106.9,129.4
Favored (81.3%) mt
chi angles: 297.1,180.6
0.12Å---
A 571 LEU323.97-Favored (4.43%)
General / -121.2,94.7
Favored (59.6%) mt
chi angles: 298.9,168.7
0.03Å---
A 572 ASP327.670.58Å
HB2 with A 468 LEU HD22
Favored (11.67%)
General / -95.7,99.9
Favored (7.5%) t0
chi angles: 199.1,129.3
0.12Å---
A 573 SER327.67-Favored (5.33%)
Pre-Pro / 45.8,66.5
Favored (32%) t
chi angles: 183.3
0.07Å---
A 574 PRO316.91-Allowed (1.23%)
Trans-Pro / -71.1,-44.4
Favored (6.8%) Cg_exo
chi angles: 349.5,26.2,328.9
0.04Å---
A 575 PHE297.78-Favored (5.14%)
General / -92.5,71.5
Favored (73.9%) m-80
chi angles: 303.8,272
0.03Å---
A 576 GLY296.91-Allowed (0.6%)
Glycine / -107.2,-57.6
-----
A 577 TYR305.38-Favored (2.27%)
General / -95.6,61.2
Favored (65.5%) m-80
chi angles: 305,272.5
0.01Å---
A 578 LEU301.65-Favored (28.8%)
General / -145.3,141.7
Favored (79.3%) mt
chi angles: 295.8,169.4
0.04Å---
A 579 ASP327.67-Favored (45.59%)
General / -73.5,139.2
Favored (17.4%) p0
chi angles: 63,318.7
0.07Å---
A 580 VAL327.67-Favored (46.68%)
Ile or Val / -54.3,-40.1
Favored (32.3%) m
chi angles: 297.5
0.11Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 581 LEU327.67-Favored (15.48%)
General / -69.5,-54.2
Allowed (1.1%) tt
chi angles: 208,163.1
0.04Å---
A 582 THR327.67-Favored (68.85%)
General / -68.2,-29.9
Favored (2.8%) m
chi angles: 316.3
0.02Å---
A 583 GLU318.93-Favored (61.12%)
General / -63.9,-52.2
Favored (45.9%) tt0
chi angles: 183.9,185.5,319.5
0.01Å---
A 584 LYS322.68-Favored (86.76%)
General / -58.5,-42.1
Favored (28.9%) mmtt
chi angles: 284.3,276.1,167.9,178.6
0.05Å---
A 585 GLU321.06-Favored (94.5%)
General / -59.9,-44.2
Favored (94.3%) mt-10
chi angles: 289.3,177.1,5.2
0.03Å---
A 586 ILE318.1-Favored (48.81%)
Ile or Val / -73.6,-46.1
Favored (49.3%) mt
chi angles: 298.3,159.1
0.02Å---
A 587 PHE287.2-Favored (71.31%)
General / -59.4,-51.1
Favored (20.6%) t80
chi angles: 184.6,49.6
0.04Å---
A 588 GLU313.66-Favored (72.08%)
General / -68.1,-32.0
Favored (65.7%) mt-10
chi angles: 293.6,169.2,25.7
0.04Å---
A 589 SER298.81-Favored (9.2%)
General / -74.0,-53.9
Favored (76.2%) p
chi angles: 60.1
0.01Å---
A 590 CYS324.77-Favored (86.48%)
General / -61.1,-38.5
Favored (11.1%) p
chi angles: 74.8
0.05Å---
A 591 VAL327.67-Favored (74.65%)
Ile or Val / -57.3,-40.6
Favored (32%) t
chi angles: 165.4
0.09Å---
A 592 CYS327.67-Favored (52.26%)
General / -75.2,-43.5
Favored (83.4%) m
chi angles: 295.2
0.02Å---
A 593 LYS327.67-Favored (21.18%)
General / -74.6,-49.6
Favored (66.7%) mmtt
chi angles: 296.6,286,179.8,186.2
0.03Å---
A 594 LEU327.670.53Å
CD2 with A 562 VAL HG21
Favored (40.71%)
General / -72.8,-48.2
Favored (5.4%) mp
chi angles: 281.1,53.3
0.06Å---
A 595 MET327.67-Favored (2.89%)
General / -76.0,81.8
Allowed (1.5%) ttm
chi angles: 195.6,217.4,306.8
0.02Å---
A 596 ALA321.77-Favored (6.5%)
General / -80.6,-53.5
-0.02Å---
A 597 ASN322.87-Allowed (0.47%)
General / -156.3,47.7
Favored (5.5%) t0
chi angles: 197.8,243.6
0.04Å---
A 598 LYS305.97-Favored (47.38%)
General / -105.1,134.9
Favored (16.6%) mmtp
chi angles: 297.5,297.5,187.8,79.9
0.00Å---
A 599 THR309.02-Favored (19.77%)
General / -77.3,118.4
Favored (3.1%) m
chi angles: 315.9
0.02Å---
A 600 ARG327.67-Favored (50.71%)
General / -132.4,144.7
Favored (44.7%) mtp180
chi angles: 281.9,161.7,64.3,171.5
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 601 ILE327.67-Favored (43.81%)
Ile or Val / -130.4,118.6
Favored (31.3%) mt
chi angles: 308.2,179.7
0.01Å---
A 602 LEU312.72-Favored (54.28%)
General / -119.4,128.7
Favored (29.8%) tp
chi angles: 187.5,63.8
0.01Å---
A 603 VAL318.140.40Å
CG2 with A 468 LEU HD11
Favored (26.39%)
Ile or Val / -92.7,112.6
Favored (64.9%) t
chi angles: 179.4
0.03Å---
A 604 THR327.67-Favored (17.61%)
General / -156.7,173.0
Favored (11%) t
chi angles: 186.7
0.04Å---
A 605 SER327.67-Allowed (1.53%)
General / -141.3,55.9
Favored (44.5%) m
chi angles: 301.8
0.02Å---
A 606 LYS314.49-Favored (34.14%)
General / -125.8,121.7
Favored (13.9%) mmtp
chi angles: 297.2,285.1,159.7,64.3
0.02Å---
A 607 MET323.97-Favored (65.5%)
General / -71.3,-44.3
Allowed (1%) mpt
chi angles: 299.5,73.1,187.1
0.03Å---
A 608 GLU327.67-Favored (71.29%)
General / -54.4,-43.1
Favored (41.8%) tt0
chi angles: 189.1,170.9,32.5
0.01Å---
A 609 HIS327.67-Favored (87.96%)
General / -66.7,-39.1
Favored (73%) t70
chi angles: 188.2,67.8
0.02Å---
A 610 LEU312.19-Favored (90.04%)
General / -61.9,-38.9
Favored (3.7%) mp
chi angles: 264.8,69.2
0.06Å---
A 611 LYS327.67-Favored (85.38%)
General / -67.5,-40.4
Favored (96.1%) mttt
chi angles: 292.3,173.5,181.3,179
0.02Å---
A 612 LYS327.67-Favored (59.81%)
General / -79.8,-11.7
Favored (96.8%) mttt
chi angles: 289.7,180.3,178.3,181.4
0.05Å---
A 613 ALA327.67-Favored (21.46%)
General / -72.0,166.8
-0.02Å---
A 614 ASP322.48-Favored (9.91%)
General / -87.6,-46.0
Favored (56.9%) m-30
chi angles: 301.4,302.5
0.01Å---
A 615 LYS310.11-Favored (48.4%)
General / -135.9,148.2
OUTLIER (0%)
chi angles: 180,70.2,110.1,286.9
0.12Å---
A 616 ILE289.41-Favored (29.97%)
Ile or Val / -134.2,148.5
Favored (22.1%) mt
chi angles: 311.5,169.5
0.03Å---
A 617 LEU308.56-Favored (3.18%)
General / -143.9,98.1
Favored (18.4%) tp
chi angles: 175.2,51.4
0.02Å---
A 618 ILE321.21-Favored (44.77%)
Ile or Val / -93.0,127.9
Favored (32.8%) mt
chi angles: 310.2,172.9
0.02Å---
A 619 LEU327.67-Favored (20.36%)
General / -112.0,157.8
Favored (54.6%) mt
chi angles: 303.8,173
0.02Å---
A 620 HIS327.67-Allowed (1.82%)
General / -147.1,89.6
Favored (44.9%) t70
chi angles: 188.8,86.9
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 621 GLU309.99-Favored (11.41%)
General / 54.5,53.0
Favored (46.7%) mt-10
chi angles: 302.4,194.1,331.7
0.07Å---
A 622 GLY312.12-Favored (74.18%)
Glycine / 69.7,26.7
-----
A 623 SER292.29-Favored (5.52%)
General / -144.2,110.6
Favored (63.6%) m
chi angles: 297.6
0.02Å---
A 624 SER303.26-Favored (40.41%)
General / -75.5,146.7
Favored (34.1%) t
chi angles: 182
0.02Å---
A 625 TYR325.39-Allowed (1.22%)
General / -71.7,-63.0
Favored (87.2%) m-80
chi angles: 292.2,280.8
0.02Å---
A 626 PHE273.57-Favored (11.11%)
General / -154.2,177.4
Favored (29.2%) m-80
chi angles: 278,282.8
0.01Å---
A 627 TYR326.38-Favored (47.13%)
General / -119.0,143.3
Favored (64.1%) m-80
chi angles: 305.5,276.9
0.06Å---
A 628 GLY255.96-Favored (2.88%)
Glycine / 135.3,-122.7
-----
A 629 THR251.2-Favored (24.52%)
General / -127.4,163.2
Favored (64.2%) p
chi angles: 58
0.08Å---
A 630 PHE287.41-Favored (69.48%)
General / -59.4,-31.7
Favored (25.8%) t80
chi angles: 196.8,81.8
0.01Å---
A 631 SER321.25-Favored (96.05%)
General / -60.3,-42.7
Favored (29.6%) m
chi angles: 303.1
0.01Å---
A 632 GLU327.67-Favored (75.31%)
General / -69.5,-41.9
Favored (21.9%) mt-10
chi angles: 294.9,163.5,51.3
0.01Å---
A 633 LEU327.67-Favored (69.01%)
General / -54.1,-42.0
Favored (9.3%) tp
chi angles: 194.8,75.1
0.03Å---
A 634 GLN327.67-Favored (73.01%)
General / -60.4,-33.8
Favored (71.6%) mt0
chi angles: 285.9,184.4,48
0.05Å---
A 635 ASN286.81-Favored (8.72%)
General / -82.1,-50.8
Favored (4.4%) m110
chi angles: 297.9,53.8
0.01Å---
A 636 LEU327.67-Favored (59.42%)
General / -75.9,-36.3
Favored (22.5%) mt
chi angles: 296,160.2
0.04Å---
A 637 GLN303.39-Favored (55.56%)
Pre-Pro / -124.2,72.2
Favored (20.6%) mt0
chi angles: 297.5,169.9,233.5
0.03Å---
A 638 PRO327.67-Favored (5.47%)
Trans-Pro / -70.7,-38.6
Favored (59.1%) Cg_endo
chi angles: 26.4,327.6,25.2
0.03Å---
A 639 ASP327.67-Favored (79.5%)
General / -67.7,-43.7
Favored (69.6%) m-30
chi angles: 295.2,313.8
0.02Å---
A 640 PHE327.67-Favored (84.46%)
General / -65.1,-45.6
Favored (47.2%) t80
chi angles: 189.3,70
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 641 SER327.67-Favored (98.57%)
General / -62.2,-41.6
Favored (54.8%) m
chi angles: 300.2
0.01Å---
A 642 SER327.67-Favored (75.92%)
General / -69.0,-34.9
Favored (17.5%) t
chi angles: 186.8
0.02Å---
A 643 LYS327.67-Favored (71.9%)
General / -69.3,-44.4
Favored (49.5%) tptt
chi angles: 183.5,61,171.4,179.1
0.03Å---
A 644 LEU327.67-Favored (87.54%)
General / -66.8,-41.3
Favored (83%) mt
chi angles: 294.6,178.7
0.04Å---
A 645 MET327.67-Favored (2.95%)
General / -72.6,-59.0
Favored (96%) mtp
chi angles: 290.8,175.9,66.6
0.02Å---
A 646 GLY4.86-Favored (21.76%)
Glycine / 87.0,152.2
-----
A 647 CYS4.8-Favored (7.35%)
General / -160.0,-178.9
Favored (17.7%) p
chi angles: 71.3
0.09Å---
A 648 ASP4.95-Favored (3.26%)
General / -124.5,-31.3
Favored (18.5%) p0
chi angles: 62.6,320.4
0.07Å- OUTLIER(S)
worst is C-N-CA: 8.1 σ
-
A 649 SER4.95-Favored (26.63%)
General / -161.9,166.2
Favored (80.6%) p
chi angles: 61.6
0.40Å- OUTLIER(S)
worst is C-CA-CB: 5.2 σ
-
A 650 PHE4.720.43Å
HD2 with A 658 ARG NE
Favored (17.66%)
General / -107.1,157.7
Favored (20.1%) m-80
chi angles: 274.5,271.1
0.11Å---
A 651 ASP4.6-Favored (28.66%)
General / -66.7,-53.9
Favored (7.4%) t70
chi angles: 171.5,88
0.08Å---
A 652 GLN4.78-Favored (26.38%)
General / -90.4,143.8
Favored (15.6%) tp-100
chi angles: 176.8,59.4,262.1
0.06Å---
A 653 PHE4.65-Favored (4.92%)
General / -61.5,116.7
Favored (9.6%) t80
chi angles: 202,89.5
0.06Å---
A 654 SER4.63-Favored (20.48%)
General / -160.7,153.1
Favored (15.2%) t
chi angles: 168.7
0.13Å- OUTLIER(S)
worst is C-N-CA: 7.2 σ
-
A 655 ALA4.75-Favored (76.85%)
General / -69.5,-36.7
-0.09Å---
A 656 GLU4.690.41Å
HB2 with A 658 ARG HH21
Allowed (0.93%)
General / -37.0,127.2
Favored (2%) mt-10
chi angles: 307.2,147.3,79.3
0.16Å- OUTLIER(S)
worst is CB-CG-CD: 4.9 σ
-
A 657 ARG4.79-Favored (16.72%)
General / -63.3,122.7
Allowed (0.9%) pmt170
chi angles: 60.4,299.5,193.4,206.4
0.08Å---
A 658 ARG4.880.43Å
NE with A 650 PHE HD2
Favored (40.06%)
General / -155.1,159.2
Favored (2.8%) ptp-170
chi angles: 61,194.6,81.5,146.2
0.12Å---
A 659 ASN4.85-Favored (23.55%)
General / -160.7,155.2
Favored (3.8%) p0
chi angles: 63.8,99.4
0.10Å---
A 660 SER5.23-Favored (44.16%)
General / -113.0,143.5
Favored (46.7%) t
chi angles: 180
0.15Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 661 ILE5.49-Favored (79.3%)
Ile or Val / -62.6,-37.6
Favored (4.9%) tp
chi angles: 199.2,74.1
0.07Å---
A 662 LEU5.3-Favored (79.19%)
General / -58.1,-39.6
Favored (73.2%) mt
chi angles: 299.7,182.3
0.07Å---
A 663 THR5.17-Favored (10.54%)
General / -70.8,-54.7
Favored (16%) m
chi angles: 309.9
0.15Å---
A 664 GLU5.8-Favored (42.36%)
General / -153.7,161.2
Favored (8.1%) pt0
chi angles: 49.9,191.8,348.7
0.04Å---
A 665 THR5.960.53Å
O with A 665 THR HG23
Favored (16.81%)
General / -118.2,109.8
Favored (9.7%) t
chi angles: 185.5
0.09Å---
A 666 LEU5.62-Favored (22.31%)
General / -109.3,154.5
Favored (43%) mt
chi angles: 292.1,182.7
0.15Å---
A 667 HIS5.67-Favored (15.31%)
General / -96.0,103.4
Favored (42.2%) m-70
chi angles: 309.2,267.3
0.11Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.5 σ
-
A 668 ARG5.99-Favored (32.39%)
General / -143.9,145.6
Favored (2.3%) tpp-160
chi angles: 196.9,76.4,63.2,148.7
0.12Å---
A 669 PHE5.4-Favored (43.06%)
General / -137.1,159.0
Favored (9.8%) t80
chi angles: 203,81.4
0.09Å---
A 670 SER5.81-Favored (48.56%)
General / -72.5,142.6
Favored (80.1%) p
chi angles: 61.4
0.07Å- OUTLIER(S)
worst is C-N-CA: 4.5 σ
-
A 671 LEU7.39-Favored (4.08%)
General / -128.2,95.1
Favored (20.1%) tp
chi angles: 191.1,64.6
0.06Å---
A 672 GLU8.04-Favored (73.3%)
General / -70.5,-35.7
Favored (15.5%) mt-10
chi angles: 281.1,202.2,358.5
0.18Å---
A 673 GLY8.75-Favored (14.15%)
Glycine / 115.9,8.1
-----
A 674 ASP9.57-Favored (14.39%)
General / -86.2,168.0
Favored (15.2%) m-30
chi angles: 283.2,300.1
0.09Å- OUTLIER(S)
worst is CA-CB-CG: 6.5 σ
-
A 675 ALA10.010.55Å
HB2 with A 433 PHE O
Favored (26.61%)
Pre-Pro / -69.4,-44.7
-0.10Å- OUTLIER(S)
worst is CA-C-N: 5.7 σ
-
A 676 PRO10.54-Favored (65.57%)
Trans-Pro / -63.8,-18.8
Favored (2.1%) Cg_endo
chi angles: 5.9,336.6,32.7
0.28Å---
A 677 VAL10.550.51Å
O with A 677 VAL HG23
Favored (18.87%)
Ile or Val / -70.2,120.9
Favored (18.8%) m
chi angles: 293.7
0.07Å---
A 678 SER10.94-Favored (35.86%)
General / -113.7,148.8
Favored (14.2%) t
chi angles: 168.2
0.16Å---
A 679 TRP11.53-Favored (14.25%)
General / -132.1,114.2
Favored (6.8%) t60
chi angles: 187.6,347.1
0.09Å- OUTLIER(S)
worst is CB-CG-CD2: 4.1 σ
-
A 680 THR11.85-Favored (47.76%)
General / -114.2,141.3
Favored (38.7%) p
chi angles: 68
0.19Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 681 GLU12.83-Favored (17.95%)
General / -103.8,107.2
Favored (42.1%) mm-30
chi angles: 291.4,284.7,9.6
0.12Å---
A 682 THR13.47-Favored (10.4%)
General / -142.3,174.7
Favored (46.8%) p
chi angles: 66.2
0.25Å---
A 683 LYS13.24-Favored (17.33%)
General / -69.5,121.6
Favored (30.6%) mttp
chi angles: 296.6,169.8,180,82
0.11Å---
A 684 LYS12.79-Favored (21.57%)
General / -94.1,149.1
Allowed (1.9%) mptt
chi angles: 276.5,87.3,180,202.1
0.15Å---
A 685 GLN13.59-Favored (12.81%)
General / -98.5,163.1
Favored (7%) tt0
chi angles: 189,200.5,284
0.16Å---
A 686 SER14.23-Favored (13.74%)
General / -93.1,163.2
Favored (59.2%) m
chi angles: 293.5
0.11Å---
A 687 PHE14.28-Favored (21.86%)
General / -110.0,155.4
Favored (33.7%) p90
chi angles: 55.1,274.5
0.10Å---
A 688 LYS14.53-Favored (39.46%)
General / -76.1,131.5
Allowed (0.4%) mtpm
chi angles: 295.5,158.3,99.4,262.9
0.14Å---
A 689 GLN15.3-Favored (5.04%)
General / -114.5,176.5
Favored (7.1%) mt0
chi angles: 285.4,188.3,198.4
0.11Å---
A 690 THR15.18-Favored (7.06%)
General / -90.9,175.2
Favored (4.3%) p
chi angles: 79.7
0.24Å---
A 691 GLY15.14-Favored (36.38%)
Glycine / -95.7,-172.8
-----
A 692 GLU15.59-Favored (4.76%)
General / -95.7,87.7
Favored (79.4%) tt0
chi angles: 189.1,180.1,10.8
0.08Å---
A 693 PHE16.77-Favored (26.14%)
General / -129.7,121.0
Favored (26.6%) t80
chi angles: 196.1,87.4
0.06Å---
A 694 GLY16.77-Allowed (0.89%)
Glycine / -137.6,112.2
-----
A 695 GLU15.810.41Å
HG2 with A 696 LYS H
Allowed (0.93%)
General / -127.0,-159.5
Favored (2.5%) tt0
chi angles: 210.3,198,317.4
0.05Å---
A 696 LYS16.260.41Å
H with A 695 GLU HG2
Favored (10.61%)
General / -84.2,174.0
Favored (3.4%) pttt
chi angles: 53,158,193.4,150.9
0.17Å---
A 697 ARG17.12-Favored (20.28%)
General / -85.2,158.6
Favored (24.3%) ttm170
chi angles: 180,165.1,276.3,156.9
0.03Å- OUTLIER(S)
worst is C-N-CA: 5.0 σ
-
A 698 LYS16.87-Allowed (0.11%)
General / 51.7,79.1
Favored (3.3%) ptpt
chi angles: 63.2,168.1,69.5,203.1
0.34Å---
A 699 ASN16.67-Favored (22.45%)
General / -118.2,159.9
Favored (13.9%) t0
chi angles: 196.6,288.4
0.11Å---
A 700 SER17.33-Favored (12.36%)
General / -64.7,120.4
Favored (61.2%) m
chi angles: 298.7
0.12Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 701 ILE17.670.45Å
HG22 with A 702 LEU N
Favored (18.31%)
Ile or Val / -116.6,152.3
Favored (63.8%) mt
chi angles: 303.2,168.4
0.05Å---
A 702 LEU17.510.45Å
N with A 701 ILE HG22
Favored (2.6%)
General / -87.0,-169.4
Allowed (0.6%) mm
chi angles: 291.4,293.7
0.18Å---
A 703 ASN17.4-Favored (58.45%)
Pre-Pro / -88.9,126.7
Allowed (1.6%) m110
chi angles: 319.7,87.2
0.26Å- OUTLIER(S)
worst is CA-CB-CG: 7.4 σ
-
A 704 PRO17.91-Favored (4.8%)
Trans-Pro / -70.7,116.8
Favored (92%) Cg_exo
chi angles: 333.1,28.7,339.6
0.16Å---
A 705 ILE18.070.58Å
O with A 705 ILE HG13
Favored (18.12%)
Ile or Val / -143.0,130.0
Favored (37.2%) pt
chi angles: 60.7,166.9
0.09Å---
A 706 ASN17.67-Allowed (0.3%)
General / -55.1,107.4
Favored (6%) t0
chi angles: 167.9,73.5
0.05Å---
A 707 SER17.49-Allowed (0.19%)
General / -175.3,-165.7
Favored (78.5%) p
chi angles: 60.7
0.20Å---
A 708 ILE18.010.55Å
O with A 708 ILE HG23
Favored (23.22%)
Ile or Val / -108.5,107.6
Favored (13.9%) tt
chi angles: 180,168.5
0.03Å---
A 709 ARG17.87-Favored (28.14%)
General / -147.2,143.4
Favored (83.7%) mtt180
chi angles: 282.7,180,167.8,182.1
0.12Å---
A 710 LYS17.390.59Å
HE3 with A 711 PHE CE2
Favored (33.48%)
General / -77.0,127.9
Favored (10.4%) ttpt
chi angles: 187.3,179.9,94.4,157.5
0.13Å---
A 711 PHE17.850.59Å
CE2 with A 710 LYS HE3
OUTLIER (0.02)%)
General / 98.2,150.9
Favored (54.9%) m-80
chi angles: 285.2,284.4
0.19Å- OUTLIER(S)
worst is N-CA-CB: 4.5 σ
-
A 712 SER18.81-Allowed (0.21%)
General / 76.0,158.9
Favored (46.7%) t
chi angles: 180
0.15Å---
A 713 ILE19.38-Favored (10.14%)
Ile or Val / -110.1,159.0
Favored (32.3%) pt
chi angles: 59.2,165.8
0.07Å---
A 714 VAL20.530.52Å
O with A 714 VAL HG13
Allowed (0.13%)
Ile or Val / -55.5,106.5
Favored (7.8%) p
chi angles: 60.8
0.05Å---
A 715 GLN21.81-Favored (12%)
General / -137.8,116.3
Favored (17.3%) mt0
chi angles: 286.5,159.1,95.9
0.15Å---
A 716 LYS22.74-Favored (3.82%)
General / -145.8,104.0
Favored (9%) tptt
chi angles: 198.1,67.1,197.3,162
0.12Å---
A 717 THR22.65-Favored (38.06%)
Pre-Pro / -123.2,101.4
Favored (64%) p
chi angles: 58
0.07Å---
A 718 PRO21.99-Favored (26.9%)
Trans-Pro / -72.6,-12.6
Favored (84.5%) Cg_exo
chi angles: 334.1,29.3,337.6
0.15Å---
A 719 LEU21.490.43Å
HB3 with A 720 GLN H
Allowed (0.85%)
General / -106.2,-162.2
Allowed (0.6%) mm
chi angles: 293.6,296.6
0.11Å- OUTLIER(S)
worst is C-N-CA: 4.0 σ
-
A 720 GLN22.650.65Å
HE22 with A 728 SER H
Favored (4.52%)
General / -82.6,-173.2
Favored (3.7%) mt0
chi angles: 315.8,153.1,15.1
0.34Å- OUTLIER(S)
worst is CB-CG-CD: 6.4 σ
-
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 721 MET23.380.47Å
HE3 with A 735 ARG HD2
Allowed (0.1%)
General / -66.3,84.8
Favored (42%) ttp
chi angles: 175,192.5,69.9
0.20Å---
A 722 ASN22.440.54Å
HD21 with A 735 ARG HB3
Favored (20.41%)
General / -164.7,166.1
Allowed (1%) m110
chi angles: 268.9,96.9
0.21Å---
A 723 GLY22.270.53Å
O with A 724 ILE HB
Favored (2.12%)
Glycine / -130.9,117.1
-----
A 724 ILE23.470.53Å
HB with A 723 GLY O
OUTLIER (0.01)%)
Ile or Val / 93.6,138.7
Favored (28.9%) mm
chi angles: 292.3,297.4
0.13Å---
A 725 GLU23.72-OUTLIER (0.04)%)
General / -50.6,101.9
Favored (94.9%) mt-10
chi angles: 295.8,175.6,345.4
0.08Å---
A 726 GLU22.98-Favored (9.29%)
General / -135.9,111.5
OUTLIER (0%)
chi angles: 176.8,255.6,67
0.17Å---
A 727 ASP23.630.45Å
HA with A 720 GLN NE2
Favored (10.43%)
General / -115.4,103.1
Favored (15.6%) m-30
chi angles: 270.4,357.2
0.23Å- OUTLIER(S)
worst is CA-CB-CG: 8.7 σ
-
A 728 SER24.550.65Å
H with A 720 GLN HE22
Favored (10.56%)
General / -163.7,148.3
Favored (65.3%) m
chi angles: 294.3
0.04Å---
A 729 ASP24.25-OUTLIER (0.01)%)
General / 171.3,-42.3
Favored (4.4%) m-30
chi angles: 276.4,291.6
0.15Å- OUTLIER(S)
worst is N-CA-CB: 4.3 σ
-
A 730 GLU23.880.48Å
OE1 with A 731 PRO HD3
Favored (11.94%)
Pre-Pro / -71.5,-48.8
Favored (17.6%) tm-30
chi angles: 187,281,321.6
0.10Å- OUTLIER(S)
worst is CA-C-N: 4.1 σ
-
A 731 PRO24.580.48Å
HD3 with A 730 GLU OE1
Favored (6.69%)
Trans-Pro / -88.2,149.3
Favored (27.6%) Cg_endo
chi angles: 20.9,331.2,26.9
0.04Å- OUTLIER(S)
worst is N-CA-C: 4.7 σ
-
A 732 LEU24.670.45Å
HD23 with A 494 PHE CD2
Allowed (1.63%)
General / -109.8,82.7
Favored (3.5%) mp
chi angles: 293.6,79.5
0.14Å---
A 733 GLU23.28-Favored (14.3%)
General / -123.3,109.7
Favored (23.9%) mp0
chi angles: 305.3,96.2,347.4
0.25Å- OUTLIER(S)
worst is C-N-CA: 7.4 σ
-
A 734 ARG22.980.61Å
HD3 with A 494 PHE HE2
Allowed (1.79%)
General / -130.6,-167.2
Favored (7%) mtp180
chi angles: 280.7,172.2,32.8,177.7
0.17Å---
A 735 ARG21.860.54Å
HB3 with A 722 ASN HD21
OUTLIER (0.02)%)
General / -62.4,72.4
Allowed (0.4%) ptp-170
chi angles: 56.2,233.1,69.2,169.6
0.07Å---
A 736 LEU21.55-Allowed (0.6%)
General / -106.4,-77.0
Favored (6.8%) mp
chi angles: 277.3,68.7
0.12Å---
A 737 SER20.46-Favored (17.28%)
General / -87.5,162.3
Favored (74.7%) p
chi angles: 71.4
0.37Å- OUTLIER(S)
worst is C-CA-CB: 5.6 σ
-
A 738 LEU20.41-Favored (52.21%)
General / -110.9,124.5
Favored (35.9%) mt
chi angles: 285.6,176.9
0.12Å---
A 739 VAL19.370.52Å
O with A 739 VAL HG23
Favored (23.98%)
Pre-Pro / -126.2,111.5
Favored (15.5%) m
chi angles: 292.3
0.05Å---
A 740 PRO19.17-Allowed (1.22%)
Trans-Pro / -95.5,172.2
Favored (19.1%) Cg_endo
chi angles: 18.9,331.3,28.5
0.14Å- OUTLIER(S)
worst is C-N-CA: 5.4 σ
-
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 741 ASP18.64-Allowed (0.07%)
General / 74.2,97.6
Favored (3.7%) t0
chi angles: 204.2,307.2
0.17Å---
A 742 SER17.88-OUTLIER (0.04)%)
General / 167.7,159.9
Favored (39.7%) p
chi angles: 76.3
0.32Å- OUTLIER(S)
worst is C-CA-CB: 5.2 σ
-
A 743 GLU17.98-Favored (5.26%)
General / -71.2,-56.8
Favored (83.1%) tt0
chi angles: 180.1,170.1,354.9
0.07Å---
A 744 GLN17.8-Favored (37.67%)
General / -111.6,146.3
Favored (28.9%) mt0
chi angles: 281.4,177.5,97.7
0.12Å---
A 745 GLY16.99-Favored (25.34%)
Glycine / -61.4,121.2
-----
A 746 GLU16.7-Favored (23.02%)
General / -103.0,151.0
Favored (71.1%) tt0
chi angles: 190.7,172.2,349.2
0.06Å---
A 747 ALA16.53-Allowed (0.65%)
General / -163.4,-161.2
-0.13Å---
A 748 ILE16.490.78Å
HG23 with A 749 LEU HD12
Favored (93.29%)
Ile or Val / -63.7,-46.9
Favored (4.5%) tp
chi angles: 180.1,66.8
0.03Å- OUTLIER(S)
worst is C-N-CA: 4.1 σ
-
A 749 LEU15.710.78Å
HD12 with A 748 ILE HG23
Favored (92.43%)
Pre-Pro / -60.5,138.8
Favored (7.7%) mp
chi angles: 279.9,62
0.10Å---
A 750 PRO14.87-Favored (25.03%)
Trans-Pro / -71.8,-9.6
Favored (10.6%) Cg_endo
chi angles: 15.6,332,30.4
0.32Å- OUTLIER(S)
worst is N-CA-C: 5.9 σ
-
A 751 ARG14.62-Favored (2.92%)
General / -72.2,102.0
Favored (40.1%) ttt-90
chi angles: 182.1,198.2,182.8,271.8
0.15Å---
A 752 ILE13.770.60Å
O with A 752 ILE HG13
Favored (44.96%)
Ile or Val / -122.2,115.0
Favored (29%) pt
chi angles: 56.4,166.8
0.04Å---
A 753 SER13.9-Allowed (0.77%)
General / -173.4,-172.2
Favored (74.8%) p
chi angles: 71.3
0.20Å---
A 754 VAL13.69-Allowed (1.79%)
Ile or Val / -97.4,167.2
Favored (17.4%) m
chi angles: 293.2
0.09Å---
A 755 ILE14.25-Favored (42.11%)
Ile or Val / -121.3,114.1
Favored (17%) mt
chi angles: 309.8,162.3
0.08Å---
A 756 SER14.66-Favored (17.88%)
General / -116.7,162.3
Favored (50.7%) p
chi angles: 74.4
0.35Å- OUTLIER(S)
worst is C-CA-CB: 5.7 σ
-
A 757 THR15.22-Favored (13.89%)
General / -89.2,166.3
Favored (6.2%) t
chi angles: 181.6
0.09Å---
A 758 GLY15.57-Favored (32.54%)
Glycine / 91.8,-169.5
-----
A 759 PRO15.190.46Å
O with A 790 SER HB2
Allowed (1.68%)
Trans-Pro / -62.1,112.9
Favored (90.6%) Cg_exo
chi angles: 331,28.1,343
0.11Å---
A 760 THR14.210.73Å
HG22 with A 761 LEU H
Favored (2.85%)
General / -123.2,-174.0
Favored (52.3%) m
chi angles: 304.1
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 761 LEU13.640.73Å
H with A 760 THR HG22
Favored (68.23%)
General / -56.4,-35.8
Favored (82%) mt
chi angles: 296.5,180
0.11Å- OUTLIER(S)
worst is C-N-CA: 5.4 σ
-
A 762 GLN13.340.46Å
HE21 with A 546 ILE HG21
Favored (82.17%)
General / -66.8,-36.3
Allowed (0.4%) mp10
chi angles: 288,79.3,282
0.06Å---
A 763 ALA12.82-Favored (37.71%)
General / -137.7,136.8
-0.12Å---
A 764 ARG12.26-Favored (45.31%)
General / -113.8,121.9
Favored (5%) ttm-80
chi angles: 171.2,203.7,272.7,261.9
0.18Å---
A 765 ARG11.68-Favored (48.11%)
General / -71.9,138.4
Favored (8.2%) mtp180
chi angles: 279.2,179.9,46.6,155.1
0.12Å---
A 766 ARG11.250.48Å
HG3 with A 766 ARG O
Favored (2.29%)
General / -137.1,87.6
Allowed (0.9%) ptm-80
chi angles: 49.6,147.2,273.3,260.2
0.08Å---
A 767 GLN11-Favored (48.91%)
General / -136.9,151.3
Favored (16.9%) mt0
chi angles: 294.4,180.1,186.3
0.18Å---
A 768 SER10.38-Favored (45.04%)
General / -76.8,-41.3
Favored (29.8%) t
chi angles: 172.7
0.11Å---
A 769 VAL9.890.43Å
HG22 with A 770 LEU N
Favored (3.5%)
Ile or Val / -89.9,151.4
Favored (9.2%) p
chi angles: 61.8
0.07Å---
A 770 LEU9.890.43Å
N with A 769 VAL HG22
Favored (96.92%)
General / -63.0,-44.0
Favored (36.3%) tp
chi angles: 180.8,68.8
0.09Å---
A 771 ASN9.57-Favored (16.56%)
General / -112.4,161.6
Favored (3.3%) m110
chi angles: 307,58.1
0.10Å---
A 772 LEU8.93-Favored (87.01%)
General / -66.7,-38.5
Favored (4.6%) mp
chi angles: 281.6,74.7
0.17Å---
A 773 MET9.10.64Å
HG2 with A 533 PHE CE1
Favored (36.41%)
General / -121.7,121.0
Favored (75.3%) mtp
chi angles: 296.5,165,63
0.07Å---
A 774 THR9.54-Favored (9.77%)
General / -60.5,120.3
Favored (81.9%) m
chi angles: 302.3
0.05Å---
A 775 HIS8.90.48Å
HB2 with A 785 ARG HH12
Favored (15.68%)
General / -124.1,111.2
Favored (20.9%) m170
chi angles: 292,132.5
0.05Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.2 σ
-
A 776 SER8.81-Allowed (0.91%)
General / -69.1,-64.2
Favored (22.2%) t
chi angles: 170.8
0.10Å---
A 777 VAL8.94-Favored (14.66%)
Ile or Val / -68.1,144.1
Favored (31.1%) m
chi angles: 296.9
0.06Å---
A 778 ASN8.77-Favored (15.37%)
General / -118.2,164.3
Favored (22.3%) m-40
chi angles: 284.6,13.4
0.07Å---
A 779 GLN8.64-Favored (36.48%)
General / -98.5,137.9
Allowed (0.8%) pm20
chi angles: 66.8,287.3,73.3
0.06Å---
A 780 GLY8.92-Favored (3.9%)
Glycine / 94.7,123.3
-----
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 781 GLN9.120.42Å
OE1 with A 782 ASN ND2
Favored (3.99%)
General / -72.4,-57.7
Allowed (1%) mp10
chi angles: 317.5,104.1,15
0.22Å- OUTLIER(S)
worst is CB-CG-CD: 4.4 σ
-
A 782 ASN9.350.42Å
ND2 with A 781 GLN OE1
Favored (22.29%)
General / -73.3,-50.4
Allowed (1.1%) m-40
chi angles: 292.5,244.9
0.10Å- OUTLIER(S)
worst is CA-CB-CG: 5.3 σ
-
A 783 ILE9.26-Favored (61.46%)
Ile or Val / -115.2,133.4
Favored (67.4%) mt
chi angles: 302.9,170.2
0.12Å---
A 784 HIS9.39-Allowed (1.13%)
General / -108.0,-166.4
Favored (22.1%) m-70
chi angles: 283.1,244.4
0.12Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.5 σ
-
A 785 ARG9.660.48Å
HH12 with A 775 HIS HB2
Favored (12.68%)
General / -70.5,117.9
OUTLIER (0.1%)
chi angles: 59.5,255.1,193.4,143.9
0.15Å- OUTLIER(S)
worst is C-N-CA: 4.1 σ
-
A 786 LYS10.08-Favored (6.34%)
General / -151.9,120.2
OUTLIER (0%)
chi angles: 49.2,86.1,237.6,124.9
0.12Å---
A 787 THR9.950.62Å
HG22 with A 789 ALA O
Favored (29.55%)
General / -133.5,125.7
Favored (83.2%) m
chi angles: 302.1
0.08Å---
A 788 THR9.97-Favored (83.59%)
General / -57.3,-46.0
Favored (51.7%) p
chi angles: 65.4
0.08Å---
A 789 ALA10.140.62Å
O with A 787 THR HG22
Favored (2.81%)
General / -163.0,-171.8
-0.10Å---
A 790 SER9.970.46Å
HB2 with A 759 PRO O
Favored (16.47%)
General / -63.1,-10.8
Favored (46.6%) t
chi angles: 180
0.15Å- OUTLIER(S)
worst is C-N-CA: 4.8 σ
-
A 791 THR9.880.86Å
HG23 with A 967 LEU HA
Favored (55.39%)
General / -113.0,132.4
Favored (88.6%) m
chi angles: 298.4
0.21Å---
A 792 ARG9.730.41Å
HE with A 966 THR HG21
Favored (13.25%)
General / -77.5,111.5
Favored (17.5%) mtm180
chi angles: 281.6,195.8,282.9,196.7
0.17Å---
A 793 LYS9.790.44Å
O with A 791 THR HG22
OUTLIER (0.03)%)
General / 90.9,144.2
Favored (34%) mtmt
chi angles: 298.3,181.4,302.4,172.6
0.20Å- OUTLIER(S)
worst is N-CA-CB: 4.1 σ
-
A 794 VAL90.57Å
HG22 with A 795 SER H
OUTLIER (0.05)%)
Ile or Val / -179.1,171.1
Favored (5.5%) p
chi angles: 57.4
0.14Å- OUTLIER(S)
worst is C-N-CA: 4.4 σ
-
A 795 SER9.060.57Å
H with A 794 VAL HG22
Favored (54.86%)
General / -111.3,131.8
Favored (57%) m
chi angles: 293
0.16Å---
A 796 LEU8.530.48Å
O with A 797 ALA HB2
Allowed (0.47%)
General / -126.6,-93.9
Favored (8.7%) mt
chi angles: 279.4,183.8
0.38Å OUTLIER(S)
worst is C--N: 6.7 σ
OUTLIER(S)
worst is N-CA-CB: 6.8 σ
-
A 797 ALA8.321.27Å
O with A 838 GLU HA
Favored (12.48%)
Pre-Pro / -147.1,137.6
-1.22Å OUTLIER(S)
worst is CA--C: 8.4 σ
OUTLIER(S)
worst is N-CA-C: 8.7 σ
-
A 798 PRO8.121.43Å
C with A 799 GLN N
Favored (26.69%)
Trans-Pro / -66.5,131.6
OUTLIER (0.1%)
chi angles: 320.2,357,45.1
0.51Å OUTLIER(S)
worst is C--N: 27.8 σ
OUTLIER(S)
worst is CA-N-CD: 20.3 σ
-
A 799 GLN7.531.43Å
N with A 798 PRO C
OUTLIER (0.02)%)
General / 178.4,-158.6
Favored (4.2%) mt0
chi angles: 262.5,172.8,13.3
0.62Å OUTLIER(S)
worst is N--CA: 9.1 σ
OUTLIER(S)
worst is C-N-CA: 10.7 σ
-
A 800 ALA7.660.59Å
HB2 with A 844 THR HA
Allowed (0.24%)
General / -103.0,-110.2
-0.09Å OUTLIER(S)
worst is C--N: 6.1 σ
OUTLIER(S)
worst is C-N-CA: 11.3 σ
-
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 801 ASN7.640.65Å
HB3 with A1035 GLN NE2
OUTLIER (0.02)%)
General / -49.4,98.8
Favored (4.7%) t0
chi angles: 166.4,70.6
0.18Å- OUTLIER(S)
worst is CA-CB-CG: 7.8 σ
-
A 802 LEU7.330.59Å
HG with A 801 ASN O
Favored (7.23%)
General / -170.5,160.1
Favored (9%) mt
chi angles: 278.4,182.2
0.28Å- OUTLIER(S)
worst is N-CA-CB: 5.9 σ
-
A 803 THR7.92-Favored (14.74%)
General / -69.7,120.0
Favored (72.8%) m
chi angles: 302.9
0.10Å---
A 804 GLU8.25-Favored (13.42%)
General / -92.8,164.2
Favored (24.2%) mm-30
chi angles: 278.6,289.6,354.1
0.17Å---
A 805 LEU8.110.42Å
HD23 with A 810 ARG HH21
Favored (17.83%)
General / -89.5,158.1
Allowed (0.4%) mm
chi angles: 293.2,293.8
0.13Å---
A 806 ASP8.86-Favored (8.28%)
General / -72.2,-54.9
Favored (18.4%) t70
chi angles: 179.8,87.9
0.09Å---
A 807 ILE8.76-Favored (28.93%)
Ile or Val / -100.3,137.1
Favored (38.3%) pt
chi angles: 58.8,169.2
0.05Å---
A 808 TYR9.26-Favored (15.8%)
General / -112.1,107.0
Allowed (1%) t80
chi angles: 212.7,288.6
0.16Å---
A 809 SER9.41-Allowed (0.97%)
General / -164.8,110.5
Favored (59.1%) m
chi angles: 293.5
0.10Å---
A 810 ARG9.480.42Å
HH21 with A 805 LEU HD23
Favored (19.13%)
General / -128.6,116.1
Favored (36.7%) mtt90
chi angles: 309,185,197.5,88.8
0.17Å---
A 811 ARG9.480.58Å
NH2 with A 828 ASP HB3
Favored (3.39%)
General / -109.2,90.7
Favored (33.1%) ttm170
chi angles: 191.2,188.1,305.6,163.2
0.10Å---
A 812 LEU8.98-Allowed (0.06%)
General / -53.5,103.0
Favored (84.5%) mt
chi angles: 298.9,179.6
0.07Å---
A 813 SER9.350.43Å
HB3 with A 815 GLU OE1
Allowed (0.13%)
General / 173.0,167.5
Favored (9.8%) t
chi angles: 166.3
0.14Å---
A 814 GLN9.86-Favored (2.02%)
General / -103.1,81.9
OUTLIER (0%)
chi angles: 272.9,249.7,234.6
0.14Å---
A 815 GLU9.740.54Å
OE2 with A 811 ARG HD2
Favored (9.86%)
General / -103.2,100.0
Allowed (0.9%) mp0
chi angles: 288.6,100.5,283.6
0.13Å---
A 816 THR8.55-Favored (39.11%)
General / -138.2,138.9
Favored (76.1%) p
chi angles: 61.1
0.23Å---
A 817 GLY8.32-Favored (34.63%)
Glycine / 49.2,45.3
-----
A 818 LEU8.1-Favored (3.36%)
General / -74.8,97.7
Favored (59.5%) mt
chi angles: 291.6,180
0.12Å---
A 819 GLU8.11-Favored (11.57%)
General / -77.0,-51.2
Favored (23.1%) tt0
chi angles: 180.2,190,289.8
0.09Å---
A 820 ILE8.16-Favored (82.82%)
Ile or Val / -67.4,-46.8
Favored (48.7%) mm
chi angles: 301.5,300.1
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 821 SER8.26-Favored (17.19%)
General / -113.0,161.3
Favored (9.7%) p
chi angles: 82.4
0.20Å---
A 822 GLU8.52-Favored (22.34%)
General / -98.6,149.8
Favored (99.5%) mt-10
chi angles: 291.5,179.9,351.6
0.13Å---
A 823 GLU8.690.43Å
HB3 with A 825 ASN O
Favored (49.4%)
General / -72.0,141.7
Allowed (1.2%) mm-30
chi angles: 261.8,274.1,344.5
0.12Å- OUTLIER(S)
worst is CB-CG-CD: 4.6 σ
-
A 824 ILE9.32-Favored (84.17%)
Ile or Val / -68.3,-44.0
Favored (47.1%) mm
chi angles: 299.8,299.4
0.05Å---
A 825 ASN9.980.43Å
O with A 823 GLU HB3
Favored (6.98%)
General / -107.4,172.2
Favored (20.9%) m-40
chi angles: 278.8,10.8
0.08Å- OUTLIER(S)
worst is CA-CB-CG: 5.5 σ
-
A 826 GLU10.68-Allowed (0.53%)
General / -111.3,-153.8
Favored (28.1%) mt-10
chi angles: 288.6,188.7,83.8
0.07Å---
A 827 GLU11.33-Allowed (0.18%)
General / -63.9,97.8
Favored (78%) tt0
chi angles: 184.3,180.1,340.7
0.08Å---
A 828 ASP11.090.58Å
HB3 with A 811 ARG NH2
Favored (24.65%)
General / -115.9,157.4
Favored (11.1%) t70
chi angles: 193.9,299.9
0.15Å---
A 829 LEU11.46-Allowed (1.24%)
General / -96.8,-165.2
Favored (71.2%) mt
chi angles: 294.1,180.2
0.14Å---
A 830 LYS12.230.49Å
HD2 with A 837 MET HE3
Favored (3.33%)
General / -57.3,116.5
Favored (29.3%) mttp
chi angles: 279.1,169.5,175.6,54.4
0.18Å---
A 831 GLU11.03-Favored (86.33%)
General / -65.4,-44.8
Allowed (1%) mp0
chi angles: 281.1,88.5,297
0.12Å---
A 832 CYS10.83-Allowed (0.28%)
General / -122.3,-132.1
Favored (6.5%) t
chi angles: 197.6
0.10Å---
A 833 PHE10.01-Favored (19.44%)
General / -71.0,122.1
Allowed (1.3%) t80
chi angles: 216.1,89.1
0.14Å---
A 834 PHE8.61-Favored (49.71%)
General / -114.9,139.5
Favored (45.2%) p90
chi angles: 55.8,87.9
0.14Å---
A 835 ASP7.83-Allowed (0.62%)
General / -155.6,58.7
Favored (20.8%) p0
chi angles: 62.1,325.1
0.09Å---
A 836 ASP7.9-Allowed (0.38%)
General / -170.5,110.8
Favored (7.4%) t70
chi angles: 196.7,273.4
0.13Å OUTLIER(S)
worst is C--N: 4.2 σ
OUTLIER(S)
worst is CA-CB-CG: 4.6 σ
-
A 837 MET6.560.49Å
HE3 with A 830 LYS HD2
Allowed (0.11%)
General / -174.4,-161.4
Favored (4.5%) mtp
chi angles: 294.1,203.5,100.3
0.28Å OUTLIER(S)
worst is C--N: 12.4 σ
OUTLIER(S)
worst is C-N-CA: 7.8 σ
-
A 838 GLU6.021.27Å
HA with A 797 ALA O
Allowed (0.08%)
General / -85.2,-139.9
Allowed (1%) tt0
chi angles: 212.6,197.8,50.2
0.80Å OUTLIER(S)
worst is N--CA: 6.1 σ
OUTLIER(S)
worst is CA-C-N: 7.5 σ
-
A 839 SER6.490.64Å
H with A 799 GLN N
Favored (2.72%)
General / -146.9,96.3
Favored (19.2%) t
chi angles: 186.2
0.20Å- OUTLIER(S)
worst is N-CA-CB: 5.3 σ
-
A 840 ILE6.270.49Å
O with A 840 ILE HG23
Allowed (0.46%)
Pre-Pro / -97.8,86.7
Favored (21.3%) tt
chi angles: 185.1,168.1
0.12Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 841 PRO5.450.65Å
HG3 with A 846 TRP HB3
Allowed (0.18%)
Trans-Pro / -101.3,-180.0
Favored (34.3%) Cg_endo
chi angles: 22.1,329.5,28.5
0.07Å- OUTLIER(S)
worst is N-CA-CB: 4.0 σ
-
A 842 ALA5.07-Favored (96.99%)
General / -62.0,-44.3
-0.09Å---
A 843 VAL4.06-Allowed (0.16%)
Ile or Val / -78.2,-173.4
Favored (30.5%) m
chi angles: 296.6
0.09Å- OUTLIER(S)
worst is C-N-CA: 4.7 σ
-
A 844 THR283.360.81Å
HG22 with A 845 THR H
OUTLIER (0)%)
General / -52.8,-166.3
Favored (8.4%) m
chi angles: 312.9
0.08Å---
A 845 THR284.170.81Å
H with A 844 THR HG22
Allowed (0.79%)
General / -56.7,110.4
Favored (56.4%) m
chi angles: 303.8
0.22Å- OUTLIER(S)
worst is C-N-CA: 15.5 σ
-
A 846 TRP250.390.65Å
HB3 with A 841 PRO HG3
Allowed (1.46%)
General / -133.8,-27.8
Favored (51%) t-100
chi angles: 193.3,260.7
0.02Å---
A 847 ASN277.28-Favored (69.18%)
General / -70.8,-32.2
Favored (63.5%) t0
chi angles: 190.9,30.7
0.02Å---
A 848 THR259.55-Favored (66.91%)
General / -59.9,-27.6
Favored (9.6%) m
chi angles: 312.6
0.04Å---
A 849 TYR258.39-Favored (84.81%)
General / -61.2,-47.7
Favored (40.8%) m-80
chi angles: 281.8,77.5
0.02Å---
A 850 LEU277.94-Favored (87.47%)
General / -65.7,-44.0
Allowed (2%) tt
chi angles: 198.7,147.9
0.03Å---
A 851 ARG327.67-Favored (69.96%)
General / -67.6,-30.4
Favored (55.2%) mmt180
chi angles: 295.3,295.5,184.3,187.9
0.06Å---
A 852 TYR278.26-Favored (28.48%)
General / -76.3,-46.3
Favored (81%) t80
chi angles: 182.2,74.1
0.03Å---
A 853 ILE301.980.46Å
HG23 with A 854 THR HG23
Favored (42.17%)
Ile or Val / -71.5,-31.3
Favored (9.8%) tt
chi angles: 200.1,173.1
0.11Å---
A 854 THR291.590.46Å
HG23 with A 853 ILE HG23
Allowed (0.69%)
General / -105.0,57.1
Favored (37.5%) p
chi angles: 68.2
0.07Å---
A 855 VAL263.95-Allowed (0.81%)
Ile or Val / -134.9,31.4
Favored (2.1%) m
chi angles: 285.1
0.08Å---
A 856 HIS295.66-Allowed (1.33%)
General / -168.3,129.4
Favored (16.3%) t70
chi angles: 196.1,49.3
0.02Å---
A 857 LYS284.42-Favored (16.37%)
General / -76.3,-49.6
Favored (34.4%) mttm
chi angles: 292.1,193.5,166.9,291.2
0.04Å---
A 858 SER303.1-Favored (70.13%)
General / -57.7,-35.1
Favored (52.4%) p
chi angles: 56.7
0.06Å---
A 859 LEU297.13-Favored (69.66%)
General / -60.7,-29.9
Favored (2.7%) tt
chi angles: 188.4,137.1
0.03Å---
A 860 ILE305.65-Favored (70.8%)
Ile or Val / -71.7,-40.8
Favored (41.1%) mt
chi angles: 299.2,157.9
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 861 PHE323.66-Favored (77.55%)
General / -68.0,-44.0
Favored (58.3%) m-80
chi angles: 291.9,294.4
0.04Å---
A 862 VAL311.66-Favored (83.46%)
Ile or Val / -65.3,-38.8
Favored (4.8%) p
chi angles: 71.9
0.13Å---
A 863 LEU314.84-Favored (68.93%)
General / -71.8,-34.0
Favored (3.6%) pp
chi angles: 65.6,83.7
0.11Å---
A 864 ILE305.2-Favored (93.47%)
Ile or Val / -65.8,-43.3
Favored (10%) mm
chi angles: 292.1,284
0.04Å---
A 865 TRP290.13-Favored (74.6%)
General / -64.8,-32.8
Favored (11.1%) t60
chi angles: 190.9,45.5
0.03Å---
A 866 CYS327.67-Favored (67.08%)
General / -68.5,-47.4
Favored (45.2%) t
chi angles: 185.2
0.01Å---
A 867 LEU317.24-Favored (95.65%)
General / -64.7,-41.9
Favored (31.8%) mt
chi angles: 286.7,160
0.04Å---
A 868 VAL302.37-Favored (81.87%)
Ile or Val / -64.3,-38.2
Favored (5.1%) p
chi angles: 71.6
0.13Å---
A 869 ILE295.6-Favored (73.93%)
Ile or Val / -71.3,-40.4
Favored (81.2%) mt
chi angles: 295.5,164.2
0.06Å---
A 870 PHE288.24-Favored (87.15%)
General / -58.0,-45.1
Favored (89.5%) t80
chi angles: 178.1,75.5
0.03Å---
A 871 LEU307.21-Favored (82.98%)
General / -66.7,-36.6
Favored (5%) mp
chi angles: 267.9,68.7
0.05Å---
A 872 ALA318.14-Favored (85.4%)
General / -65.8,-44.5
-0.04Å---
A 873 GLU327.67-Favored (58.18%)
General / -73.1,-45.3
Favored (50.6%) mt-10
chi angles: 288.6,192.2,328.6
0.05Å---
A 874 VAL327.67-Favored (42.39%)
Ile or Val / -59.5,-29.4
Favored (5%) p
chi angles: 71.1
0.10Å---
A 875 ALA327.67-Favored (71.65%)
General / -69.0,-44.9
-0.02Å---
A 876 ALA327.67-Favored (68.69%)
General / -58.9,-31.5
-0.04Å---
A 877 SER327.67-Favored (82.75%)
General / -58.8,-48.0
Favored (8.4%) m
chi angles: 309
0.01Å---
A 878 LEU327.67-Favored (90.41%)
General / -61.9,-39.0
Favored (2.9%) mp
chi angles: 273.6,43.9
0.05Å---
A 879 VAL327.67-Favored (95.1%)
Ile or Val / -62.6,-42.2
Favored (61%) t
chi angles: 170.9
0.06Å---
A 880 VAL327.67-Favored (46.77%)
Ile or Val / -69.1,-51.1
Favored (62.7%) t
chi angles: 171.2
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 881 LEU305.81-Favored (62.95%)
General / -66.4,-15.0
Favored (5.5%) mp
chi angles: 272,49.3
0.09Å---
A 882 TRP301.91-Favored (78.1%)
General / -57.1,-40.9
Favored (48.9%) t-100
chi angles: 194.1,259.7
0.02Å---
A 883 LEU261.06-Favored (19.16%)
General / -81.0,113.3
Favored (2.3%) mm
chi angles: 279.7,289
0.02Å- OUTLIER(S)
worst is C-N-CA: 7.0 σ
-
A 884 LEU4.070.48Å
HD22 with A 917 TYR OH
Favored (14.05%)
General / -110.1,105.1
Allowed (1%) tm
chi angles: 192.6,279.5
0.15Å---
A 885 GLY4.04-Favored (9.55%)
Glycine / -68.2,118.6
-----
A 886 ASN4.130.43Å
O with A 899 ARG HD2
Favored (10.56%)
General / -95.1,168.8
Favored (18.4%) p0
chi angles: 66.3,312.7
0.14Å- OUTLIER(S)
worst is CA-CB-CG: 4.6 σ
-
A 887 THR4.15-Favored (85.24%)
Pre-Pro / -74.5,158.2
Favored (8.7%) p
chi angles: 46.2
0.09Å---
A 888 PRO4.07-Favored (4.24%)
Trans-Pro / -60.1,117.5
Favored (20.4%) Cg_endo
chi angles: 19.5,331.2,27.5
0.16Å- OUTLIER(S)
worst is C-N-CA: 4.7 σ
-
A 889 LEU4.260.41Å
H with A 899 ARG HH21
Favored (43.88%)
General / -146.0,157.6
Allowed (1.2%) mm
chi angles: 286.2,306.7
0.22Å- OUTLIER(S)
worst is N-CA-CB: 4.2 σ
-
A 890 GLN4.55-Favored (41.55%)
General / -73.2,131.1
Favored (17.4%) pt0
chi angles: 61.2,183.9,357.4
0.13Å---
A 891 ASP4.52-Favored (10.16%)
General / -87.2,172.1
Favored (19.1%) m-30
chi angles: 286.5,13.1
0.10Å- OUTLIER(S)
worst is CA-CB-CG: 5.3 σ
-
A 892 LYS4.52-Favored (71.94%)
General / -66.8,-47.4
Favored (15.8%) ttmt
chi angles: 195,164.3,298.2,180
0.08Å---
A 893 GLY4.41-Favored (26.57%)
Glycine / 102.7,170.9
-----
A 894 ASN4.85-Favored (22.15%)
General / 53.8,35.7
Favored (6.4%) m110
chi angles: 296,60.3
0.07Å- OUTLIER(S)
worst is CA-CB-CG: 5.0 σ
-
A 895 SER5.35-Favored (2.08%)
General / -105.0,-172.3
Favored (44.3%) p
chi angles: 75.8
0.13Å---
A 896 THR4.71-Favored (6.5%)
General / -90.3,177.1
Favored (56.4%) p
chi angles: 57
0.08Å---
A 897 HIS5.01-Allowed (0.76%)
General / -59.0,109.0
Favored (76.4%) t70
chi angles: 186.7,66.5
0.12Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.3 σ
-
A 898 SER4.99-Allowed (0.33%)
General / -120.7,-138.9
Favored (4.2%) m
chi angles: 312
0.18Å---
A 899 ARG5.340.43Å
HD2 with A 886 ASN O
Favored (67.52%)
General / -64.8,-24.3
Favored (5.9%) ttp-110
chi angles: 194.3,161.7,91,262.3
0.10Å- OUTLIER(S)
worst is C-N-CA: 4.0 σ
-
A 900 ASN5.91-Favored (15.72%)
General / 62.0,26.1
Favored (38.4%) t0
chi angles: 203.3,27.6
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 901 ASN6.42-Favored (10.46%)
General / -87.9,96.4
Favored (6.1%) p0
chi angles: 48.8,291.6
0.07Å---
A 902 SER7.39-Favored (37.75%)
General / -155.3,157.8
Favored (46.7%) t
chi angles: 180
0.12Å---
A 903 TYR8.01-Favored (19.53%)
General / -70.6,122.3
Favored (83.5%) m-80
chi angles: 299.9,284.7
0.08Å- OUTLIER(S)
worst is CA-CB-CG: 4.0 σ
-
A 904 ALA8.42-Favored (30.18%)
General / -154.9,167.5
-0.12Å---
A 905 VAL8-Favored (99.48%)
Ile or Val / -63.2,-44.6
Favored (84.3%) t
chi angles: 177.1
0.06Å---
A 906 ILE7.480.71Å
H with A 906 ILE HD13
Favored (18.77%)
Ile or Val / -81.2,138.9
OUTLIER (0%)
chi angles: 60.6,290.6
0.10Å---
A 907 ILE6.68-Favored (42.86%)
Ile or Val / -102.6,114.7
Favored (47.6%) mm
chi angles: 300.6,297.9
0.05Å---
A 908 THR5.5-Favored (11.55%)
General / -69.4,117.8
Favored (17.1%) m
chi angles: 309.4
0.04Å---
A 909 SER302.47-Favored (9.12%)
General / -71.2,-55.0
Favored (31.2%) p
chi angles: 54.9
0.01Å---
A 910 THR311.280.54Å
CG2 with A 913 TYR HB2
Favored (24.63%)
General / 58.0,34.8
Favored (2.7%) m
chi angles: 316.6
0.07Å---
A 911 SER295.19-Favored (60.15%)
General / -76.0,-15.3
Favored (59.9%) m
chi angles: 299
0.02Å---
A 912 SER327.67-Favored (3.41%)
General / -89.1,-56.1
Favored (50.3%) p
chi angles: 56.5
0.01Å---
A 913 TYR311.70.54Å
HB2 with A 910 THR CG2
Favored (54.1%)
General / -51.3,-51.5
Favored (54.6%) m-80
chi angles: 284.4,280.6
0.03Å---
A 914 TYR303.480.44Å
HD1 with A 910 THR HG22
Favored (62.62%)
General / -72.5,-28.0
Favored (50.5%) m-80
chi angles: 283.4,80.6
0.06Å---
A 915 VAL291.32-Favored (10.79%)
Ile or Val / -87.3,-11.9
Favored (54.6%) t
chi angles: 180.7
0.10Å---
A 916 PHE289.04-Favored (65.92%)
General / -67.4,-25.3
Favored (4.6%) t80
chi angles: 206.5,270.4
0.05Å---
A 917 TYR299.60.48Å
OH with A 884 LEU HD22
Favored (57.04%)
General / -52.3,-37.9
Favored (44.4%) m-80
chi angles: 281.4,273.1
0.04Å---
A 918 ILE297.96-Favored (70.67%)
Ile or Val / -62.4,-35.6
Favored (16%) tt
chi angles: 196.6,170.1
0.09Å---
A 919 TYR306.32-Favored (63.44%)
General / -69.9,-47.2
Favored (46.5%) t80
chi angles: 183.6,61.1
0.03Å---
A 920 VAL327.67-Favored (40.11%)
Ile or Val / -72.6,-32.1
Favored (85.9%) t
chi angles: 177.4
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 921 GLY325.82-Favored (94.34%)
Glycine / -64.3,-45.1
-----
A 922 VAL327.67-Favored (2.12%)
Ile or Val / -82.1,90.7
Favored (80.7%) t
chi angles: 177.9
0.04Å---
A 923 ALA327.67-Favored (65.93%)
General / -67.2,-25.1
-0.02Å---
A 924 ASP327.67-Favored (62.13%)
General / -55.6,-31.2
Favored (19.7%) t70
chi angles: 196.6,50.3
0.02Å---
A 925 THR297.74-Favored (8.06%)
General / -97.1,-42.1
Favored (2.9%) m
chi angles: 316.3
0.02Å---
A 926 LEU277.8-Favored (4.16%)
General / -66.3,-59.0
Allowed (0.3%) tm
chi angles: 182.5,268.8
0.03Å---
A 927 LEU295.3-Favored (10.8%)
General / -84.9,72.2
Favored (63.8%) mt
chi angles: 300.9,171.3
0.01Å---
A 928 ALA295.91-Favored (9.4%)
General / -162.6,142.3
-0.02Å---
A 929 MET297.38-Favored (13.74%)
General / -91.1,164.9
Favored (66.9%) mmm
chi angles: 309.3,307.1,297.3
0.01Å---
A 930 GLY295.26-Favored (20.33%)
Glycine / -157.7,-168.6
-----
A 931 PHE320.97-Favored (51.77%)
General / -52.0,-37.1
Favored (52.9%) p90
chi angles: 65.4,88.1
0.09Å---
A 932 PHE313.98-Favored (17.28%)
General / -80.7,-45.3
Favored (28.1%) t80
chi angles: 196.1,84.7
0.01Å---
A 933 ARG301.42-Favored (8.97%)
General / -123.7,10.3
Favored (13.3%) ptt-90
chi angles: 68.1,214.6,183.5,282.5
0.07Å---
A 934 GLY285.55-Favored (2.09%)
Glycine / -144.2,20.4
-----
A 935 LEU288.25-Favored (2.38%)
Pre-Pro / -77.7,-47.4
Allowed (0.9%) tm
chi angles: 188.3,276
0.05Å---
A 936 PRO301.92-Favored (17.39%)
Trans-Pro / -75.2,-6.0
Favored (76.9%) Cg_endo
chi angles: 28.3,333.7,13.5
0.04Å---
A 937 LEU305.64-Favored (61.83%)
General / -53.6,-36.3
Favored (3.8%) tt
chi angles: 186.2,138.8
0.02Å---
A 938 VAL286.18-Favored (44.1%)
Ile or Val / -73.6,-47.6
Favored (90.7%) t
chi angles: 176
0.03Å---
A 939 HIS290.44-Favored (61.04%)
General / -51.5,-41.4
Favored (82.8%) t70
chi angles: 174.6,78.3
0.03Å---
A 940 THR287.49-Favored (88.97%)
General / -65.6,-43.6
Favored (21.7%) p
chi angles: 51
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 941 LEU287.38-Favored (76.39%)
General / -64.8,-33.6
Favored (36.7%) mt
chi angles: 289.7,160.7
0.05Å---
A 942 ILE271.53-Favored (79.39%)
Ile or Val / -68.5,-38.5
Favored (80.3%) mt
chi angles: 294.7,163.5
0.10Å---
A 943 THR269.11-Favored (74.05%)
General / -67.5,-32.9
Favored (29.6%) p
chi angles: 53
0.07Å---
A 944 VAL282.77-Favored (88%)
Ile or Val / -59.2,-42.7
Favored (40.7%) t
chi angles: 167.8
0.09Å---
A 945 SER291-Favored (97.2%)
General / -64.0,-42.4
Favored (46.6%) t
chi angles: 180
0.06Å---
A 946 LYS303.62-Favored (98.49%)
General / -62.6,-43.6
Favored (27.5%) ttpt
chi angles: 189.5,185.2,77.8,179.5
0.01Å---
A 947 ILE267.94-Favored (89.98%)
Ile or Val / -66.2,-41.9
Favored (58%) mt
chi angles: 293,158.8
0.08Å---
A 948 LEU298.77-Favored (80.95%)
General / -64.3,-47.0
Favored (2.2%) mp
chi angles: 258.9,66
0.06Å---
A 949 HIS284.15-Favored (74.96%)
General / -56.8,-49.6
Favored (84.5%) t70
chi angles: 176.1,78.4
0.03Å---
A 950 HIS309.91-Favored (63.98%)
General / -51.7,-47.5
Favored (67.7%) t70
chi angles: 178.3,58.8
0.01Å---
A 951 LYS327.67-Favored (61.95%)
General / -75.0,-36.0
Favored (17.2%) mtmm
chi angles: 289.2,200.3,295.1,298.8
0.05Å---
A 952 MET264.86-Favored (79.81%)
General / -60.9,-48.9
Favored (14.3%) ttt
chi angles: 190,194.3,180.5
0.02Å---
A 953 LEU265.31-Favored (99.22%)
General / -62.3,-42.2
Allowed (1.2%) tm
chi angles: 184,282.5
0.04Å---
A 954 HIS311.29-Favored (75.03%)
General / -66.9,-33.2
Favored (10.2%) t-90
chi angles: 198.8,306.6
0.01Å---
A 955 SER269.16-Favored (39.79%)
General / -80.4,-24.3
Favored (9.6%) t
chi angles: 191.4
0.02Å---
A 956 VAL282.94-Favored (77.16%)
Ile or Val / -64.8,-50.1
Favored (50.9%) t
chi angles: 169.5
0.05Å---
A 957 LEU272.01-Favored (16.51%)
General / -75.1,170.2
Favored (6.2%) mp
chi angles: 279.6,69.4
0.02Å---
A 958 GLN327.67-Allowed (1.28%)
General / 56.6,66.0
Favored (15.5%) mm110
chi angles: 302.2,282.2,116
0.03Å---
A 959 ALA255.96-Favored (31.5%)
Pre-Pro / -155.8,159.6
-0.02Å---
A 960 PRO273.19-Favored (32.87%)
Trans-Pro / -69.6,136.2
Favored (13.6%) Cg_exo
chi angles: 345.3,28.6,329.3
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 961 MET278.75-Favored (73.32%)
General / -67.5,-32.5
Favored (12.4%) tpt
chi angles: 194.2,68.4,192.5
0.02Å---
A 962 SER288.25-Favored (98.97%)
General / -63.3,-42.2
Favored (60.7%) p
chi angles: 57.8
0.01Å---
A 963 THR301.73-Favored (64.43%)
General / -74.0,-37.1
Favored (70.7%) p
chi angles: 59.3
0.02Å---
A 964 LEU302.46-Favored (6.56%)
General / -72.3,-55.8
Allowed (0.5%) tm
chi angles: 199.9,291.7
0.03Å---
A 965 ASN318.95-Favored (68.77%)
General / -60.4,-29.1
Favored (66.7%) t0
chi angles: 192.8,32.4
0.04Å---
A 966 THR281.30.41Å
HG21 with A 792 ARG HE
Favored (82.93%)
General / -62.1,-36.8
Favored (4.8%) p
chi angles: 44.4
0.03Å---
A 967 LEU272.670.86Å
HA with A 791 THR HG23
Favored (24.09%)
General / -76.8,121.9
Favored (43.6%) tp
chi angles: 185,61
0.03Å---
A 968 LYS303-Favored (45.42%)
General / -66.4,152.3
Favored (13.6%) pttm
chi angles: 69.3,193.5,176.8,287.4
0.06Å---
A 969 ALA305.74-Favored (88.41%)
General / -66.4,-41.9
-0.03Å---
A 970 GLY312.59-Favored (55.94%)
Glycine / -52.8,-39.9
-----
A 971 GLY311.12-Favored (94.71%)
Glycine / -66.3,-41.3
-----
A 972 ILE291.33-Favored (34.94%)
Ile or Val / -66.9,-53.4
Favored (45.2%) mt
chi angles: 297.2,157.6
0.03Å---
A 973 LEU256.17-Favored (85.92%)
General / -58.6,-46.9
Favored (3.2%) tt
chi angles: 197.1,153.2
0.02Å---
A 974 ASN315.85-Favored (77.78%)
General / -64.4,-47.8
Favored (24.7%) t0
chi angles: 186.2,274.3
0.03Å---
A 975 ARG327.67-Favored (74.66%)
General / -67.1,-33.0
Favored (30.9%) ttm170
chi angles: 197.3,185,298.9,180.9
0.02Å---
A 976 PHE294.97-Favored (61.33%)
General / -75.0,-38.9
Favored (35.9%) t80
chi angles: 193.6,88.1
0.02Å---
A 977 SER290.45-Favored (3.56%)
General / -86.7,-56.1
Favored (79.6%) p
chi angles: 61.2
0.15Å---
A 978 LYS327.67-Favored (67.05%)
General / -69.4,-46.3
Favored (43.5%) tttp
chi angles: 190.2,174.5,166.9,62.1
0.02Å---
A 979 ASP305.23-Favored (41.74%)
General / -72.4,-48.4
Favored (27.2%) t0
chi angles: 186.3,40.3
0.03Å---
A 980 ILE288.67-Favored (44.02%)
Ile or Val / -63.1,-27.9
Favored (10.1%) tt
chi angles: 201.7,167.7
0.09Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A 981 ALA300.39-Favored (95.43%)
General / -65.0,-41.3
-0.02Å---
A 982 ILE316.35-Favored (83.6%)
Ile or Val / -67.9,-40.5
Favored (55.9%) mt
chi angles: 296.6,159.5
0.05Å---
A 983 LEU295.96-Favored (80.8%)
General / -62.7,-35.8
Favored (4.7%) tt
chi angles: 186.9,141
0.01Å---
A 984 ASP327.67-Favored (38.26%)
General / -77.4,-41.8
Favored (29.4%) t0
chi angles: 185.5,35.3
0.01Å---
A 985 ASP327.67-Favored (2.85%)
General / -89.6,-57.5
Favored (2%) m-30
chi angles: 295.4,25.3
0.03Å---
A 986 LEU296.51-Favored (22.4%)
General / -85.0,-34.0
Favored (7.3%) mp
chi angles: 280.1,64.8
0.05Å---
A 987 LEU282.23-Favored (13.88%)
Pre-Pro / -68.1,-38.4
Allowed (1.3%) tt
chi angles: 196,138.5
0.08Å---
A 988 PRO266.85-Favored (65.66%)
Trans-Pro / -64.1,-29.3
Favored (53.6%) Cg_exo
chi angles: 337.1,35.2,326.8
0.04Å---
A 989 LEU272.06-Favored (28.18%)
General / -72.3,-50.2
Favored (73.7%) mt
chi angles: 299.5,171.5
0.02Å---
A 990 THR264.89-Favored (68.62%)
General / -59.7,-30.2
Favored (16.5%) p
chi angles: 48.9
0.06Å---
A 991 ILE284.8-Favored (80.82%)
Ile or Val / -67.2,-47.7
Favored (66.5%) mt
chi angles: 287.8,169
0.07Å---
A 992 PHE303.33-Favored (96.62%)
General / -61.2,-41.3
Favored (39.9%) t80
chi angles: 171.8,61.9
0.04Å---
A 993 ASP327.67-Favored (80.41%)
General / -62.0,-48.4
Favored (25.4%) t70
chi angles: 190.5,46.5
0.01Å---
A 994 PHE267.45-Favored (75.99%)
General / -57.5,-49.5
Favored (84.2%) t80
chi angles: 175.6,73.6
0.02Å---
A 995 ILE267.53-Favored (78.01%)
Ile or Val / -63.9,-50.3
Favored (57.4%) mt
chi angles: 291.8,158.9
0.06Å---
A 996 GLN307.8-Favored (73.01%)
General / -55.1,-48.9
Favored (53.1%) tp40
chi angles: 177.6,57,30.3
0.02Å---
A 997 LEU285.58-Favored (62.15%)
General / -71.3,-24.4
Favored (44.7%) mt
chi angles: 294,163.2
0.05Å---
A 998 LEU284.89-Favored (10.58%)
General / -74.3,-53.0
Allowed (0.8%) tm
chi angles: 196,289.9
0.01Å---
A 999 LEU275.04-Favored (78.33%)
General / -55.8,-45.5
Favored (73.6%) mt
chi angles: 288.5,173.3
0.04Å---
A1000 ILE274.03-Favored (83.01%)
Ile or Val / -59.5,-40.9
Favored (15%) tt
chi angles: 190.3,174.1
0.10Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1001 VAL280.82-Favored (18.82%)
Ile or Val / -74.1,-52.9
Favored (80.6%) t
chi angles: 173.1
0.06Å---
A1002 ILE283.92-Favored (52.39%)
Ile or Val / -64.5,-31.1
Favored (15.2%) tt
chi angles: 197.6,169.7
0.11Å---
A1003 GLY296.22-Favored (49.77%)
Glycine / -70.1,-46.7
-----
A1004 ALA307.38-Favored (78.13%)
General / -66.4,-46.0
-0.03Å---
A1005 ILE315.57-Favored (44.23%)
Ile or Val / -64.2,-28.1
Favored (14.2%) tt
chi angles: 197.8,170.9
0.09Å---
A1006 ALA306.17-Favored (3.77%)
General / -69.9,-58.5
-0.02Å---
A1007 VAL324.57-Favored (44.21%)
Ile or Val / -59.6,-30.2
Favored (30.5%) m
chi angles: 298
0.13Å---
A1008 VAL327.67-Favored (88.69%)
Ile or Val / -65.9,-46.4
Favored (40.8%) t
chi angles: 167.8
0.04Å---
A1009 ALA316.54-Favored (65.26%)
General / -68.0,-25.2
-0.04Å---
A1010 VAL307.01-Favored (85.02%)
Ile or Val / -67.0,-46.2
Favored (54.8%) t
chi angles: 170.1
0.06Å---
A1011 LEU298.51-Favored (7.45%)
General / -69.2,-56.5
Favored (4.4%) mp
chi angles: 275.8,74
0.06Å---
A1012 GLN327.67-Favored (26.97%)
Pre-Pro / -100.3,104.0
Favored (30.8%) mt0
chi angles: 292.9,202.6,326.7
0.01Å---
A1013 PRO267.78-Favored (22.91%)
Trans-Pro / -71.2,-24.7
Favored (81%) Cg_endo
chi angles: 30.6,326.3,23
0.03Å---
A1014 TYR262.07-Favored (64.08%)
General / -69.1,-19.6
Favored (97.2%) m-80
chi angles: 294.1,275.1
0.05Å---
A1015 ILE278.51-Favored (70.12%)
Ile or Val / -64.8,-34.4
Favored (80.4%) mt
chi angles: 294.9,163.7
0.05Å---
A1016 PHE312.25-Favored (39.27%)
General / -52.2,-33.0
Favored (32.1%) t80
chi angles: 195,85
0.03Å---
A1017 VAL306.11-Favored (52.19%)
Ile or Val / -74.1,-41.7
Favored (85.2%) t
chi angles: 177.3
0.03Å---
A1018 ALA298.48-Favored (65.45%)
General / -67.5,-21.9
-0.05Å---
A1019 THR286.6-Favored (67.76%)
General / -72.7,-38.0
Favored (14.8%) p
chi angles: 48
0.04Å---
A1020 VAL295.51-Favored (82.42%)
Pre-Pro / -63.6,-45.0
Favored (82.2%) t
chi angles: 173.3
0.14Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1021 PRO306.73-Favored (65.05%)
Trans-Pro / -64.1,-26.9
Favored (36.2%) Cg_exo
chi angles: 338.9,33.3,328.2
0.04Å---
A1022 VAL301.08-Favored (23.95%)
Ile or Val / -79.4,-44.9
Favored (81.9%) t
chi angles: 176.7
0.05Å---
A1023 ILE293.01-Favored (97.46%)
Ile or Val / -64.2,-44.2
Favored (57%) mt
chi angles: 294.3,159
0.07Å---
A1024 VAL301.09-Favored (57.9%)
Ile or Val / -66.2,-32.4
Favored (4.8%) p
chi angles: 71.9
0.09Å---
A1025 ALA313.31-Favored (93.13%)
General / -65.4,-40.3
-0.04Å---
A1026 PHE313.91-Favored (72.47%)
General / -58.4,-50.8
Favored (30.6%) m-80
chi angles: 285.7,303
0.04Å---
A1027 ILE286.76-Favored (85.58%)
Ile or Val / -67.3,-40.8
Favored (62.6%) mt
chi angles: 296.8,160.9
0.06Å---
A1028 MET268.98-Favored (71.34%)
General / -65.3,-49.0
Favored (47.9%) ttp
chi angles: 187.9,169.9,65.5
0.01Å---
A1029 LEU269.08-Favored (72.7%)
General / -70.7,-35.1
Allowed (0.4%) tm
chi angles: 192.7,272.6
0.05Å---
A1030 ARG327.67-Favored (70.84%)
General / -69.5,-44.5
Favored (63.3%) ttp80
chi angles: 195.9,178.2,74.5,82.8
0.03Å---
A1031 ALA279.41-Favored (87.8%)
General / -63.7,-37.5
-0.02Å---
A1032 TYR274.75-Favored (85.68%)
General / -65.2,-36.9
Favored (71.2%) t80
chi angles: 181.8,69.1
0.02Å---
A1033 PHE294.69-Favored (60.88%)
General / -72.8,-45.0
Favored (41.3%) t80
chi angles: 177,58.8
0.03Å---
A1034 LEU295.14-Favored (82.15%)
General / -57.9,-41.3
Favored (34.2%) mt
chi angles: 282.6,166.6
0.05Å---
A1035 GLN313.140.65Å
NE2 with A 801 ASN HB3
Favored (28.54%)
General / -48.4,-41.4
Favored (63.8%) mm-40
chi angles: 288.2,294.4,336.8
0.03Å---
A1036 THR284.38-Favored (9.45%)
General / -75.5,-53.0
Favored (6.1%) p
chi angles: 45.2
0.01Å---
A1037 SER295.14-Favored (58.2%)
General / -51.5,-51.1
Favored (58.8%) m
chi angles: 299.3
0.03Å---
A1038 GLN325.67-Favored (96.36%)
General / -62.7,-40.2
Favored (21.8%) mm110
chi angles: 293.8,288.6,130.5
0.03Å---
A1039 GLN302.99-Favored (70.08%)
General / -70.4,-32.4
Favored (4.1%) tt0
chi angles: 193,166.5,210.2
0.01Å---
A1040 LEU287.29-Favored (24.96%)
General / -76.6,-46.7
Favored (13.6%) tp
chi angles: 195,64.9
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1041 LYS327.67-Favored (67%)
General / -61.0,-25.6
Favored (75.9%) tttt
chi angles: 191.7,170,179.2,180.8
0.03Å---
A1042 GLN296.31-Favored (94.43%)
General / -61.1,-45.5
Favored (42.6%) tt0
chi angles: 188.7,182.8,307.3
0.01Å---
A1043 LEU270.85-Favored (66.67%)
General / -68.3,-27.9
Favored (8.1%) mp
chi angles: 271.9,63.7
0.07Å---
A1044 GLU326.16-Favored (90.65%)
General / -66.1,-40.2
Favored (75%) mt-10
chi angles: 294,182.4,322.7
0.02Å---
A1045 SER286.04-Favored (75.14%)
General / -69.4,-42.3
Favored (10.3%) t
chi angles: 190.5
0.01Å---
A1046 GLU318.31-Favored (67.8%)
General / -69.3,-46.2
Favored (58.2%) mt-10
chi angles: 292.2,193,330.2
0.02Å---
A1047 GLY295.27-Favored (21.38%)
Glycine / -67.5,-2.5
-----
A1048 ARG327.67-Favored (80.17%)
General / -68.8,-39.0
Favored (69.7%) ttm-80
chi angles: 189.1,187.2,299.1,283
0.02Å---
A1049 SER282.55-Favored (10.21%)
Pre-Pro / -68.3,-37.2
Favored (60.4%) p
chi angles: 73.1
0.13Å---
A1050 PRO279.06-Favored (89.6%)
Trans-Pro / -54.4,-37.7
Favored (81.2%) Cg_exo
chi angles: 334.6,36.8,326.7
0.04Å---
A1051 ILE293.55-Favored (80.73%)
Ile or Val / -67.8,-47.2
Favored (47.8%) mt
chi angles: 297.3,158.2
0.04Å---
A1052 PHE285.8-Favored (77.75%)
General / -67.5,-44.8
Favored (36%) m-80
chi angles: 279.5,79.7
0.06Å---
A1053 THR280.54-Favored (81.01%)
General / -62.6,-35.9
Favored (26.6%) p
chi angles: 52.2
0.03Å---
A1054 HIS323.41-Favored (61.98%)
General / -71.9,-45.2
Favored (32.9%) t-90
chi angles: 186.3,253.5
0.01Å---
A1055 LEU275.71-Favored (71.33%)
General / -65.0,-30.3
Favored (2.7%) tt
chi angles: 187.2,136.3
0.04Å---
A1056 VAL295.41-Favored (21.95%)
Ile or Val / -69.2,-54.1
Favored (33.8%) t
chi angles: 165.8
0.07Å---
A1057 THR299.39-Favored (90.31%)
General / -58.7,-45.0
Favored (19.3%) p
chi angles: 50.4
0.03Å---
A1058 SER311.2-Favored (64.94%)
General / -57.3,-30.6
Favored (78%) p
chi angles: 60.6
0.03Å---
A1059 LEU314.21-Favored (66.62%)
General / -70.8,-30.2
Favored (27.9%) tp
chi angles: 188.6,62.4
0.02Å---
A1060 LYS321.33-Favored (42.56%)
General / -69.2,-50.9
Favored (28.1%) mmmt
chi angles: 301.4,302.6,298,188
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1061 GLY299.94-Favored (2.55%)
Glycine / -93.0,52.9
-----
A1062 LEU287.62-Favored (28.4%)
General / -73.7,-48.9
Favored (37.3%) tp
chi angles: 185.8,58.7
0.02Å---
A1063 TRP284.9-Favored (94.57%)
General / -64.3,-39.7
Favored (14.7%) m-90
chi angles: 293.9,285.5
0.02Å---
A1064 THR277.08-Favored (90.55%)
General / -65.7,-38.9
Favored (26.5%) p
chi angles: 52.2
0.01Å---
A1065 LEU284.33-Favored (81.45%)
General / -67.7,-42.8
Favored (36.9%) tp
chi angles: 183.4,54.8
0.02Å---
A1066 ARG327.67-Favored (83.75%)
General / -65.7,-45.1
Favored (76.5%) mtt180
chi angles: 287.1,160.9,168,173.8
0.02Å---
A1067 ALA294.56-Favored (73.18%)
General / -65.2,-48.5
-0.02Å---
A1068 PHE303.5-Favored (69.09%)
General / -72.2,-35.7
Favored (22.4%) m-80
chi angles: 280.1,69.6
0.04Å---
A1069 GLY306.02-Favored (3.98%)
Glycine / 75.9,57.8
-----
A1070 ARG327.67-Favored (2.99%)
General / -113.0,37.9
Favored (16.2%) mmm-85
chi angles: 302.3,291,322.1,291.6
0.04Å---
A1071 GLN327.67-Allowed (1.49%)
Pre-Pro / -71.1,-29.7
Favored (20.1%) pt0
chi angles: 67.3,178.4,4.9
0.15Å---
A1072 PRO246.45-Favored (38.66%)
Trans-Pro / -63.6,-38.9
Favored (35.4%) Cg_exo
chi angles: 339.1,34.4,326
0.04Å---
A1073 TYR258.1-Favored (76.02%)
General / -60.0,-49.9
Favored (92.3%) t80
chi angles: 178.6,77.9
0.02Å---
A1074 PHE265.41-Favored (96.74%)
General / -64.1,-42.6
Favored (11.2%) m-80
chi angles: 274,63.6
0.04Å---
A1075 GLU294.15-Favored (94.34%)
General / -63.1,-45.0
Favored (72.7%) mt-10
chi angles: 283.3,168,10.7
0.04Å---
A1076 THR276.49-Favored (84.25%)
General / -66.4,-37.0
Favored (18.4%) p
chi angles: 49.8
0.03Å---
A1077 LEU284.89-Favored (73.67%)
General / -70.7,-38.0
Allowed (0.7%) tt
chi angles: 203.3,145.1
0.03Å---
A1078 PHE275.21-Favored (72.69%)
General / -59.8,-34.2
Favored (87.5%) t80
chi angles: 181,77.1
0.03Å---
A1079 HIS324.42-Favored (82.32%)
General / -65.6,-35.9
Favored (19.1%) m-70
chi angles: 300.1,324.3
0.04Å---
A1080 LYS327.67-Favored (80.88%)
General / -59.9,-37.9
Favored (80.5%) tttt
chi angles: 191.4,174.6,177.5,182.1
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1081 ALA295.34-Favored (79.79%)
General / -66.3,-35.2
-0.03Å---
A1082 LEU292.3-Favored (46.24%)
General / -69.7,-50.2
Favored (84.2%) mt
chi angles: 295.6,170.2
0.02Å---
A1083 ASN303.87-Favored (80.14%)
General / -56.5,-43.6
Favored (76.4%) m-40
chi angles: 290,312.5
0.04Å---
A1084 LEU267.65-Favored (79.86%)
General / -58.5,-39.4
Favored (59.9%) mt
chi angles: 288.5,164.3
0.03Å---
A1085 HIS273.51-Favored (63.44%)
General / -73.5,-41.2
Favored (21.2%) t-90
chi angles: 189.3,249.6
0.03Å---
A1086 THR262.09-Favored (68.19%)
General / -68.9,-46.5
Favored (29.5%) m
chi angles: 306.9
0.02Å---
A1087 ALA252.54-Favored (66.6%)
General / -53.0,-43.7
-0.01Å---
A1088 ASN293.29-Favored (48.61%)
General / -71.7,-48.2
Favored (35.1%) t0
chi angles: 189.6,67.1
0.01Å---
A1089 TRP273.76-Favored (73.98%)
General / -69.4,-43.2
Favored (24.6%) t-100
chi angles: 188.6,280.8
0.03Å---
A1090 PHE284.92-Favored (63.27%)
General / -54.2,-36.4
Favored (72.2%) t80
chi angles: 173.7,70.1
0.03Å---
A1091 LEU267.27-Favored (66.75%)
General / -65.9,-24.1
Favored (7.9%) tp
chi angles: 201.2,68.9
0.03Å---
A1092 TYR274.1-Favored (92.27%)
General / -65.5,-42.4
Favored (44%) t80
chi angles: 192.1,84.6
0.04Å---
A1093 LEU257.31-Favored (92.31%)
General / -64.5,-38.8
Favored (67%) mt
chi angles: 294.2,166.1
0.02Å---
A1094 SER281.64-Favored (94.93%)
General / -65.0,-42.1
Favored (92.6%) p
chi angles: 66.5
0.03Å---
A1095 THR273.47-Favored (74.54%)
General / -68.4,-44.7
Favored (36.2%) p
chi angles: 54.1
0.02Å---
A1096 LEU261.72-Favored (93.97%)
General / -60.5,-41.4
Favored (2.4%) tt
chi angles: 195.6,143.7
0.04Å---
A1097 ARG322.04-Favored (83.25%)
General / -60.6,-38.0
Favored (3.2%) mmp-170
chi angles: 276.2,303,97.5,199.7
0.05Å---
A1098 TRP262.45-Favored (88.3%)
General / -66.7,-40.0
Favored (22.9%) t-100
chi angles: 168.8,235.6
0.05Å---
A1099 PHE263.67-Favored (83.36%)
General / -62.4,-47.6
Favored (59.8%) t80
chi angles: 187,71.8
0.01Å---
A1100 GLN299.69-Favored (66.15%)
General / -67.7,-26.3
Favored (95.6%) mm-40
chi angles: 296,295,313
0.04Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1101 MET301.47-Favored (34.04%)
General / -71.1,-50.4
Favored (26.2%) mmm
chi angles: 275.3,282.9,282.4
0.03Å---
A1102 ARG327.67-Favored (73.29%)
General / -70.8,-37.9
Favored (64.1%) ttt180
chi angles: 189.3,163.1,174.8,178.6
0.06Å---
A1103 ILE311.26-Favored (49.43%)
Ile or Val / -58.4,-34.0
Favored (16.9%) tt
chi angles: 195.5,170.5
0.11Å---
A1104 GLU301.79-Favored (57.07%)
General / -76.9,-35.9
Favored (15%) tt0
chi angles: 190.7,157.6,33.2
0.03Å---
A1105 MET309.93-Favored (68.75%)
General / -65.8,-28.1
Favored (95.4%) mtp
chi angles: 291,174.1,65.9
0.04Å---
A1106 ILE296.93-Favored (68.05%)
Ile or Val / -68.8,-35.1
Favored (71.4%) mt
chi angles: 293.4,161.1
0.06Å---
A1107 PHE293.98-Favored (30.34%)
General / -76.2,-46.0
Favored (65.8%) t80
chi angles: 186.8,78.1
0.02Å---
A1108 VAL288.92-Favored (60.28%)
Ile or Val / -60.4,-35.1
Favored (3.9%) p
chi angles: 72.9
0.12Å---
A1109 ILE288.25-Favored (58.1%)
Ile or Val / -68.6,-33.1
Allowed (1.1%) pp
chi angles: 65.3,98.9
0.12Å---
A1110 PHE286.2-Favored (77.79%)
General / -68.3,-43.3
Favored (86.2%) t80
chi angles: 180.2,75.4
0.01Å---
A1111 PHE299.96-Favored (79.38%)
General / -63.2,-48.2
Favored (34.3%) t80
chi angles: 194.4,80.1
0.07Å- OUTLIER(S)
worst is CA-CB-CG: 5.4 σ
-
A1112 ILE302.54-Favored (88.63%)
Ile or Val / -58.8,-47.6
Favored (33%) mt
chi angles: 287.1,157.6
0.05Å---
A1113 ALA301.9-Favored (96.28%)
General / -61.8,-44.7
-0.03Å---
A1114 VAL312.49-Favored (96.5%)
Ile or Val / -64.8,-43.2
Favored (52.2%) t
chi angles: 169.7
0.07Å---
A1115 THR318.34-Favored (69.95%)
General / -66.4,-48.5
Favored (9.6%) p
chi angles: 46.5
0.04Å---
A1116 PHE323.22-Favored (42.78%)
General / -56.3,-54.7
Favored (4.3%) m-80
chi angles: 268.8,51.2
0.04Å---
A1117 ILE311.73-Favored (76.31%)
Ile or Val / -65.5,-35.9
Favored (15.5%) tt
chi angles: 198.2,167.6
0.12Å---
A1118 SER315-Favored (80.47%)
General / -67.6,-43.5
Favored (74.6%) p
chi angles: 59.6
0.02Å---
A1119 ILE319.37-Favored (71.23%)
Ile or Val / -71.7,-42.9
Favored (53.2%) mt
chi angles: 296.1,158.8
0.06Å---
A1120 LEU327.67-Favored (65.99%)
General / -71.7,-43.4
Favored (48.9%) mt
chi angles: 290.3,162.8
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1121 THR327.67-Favored (33.24%)
General / -72.7,159.8
Favored (60.1%) p
chi angles: 57.4
0.05Å---
A1122 THR327.67-Favored (2.52%)
General / -75.4,84.7
Favored (48.3%) p
chi angles: 55.9
0.02Å---
A1123 GLY327.67-Favored (3.11%)
Glycine / -81.0,110.3
-----
A1124 GLU327.67-Favored (13.71%)
General / -73.5,-52.4
Favored (31.2%) tt0
chi angles: 192.1,170.2,33.8
0.01Å---
A1125 GLY327.67-Favored (54.46%)
Glycine / -75.8,166.3
-----
A1126 GLU327.67-Favored (12.09%)
General / -95.7,-34.0
Favored (15%) pm20
chi angles: 58,265.2,41.1
0.09Å---
A1127 GLY305.75-Favored (59.16%)
Glycine / -72.0,-39.4
-----
A1128 ARG327.67-Favored (53.02%)
General / -54.0,-32.0
Favored (39.6%) ttm170
chi angles: 187.1,161.8,290.8,178.8
0.02Å---
A1129 VAL309.07-Favored (43.07%)
Ile or Val / -72.3,-49.4
Favored (92.7%) t
chi angles: 175.9
0.02Å---
A1130 GLY300.73-Favored (90.57%)
Glycine / -67.0,-43.7
-----
A1131 ILE300.58-Favored (82.83%)
Ile or Val / -62.5,-49.7
Favored (49.9%) mt
chi angles: 294.6,157.8
0.05Å---
A1132 ILE313.69-Favored (96.44%)
Ile or Val / -62.8,-42.5
Allowed (1%) mp
chi angles: 277.5,64.9
0.10Å---
A1133 LEU320.53-Favored (87.99%)
General / -66.2,-42.9
Favored (57.8%) mt
chi angles: 291.4,180.1
0.09Å---
A1134 THR327.670.46Å
HG22 with A 102 LEU HD21
Favored (87.02%)
General / -66.8,-41.8
Favored (61.3%) p
chi angles: 57.5
0.13Å---
A1135 LEU319.43-Favored (83.72%)
General / -66.7,-36.9
Favored (7.8%) mp
chi angles: 278.4,64.8
0.14Å---
A1136 ALA327.670.53Å
O with A1139 ILE HG22
Favored (99.35%)
General / -62.9,-41.2
-0.06Å---
A1137 MET327.67-Favored (81.97%)
General / -66.1,-45.2
Favored (67%) mtt
chi angles: 295.8,177.5,186
0.07Å---
A1138 ASN327.67-Favored (61.95%)
General / -72.9,-27.6
Favored (74.5%) m-40
chi angles: 288.4,313.5
0.15Å- OUTLIER(S)
worst is CA-CB-CG: 6.0 σ
-
A1139 ILE312.730.53Å
HG22 with A1136 ALA O
Favored (43.72%)
Ile or Val / -62.9,-27.8
Favored (8.3%) tt
chi angles: 202.4,170.2
0.18Å---
A1140 MET327.670.46Å
HE1 with A 131 PHE CE1
Favored (94.8%)
General / -63.4,-39.5
Favored (26.9%) ptp
chi angles: 65.3,188.3,77.5
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1141 SER325.84-Favored (71.01%)
General / -56.5,-37.9
Favored (75.5%) p
chi angles: 59.9
0.03Å---
A1142 THR305.2-Favored (60.88%)
General / -74.2,-41.7
Favored (75.3%) p
chi angles: 59.9
0.03Å---
A1143 LEU301.59-Favored (77.18%)
General / -58.9,-37.7
Favored (43%) tp
chi angles: 179,54.7
0.02Å---
A1144 GLN327.67-Favored (86.91%)
General / -63.7,-46.1
Favored (65%) mt0
chi angles: 289.5,190,334.8
0.04Å---
A1145 TRP320.34-Favored (85.06%)
General / -64.3,-36.7
Favored (42%) m-10
chi angles: 296.3,329.4
0.04Å---
A1146 ALA289.74-Favored (80.05%)
General / -61.7,-48.6
-0.02Å---
A1147 VAL282.68-Favored (43.86%)
Ile or Val / -74.2,-36.5
Favored (83.1%) t
chi angles: 176.9
0.06Å---
A1148 ASN276.69-Favored (91.72%)
General / -62.6,-38.8
Favored (8%) t0
chi angles: 183.7,234.1
0.02Å---
A1149 SER275.8-Favored (73.07%)
General / -68.9,-44.5
Favored (52%) p
chi angles: 56.7
0.01Å---
A1150 SER278.88-Favored (52.09%)
General / -52.1,-36.8
Favored (67%) p
chi angles: 58.5
0.02Å---
A1151 ILE294.3-Favored (93.56%)
Ile or Val / -65.6,-42.7
Favored (47.2%) mt
chi angles: 296.1,157.7
0.05Å---
A1152 ASP307.01-Favored (88.14%)
General / -66.7,-39.5
Favored (75.2%) m-30
chi angles: 297.7,327.2
0.03Å---
A1153 VAL272.3-Favored (97.08%)
Ile or Val / -64.4,-45.0
Favored (65.6%) t
chi angles: 171.6
0.03Å---
A1154 ASP270.93-Favored (96.71%)
General / -64.3,-40.8
Favored (29.2%) t70
chi angles: 186.7,51.3
0.01Å---
A1155 SER259.48-Favored (92.86%)
General / -65.7,-40.8
Favored (83%) p
chi angles: 62.5
0.03Å---
A1156 LEU267.71-Favored (77.26%)
General / -66.3,-46.4
Favored (46.9%) mt
chi angles: 289.9,162.5
0.01Å---
A1157 MET288.1-Favored (65.07%)
General / -66.6,-17.9
Favored (14.3%) ttm
chi angles: 192,158.3,288
0.04Å---
A1158 ARG327.67-Favored (65.45%)
General / -55.7,-34.9
Favored (45.6%) ttp-170
chi angles: 195.5,189.3,71.1,183.4
0.02Å---
A1159 SER257.77-Favored (39.91%)
General / -83.8,2.1
Favored (47.6%) p
chi angles: 75.3
0.03Å---
A1160 VAL281.67-Favored (30.22%)
Ile or Val / -77.3,-41.5
Favored (97.9%) t
chi angles: 175.2
0.03Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1161 SER281.170.56Å
CB with A 798 PRO HG3
Favored (75.2%)
General / -55.0,-45.8
Favored (50.5%) p
chi angles: 56.5
0.01Å---
A1162 ARG327.67-Favored (67.89%)
General / -61.0,-26.9
Favored (18.3%) ptp-170
chi angles: 65.3,176.6,67.1,180
0.09Å---
A1163 VAL253.33-Favored (69.15%)
Ile or Val / -71.8,-44.1
Favored (90.6%) t
chi angles: 174.2
0.05Å---
A1164 PHE258.76-Favored (69.46%)
General / -63.0,-27.5
Favored (27.9%) m-80
chi angles: 277.3,280.5
0.10Å---
A1165 LYS293.87-Favored (94.92%)
General / -60.2,-44.7
Favored (51.9%) mtpt
chi angles: 290.8,176.8,74.1,176.6
0.02Å---
A1166 PHE291.23-Favored (77.32%)
General / -66.7,-34.2
Favored (7.1%) m-80
chi angles: 268.3,88.8
0.05Å---
A1167 ILE269.99-Favored (77.69%)
Ile or Val / -70.7,-41.7
Favored (71.7%) mt
chi angles: 296.3,162.5
0.05Å---
A1168 ASP308.08-Favored (60.37%)
General / -74.0,-11.6
Favored (8.3%) m-30
chi angles: 287.5,19.2
0.07Å---
A1169 MET297.43-Favored (95.71%)
Pre-Pro / -69.2,153.7
Favored (13.3%) ptp
chi angles: 78.7,170.8,71.7
0.09Å---
A1170 PRO268.39-Favored (23.73%)
Trans-Pro / -76.2,168.6
Favored (75.6%) Cg_endo
chi angles: 30.9,329.8,17.2
0.03Å---
A1171 THR279.26-Favored (45.74%)
General / -130.2,131.8
Favored (26.4%) p
chi angles: 70.6
0.02Å---
A1172 GLU282.58-Favored (15.66%)
General / -91.4,-32.4
Favored (41.1%) mt-10
chi angles: 305.6,189.7,317
0.02Å---
A1173 GLY4.61-Favored (19.91%)
Glycine / -95.1,-146.0
-----
A1174 LYS5.43-Favored (40.63%)
Pre-Pro / -131.0,141.1
OUTLIER (0%)
chi angles: 56.1,83.5,228,117.7
0.05Å---
A1175 PRO6.17-Allowed (1.2%)
Trans-Pro / -90.5,-177.3
Favored (43.1%) Cg_exo
chi angles: 338.2,29.9,332.4
0.04Å---
A1176 THR6.42-Favored (45.03%)
General / -72.5,148.4
Favored (4.8%) t
chi angles: 180.2
0.10Å---
A1177 LYS6.25-Favored (38.56%)
General / -112.5,146.4
Favored (5.3%) ttmt
chi angles: 199.2,180,320.1,177.1
0.15Å---
A1178 SER6.56-Favored (19.76%)
General / -124.3,164.3
Favored (40.1%) p
chi angles: 76.2
0.22Å---
A1179 THR6.58-Favored (4.72%)
General / -71.0,108.7
Favored (84.1%) m
chi angles: 301.9
0.06Å---
A1180 LYS7.090.45Å
HB3 with A1182 TYR HD2
Favored (34.11%)
Pre-Pro / -107.3,146.9
Favored (32.5%) mtpt
chi angles: 286,161.7,81.9,178.9
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1181 PRO7.15-Favored (13.43%)
Trans-Pro / -73.9,-3.2
Favored (11.2%) Cg_endo
chi angles: 16,331.9,30
0.12Å---
A1182 TYR70.45Å
HD2 with A1180 LYS HB3
Favored (21.35%)
General / -95.0,149.3
Favored (6.5%) m-80
chi angles: 316.8,275
0.08Å---
A1183 LYS8.19-Favored (77.5%)
General / -55.6,-44.8
Favored (8.3%) ttmt
chi angles: 189.9,178.5,313.3,166.6
0.14Å---
A1184 ASN8.68-Favored (4.25%)
General / -128.2,-177.7
Favored (15.6%) m110
chi angles: 293.9,87.5
0.13Å- OUTLIER(S)
worst is CA-CB-CG: 5.6 σ
-
A1185 GLY9.71-Favored (35.26%)
Glycine / -95.7,-168.2
-----
A1186 GLN9.7-Favored (3.19%)
General / -70.3,106.0
Favored (22.5%) mp10
chi angles: 292.1,94.2,319.7
0.09Å---
A1187 LEU9.82-Favored (17.16%)
General / -138.0,121.4
Favored (12.6%) tp
chi angles: 194.9,69.6
0.08Å---
A1188 SER10.42-Favored (7.57%)
General / -137.9,110.6
Favored (46.3%) t
chi angles: 179.7
0.10Å---
A1189 LYS11.03-Favored (8.17%)
General / 49.1,36.1
Favored (9.5%) mmmt
chi angles: 271.7,290.1,301.6,184.1
0.11Å---
A1190 VAL10.390.51Å
HG13 with A1191 MET N
Favored (10.3%)
Ile or Val / -72.0,-56.4
Favored (8%) p
chi angles: 61.1
0.13Å---
A1191 MET9.790.51Å
N with A1190 VAL HG13
Favored (4.47%)
General / -145.7,108.2
Favored (28.2%) mtm
chi angles: 281.7,165.4,284.7
0.16Å---
A1192 ILE9.01-Favored (20.02%)
Ile or Val / -122.2,107.6
Favored (39.9%) mm
chi angles: 296,296.9
0.09Å---
A1193 ILE8.62-OUTLIER (0.01)%)
Ile or Val / -161.5,-165.5
Favored (6.7%) tt
chi angles: 199.6,158.3
0.14Å---
A1194 GLU8.60.41Å
H with A1194 GLU HG3
Favored (72.09%)
General / -59.9,-33.6
OUTLIER (0.2%)
chi angles: 31.3,96.8,19.1
0.10Å---
A1195 ASN7.70.43Å
O with A1275 ASP HB2
Favored (70.08%)
General / -61.5,-29.6
Favored (70%) m-40
chi angles: 292.8,354.1
0.12Å- OUTLIER(S)
worst is CA-CB-CG: 7.4 σ
-
A1196 SER7.07-Favored (32.55%)
General / -77.6,127.5
Favored (63.7%) m
chi angles: 297.6
0.08Å---
A1197 HIS6.76-Favored (5.66%)
General / -172.3,163.2
Favored (13.6%) t-90
chi angles: 190.3,243.7
0.12Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.4 σ
-
A1198 VAL6.42-Favored (32.37%)
Ile or Val / -74.3,-32.7
Favored (7.1%) p
chi angles: 60.3
0.13Å---
A1199 LYS6.2-Favored (49.95%)
General / -55.9,132.6
OUTLIER (0.2%)
chi angles: 52.3,161.8,303.7,329
0.08Å---
A1200 LYS5.82-Favored (15.08%)
General / -106.7,161.0
Favored (4.3%) mtmt
chi angles: 301.3,180,315,157.4
0.21Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1201 ASP5.87-Favored (3.12%)
General / -124.2,89.6
Favored (8.7%) m-30
chi angles: 293.3,12.7
0.19Å---
A1202 ASP4.56-Favored (82.09%)
General / -67.4,-36.9
Favored (64%) m-30
chi angles: 291.6,358.6
0.09Å- OUTLIER(S)
worst is CA-CB-CG: 4.5 σ
-
A1203 ILE4.43-Favored (14.34%)
Ile or Val / -83.3,141.8
Favored (44.1%) mm
chi angles: 299.6,296.7
0.03Å---
A1204 TRP4.13-Favored (75.3%)
Pre-Pro / -74.2,139.0
Favored (34.6%) t-100
chi angles: 174,273
0.07Å---
A1205 PRO4.46-Favored (17.71%)
Trans-Pro / -81.0,149.4
Favored (22.1%) Cg_endo
chi angles: 19.8,329.8,29.5
0.10Å---
A1206 SER4.34-Favored (50.53%)
General / -130.4,142.2
Favored (66.8%) m
chi angles: 297
0.17Å- OUTLIER(S)
worst is C-N-CA: 6.9 σ
-
A1207 GLY285.75-Favored (4.27%)
Glycine / 123.0,133.8
-----
A1208 GLY293.89-Favored (39.06%)
Glycine / -107.6,11.8
-----
A1209 GLN327.67-Favored (29.99%)
General / -79.4,153.1
Favored (33.7%) tt0
chi angles: 197.5,171.9,47
0.02Å---
A1210 MET327.67-Favored (23.29%)
General / -149.6,141.0
Favored (20.3%) ttt
chi angles: 196.1,181.7,177.7
0.02Å---
A1211 THR323.98-Favored (16.57%)
General / -137.1,120.2
Favored (28.6%) m
chi angles: 307.1
0.01Å---
A1212 VAL326.73-Favored (17.72%)
Ile or Val / -103.7,142.3
Favored (84.7%) t
chi angles: 177.2
0.06Å---
A1213 LYS327.67-Favored (11.45%)
General / -149.3,126.6
Favored (40.3%) pttt
chi angles: 49.6,177.5,175,174.1
0.05Å---
A1214 ASP321.94-Favored (20.64%)
General / 57.4,44.9
Favored (34.9%) m-30
chi angles: 305.7,324.8
0.07Å---
A1215 LEU327.67-Favored (34.04%)
General / -82.1,128.3
Allowed (1.4%) tt
chi angles: 206.8,173.1
0.01Å---
A1216 THR290.87-Favored (12%)
General / -138.4,116.8
Favored (82.1%) m
chi angles: 302.3
0.04Å---
A1217 ALA310.28-Favored (44.99%)
General / -121.9,148.2
-0.02Å---
A1218 LYS300.06-Favored (51.43%)
General / -134.5,151.9
Favored (88%) mttt
chi angles: 303.7,184.3,183.5,182.4
0.02Å---
A1219 TYR284.67-Favored (5.44%)
General / -74.9,-55.8
Favored (48.4%) t80
chi angles: 189.4,71.1
0.02Å---
A1220 THR305.48-Favored (15.83%)
General / -108.7,160.6
Favored (22.6%) p
chi angles: 51.3
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1221 GLU327.31-Favored (3.16%)
General / -57.3,116.2
Allowed (1.9%) pm20
chi angles: 79.5,302.9,330
0.13Å---
A1222 GLY320.54-Favored (80.84%)
Glycine / 65.6,31.7
-----
A1223 GLY316.42-Favored (16.54%)
Glycine / -89.7,-147.4
-----
A1224 ASN324.4-Favored (28.37%)
General / -75.9,125.1
Favored (36.3%) m110
chi angles: 295,121.2
0.03Å---
A1225 ALA311.85-Favored (4.13%)
General / -76.8,95.9
-0.02Å---
A1226 ILE292.52-Favored (13.51%)
Ile or Val / -78.9,-53.5
Favored (2%) mp
chi angles: 306.4,107.4
0.04Å---
A1227 LEU293.260.42Å
HB3 with A1230 ILE HD12
Favored (35.67%)
General / -97.1,137.7
Favored (31.1%) mt
chi angles: 309.5,182.2
0.06Å---
A1228 GLU298.65-Favored (4.5%)
General / -145.2,108.1
Favored (30.8%) tp30
chi angles: 173.4,53.6,39.5
0.02Å---
A1229 ASN318.11-Favored (25.36%)
General / 56.7,43.4
Favored (57.4%) t0
chi angles: 199.3,38.2
0.07Å---
A1230 ILE316.410.42Å
HD12 with A1227 LEU HB3
Favored (19.55%)
Ile or Val / -79.3,138.7
Favored (61.4%) mt
chi angles: 292.5,177.5
0.07Å---
A1231 SER327.67-Favored (7.25%)
General / -147.5,117.5
Favored (52%) m
chi angles: 300.8
0.03Å---
A1232 PHE327.67-Favored (15.97%)
General / -160.6,173.1
Favored (39.3%) p90
chi angles: 64.2,279.6
0.03Å---
A1233 SER324.52-Favored (50.18%)
General / -135.7,151.5
Favored (11.9%) t
chi angles: 189.3
0.01Å---
A1234 ILE297.46-Favored (69.12%)
Ile or Val / -127.2,127.2
Favored (36.7%) mt
chi angles: 309.1,175.3
0.02Å---
A1235 SER300.08-Favored (89.22%)
Pre-Pro / -73.8,154.0
Favored (60.8%) m
chi angles: 298.8
0.01Å---
A1236 PRO281.52-Favored (11.42%)
Trans-Pro / -76.3,129.7
Favored (77.6%) Cg_endo
chi angles: 28.6,328.7,21.3
0.04Å---
A1237 GLY288.94-Favored (6.4%)
Glycine / 72.9,55.5
-----
A1238 GLN315.32-Favored (41.21%)
General / -137.3,139.8
Favored (43.6%) mm-40
chi angles: 285.5,281.8,311.7
0.03Å---
A1239 ARG327.67-Favored (22.26%)
General / -84.0,115.2
Favored (22.3%) ttm110
chi angles: 196.8,182.6,288.2,93.6
0.01Å---
A1240 VAL304.02-Favored (27.63%)
Ile or Val / -104.9,138.9
Favored (19.9%) t
chi angles: 187
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1241 GLY308.21-Favored (4.24%)
Glycine / -105.4,113.3
-----
A1242 LEU327.67-Favored (26.39%)
General / -88.7,115.6
Favored (14%) tp
chi angles: 194.6,65.1
0.01Å---
A1243 LEU324.480.41Å
CD1 with A1430 LEU HD21
Favored (35.75%)
General / -135.2,161.3
Favored (63.7%) mt
chi angles: 295.8,166.7
0.02Å---
A1244 GLY297.95-Favored (9.23%)
Glycine / 163.5,-144.1
-----
A1245 ARG301.3-Favored (4.66%)
General / -73.9,104.1
Favored (90.4%) mtm180
chi angles: 295.9,176.3,290.5,175.2
0.01Å---
A1246 THR314.07-Favored (18.63%)
General / -64.4,123.2
Favored (11.1%) t
chi angles: 189.1
0.07Å---
A1247 GLY278.43-Favored (75.6%)
Glycine / 92.1,-9.8
-----
A1248 SER282.25-Favored (79.49%)
General / -65.4,-35.0
Favored (97.3%) p
chi angles: 65.1
0.03Å---
A1249 GLY202.73-Allowed (0.59%)
Glycine / 125.3,85.1
-----
A1250 LYS327.67-Favored (76.63%)
General / -67.3,-45.4
Favored (15.2%) pttm
chi angles: 64.7,183.7,168.2,293.4
0.07Å---
A1251 SER327.67-Favored (66.7%)
General / -56.5,-34.1
Favored (15.7%) t
chi angles: 187.8
0.02Å---
A1252 THR327.67-Favored (87.03%)
General / -62.9,-37.4
Allowed (1.5%) m
chi angles: 319.3
0.01Å---
A1253 LEU327.67-Favored (65.69%)
General / -71.6,-43.8
Allowed (0.7%) tt
chi angles: 206.6,154
0.04Å---
A1254 LEU327.67-Favored (70.34%)
General / -59.1,-33.0
Favored (52.4%) mt
chi angles: 289.5,163.2
0.04Å---
A1255 SER327.67-Favored (73.84%)
General / -68.1,-33.1
Favored (47.3%) m
chi angles: 301.6
0.01Å---
A1256 ALA315.17-Favored (67.25%)
General / -67.0,-27.2
-0.05Å---
A1257 PHE327.67-Favored (16.35%)
General / -67.2,-55.0
Favored (49.2%) m-80
chi angles: 285.6,290.8
0.03Å---
A1258 LEU327.670.60Å
HD11 with A1288 VAL HG21
Favored (60.41%)
General / -75.5,-14.0
Favored (81.4%) mt
chi angles: 300.5,175.4
0.02Å---
A1259 ARG327.67-Allowed (0.14%)
General / 72.0,67.0
Favored (42.6%) mtp180
chi angles: 310.8,175.8,76.9,173
0.10Å---
A1260 LEU307.04-Favored (5.84%)
General / -114.6,32.6
Favored (31.1%) mt
chi angles: 306.1,170.6
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1261 LEU304.55-Favored (5.51%)
General / -163.8,-178.1
Allowed (1.2%) pt
chi angles: 64,166.8
0.02Å---
A1262 ASN307.76-Favored (43.34%)
General / -73.0,132.4
Favored (11.2%) m-40
chi angles: 294.2,261.3
0.03Å---
A1263 THR292.89-Favored (49.59%)
General / -135.3,148.5
Favored (29.8%) p
chi angles: 53
0.02Å---
A1264 GLU321.67-Favored (27.52%)
General / -149.0,145.9
Favored (61.1%) tp30
chi angles: 180.5,59.1,31.9
0.03Å---
A1265 GLY299.75-Favored (21.57%)
Glycine / 131.3,-156.0
-----
A1266 GLU284.41-Favored (9.91%)
General / -150.2,125.1
Favored (39.9%) tt0
chi angles: 192.1,165.5,20.5
0.01Å---
A1267 ILE286.35-Favored (32.14%)
Ile or Val / -126.5,146.5
Favored (38.1%) mt
chi angles: 305.5,163.1
0.03Å---
A1268 GLN305.45-Favored (49.04%)
General / -137.5,152.0
Favored (79.9%) mt0
chi angles: 299.1,184.2,328.3
0.03Å---
A1269 ILE273.75-Favored (4.34%)
Ile or Val / -113.6,96.0
Favored (79.7%) mt
chi angles: 300.2,173
0.04Å---
A1270 ASP257.1-Favored (25.26%)
General / 55.6,45.3
Favored (33.5%) t0
chi angles: 197.1,19.2
0.06Å---
A1271 GLY267.86-Favored (84.87%)
Glycine / 87.2,0.7
-----
A1272 VAL277.74-Favored (24.81%)
Ile or Val / -79.4,135.8
Favored (86.9%) t
chi angles: 176.2
0.03Å---
A1273 SER295.34-Favored (28.49%)
General / -75.7,162.1
Favored (16.8%) t
chi angles: 187.1
0.01Å---
A1274 TRP271.59-Favored (6.06%)
General / -88.2,-50.9
Favored (44.6%) t-100
chi angles: 190.8,244.3
0.04Å---
A1275 ASP242.550.43Å
HB2 with A1195 ASN O
Favored (61.92%)
General / -71.9,-25.4
Favored (7.3%) p0
chi angles: 71.2,318.2
0.04Å---
A1276 SER260.03-Favored (2.38%)
General / -64.1,-61.2
Favored (96%) p
chi angles: 63.4
0.04Å---
A1277 ILE254.99-Favored (38.43%)
Ile or Val / -79.6,128.7
Favored (46.4%) mm
chi angles: 305.1,300.7
0.02Å---
A1278 THR258.44-Favored (44.85%)
General / -69.0,152.8
Favored (48.5%) p
chi angles: 55.9
0.03Å---
A1279 LEU283.51-Favored (14.2%)
General / -55.3,-21.3
Favored (3.3%) pp
chi angles: 57.1,84.7
0.12Å---
A1280 GLN315.42-Favored (6.98%)
General / -72.0,-55.7
Favored (23.6%) mt0
chi angles: 294.2,179,231.4
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1281 GLN327.67-Favored (64.29%)
General / -69.7,-26.4
Favored (79.7%) mt0
chi angles: 293.3,177.2,21.3
0.03Å---
A1282 TRP278.95-Favored (82.69%)
General / -57.5,-42.3
Favored (71.6%) t-100
chi angles: 175.7,252.9
0.01Å---
A1283 ARG327.67-Favored (65.28%)
General / -65.6,-18.4
Favored (70.5%) mtt90
chi angles: 293.9,182.6,187.8,99.3
0.04Å---
A1284 LYS327.67-Favored (39.41%)
General / -53.0,-31.1
Favored (27.7%) mmtm
chi angles: 293.6,290,190.4,297.4
0.03Å---
A1285 ALA324.76-Favored (87.84%)
General / -66.9,-40.8
-0.03Å---
A1286 PHE313.75-Favored (21.21%)
General / -82.5,164.0
Favored (36.7%) m-80
chi angles: 281.2,288.9
0.05Å---
A1287 GLY297.58-Allowed (0.36%)
Glycine / -149.2,107.4
-----
A1288 VAL301.90.60Å
HG21 with A1258 LEU HD11
Favored (12.38%)
Ile or Val / -101.1,144.8
Favored (17.1%) t
chi angles: 187.6
0.02Å---
A1289 ILE300.88-Favored (79.38%)
Pre-Pro / -128.6,75.6
Favored (4.4%) tt
chi angles: 178,157.1
0.15Å---
A1290 PRO317.14-Favored (2%)
Trans-Pro / -79.9,-173.8
Favored (10.8%) Cg_endo
chi angles: 15.6,359.2,345.7
0.03Å---
A1291 GLN327.67-Favored (73.65%)
General / -67.5,-46.1
Favored (6.5%) mm110
chi angles: 303.2,284.1,53.7
0.03Å---
A1292 LYS327.67-Favored (29.48%)
General / -89.8,140.5
Favored (31.7%) mtmt
chi angles: 298.2,168.6,294.4,179.1
0.12Å---
A1293 VAL304.27-Favored (68.83%)
Ile or Val / -123.0,133.5
Favored (14%) t
chi angles: 188.5
0.01Å---
A1294 PHE301.96-Favored (40.09%)
General / -76.2,132.7
Favored (28.5%) t80
chi angles: 193.7,68.1
0.01Å---
A1295 ILE299.95-Favored (41.38%)
Ile or Val / -125.1,114.7
Favored (33.3%) mt
chi angles: 305.6,161.8
0.03Å---
A1296 PHE325.07-Favored (37.63%)
General / -72.2,157.5
Favored (77%) m-80
chi angles: 287.9,89.1
0.04Å---
A1297 SER315.44-Favored (2.36%)
General / -97.1,70.1
Favored (70.8%) m
chi angles: 296.2
0.02Å---
A1298 GLY276.51-Favored (5.43%)
Glycine / -171.8,-146.8
-----
A1299 THR253.8-Favored (18.3%)
General / -96.2,152.7
Favored (69.1%) p
chi angles: 58.9
0.04Å---
A1300 PHE286.07-Favored (67.02%)
General / -65.6,-24.2
Favored (56.9%) m-80
chi angles: 293.7,295.8
0.05Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1301 ARG327.67-Favored (96.62%)
General / -64.2,-42.8
Favored (61.1%) mtp180
chi angles: 298.2,191.6,71.7,176.4
0.02Å---
A1302 LYS327.67-Favored (60.59%)
General / -75.6,-33.3
Favored (28.8%) tttp
chi angles: 197.6,172.4,185.5,75.2
0.03Å---
A1303 ASN276.12-Favored (71.48%)
General / -63.0,-50.2
Allowed (1.3%) m-40
chi angles: 279.4,240.3
0.04Å---
A1304 LEU301.94-Favored (76.02%)
General / -69.8,-36.9
Favored (4.2%) mp
chi angles: 286.3,77
0.19Å---
A1305 ASP278.97-Favored (58.33%)
Pre-Pro / -132.0,82.8
Favored (43.1%) t0
chi angles: 188.3,9.4
0.05Å---
A1306 PRO271.9-Favored (47.08%)
Trans-Pro / -65.8,-32.2
Favored (49.4%) Cg_exo
chi angles: 337.8,34.1,328
0.04Å---
A1307 TYR253.65-Favored (61.16%)
General / -72.8,-20.2
Favored (81.1%) m-80
chi angles: 289.5,276.9
0.04Å---
A1308 GLU296.48-Favored (7.98%)
General / 59.4,50.2
Favored (41.6%) mt-10
chi angles: 305.2,189.9,316.9
0.08Å---
A1309 GLN327.67-Favored (2.54%)
General / -132.8,47.1
Favored (58.1%) mt0
chi angles: 303.4,186.9,339.2
0.02Å---
A1310 TRP293.32-Favored (29.46%)
General / -140.1,133.2
Favored (55.3%) m100
chi angles: 289.5,120.1
0.03Å---
A1311 SER262.05-Favored (38.88%)
General / -73.9,155.3
Favored (45.4%) p
chi angles: 56.1
0.01Å---
A1312 ASP294-Favored (78.85%)
General / -68.1,-35.8
Favored (69.5%) m-30
chi angles: 296.2,312.1
0.02Å---
A1313 GLN314.59-Favored (64.05%)
General / -54.7,-51.9
Favored (84%) mt0
chi angles: 289.4,184.1,327.8
0.03Å---
A1314 GLU311.98-Favored (59.72%)
General / -75.4,-29.1
Favored (7.7%) pt0
chi angles: 72.9,189.7,298.7
0.11Å---
A1315 ILE286.93-Favored (95.4%)
Ile or Val / -62.1,-46.9
Favored (41.9%) mt
chi angles: 289.7,157.5
0.06Å---
A1316 TRP294.11-Favored (86.5%)
General / -66.6,-38.2
Favored (47.2%) m100
chi angles: 273.9,100.7
0.08Å---
A1317 LYS327.67-Favored (83.8%)
General / -66.9,-37.1
Favored (10.7%) ttpp
chi angles: 193.1,165.6,68.9,63.6
0.03Å---
A1318 VAL292.42-Favored (64.85%)
Ile or Val / -72.1,-44.8
Favored (40%) t
chi angles: 167.6
0.06Å---
A1319 ALA316.08-Favored (63.6%)
General / -56.6,-30.8
-0.03Å---
A1320 ASP327.67-Favored (65.63%)
General / -70.5,-45.4
Favored (28%) t0
chi angles: 185.1,36.5
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1321 GLU327.67-Favored (60.07%)
General / -66.2,-51.2
Favored (56.2%) mt-10
chi angles: 286.5,186.5,324
0.03Å---
A1322 VAL327.670.48Å
HG21 with A1357 ALA HB2
Favored (34.22%)
Ile or Val / -68.5,-26.8
Favored (27.3%) m
chi angles: 301
0.08Å---
A1323 GLY289.04-Favored (4.16%)
Glycine / 98.5,37.8
-----
A1324 LEU292.36-Favored (22.21%)
General / -98.9,-10.9
Favored (64.7%) mt
chi angles: 292.3,164.8
0.01Å---
A1325 ARG324-Favored (3.93%)
General / -41.7,-52.1
Favored (30.3%) ttt90
chi angles: 175.3,158.5,178.6,75.2
0.01Å---
A1326 SER322.42-Favored (3.14%)
General / -68.3,-59.5
Favored (56.7%) p
chi angles: 57.4
0.02Å---
A1327 VAL296.75-Favored (59.28%)
Ile or Val / -64.0,-33.0
Favored (95.1%) t
chi angles: 174.8
0.07Å---
A1328 ILE326.41-Favored (99.68%)
Ile or Val / -62.5,-45.1
Favored (11.2%) mm
chi angles: 292,284.8
0.04Å---
A1329 GLU313.18-Favored (62.3%)
General / -71.6,-16.2
Favored (59.9%) mt-10
chi angles: 284.6,168.2,325.6
0.10Å---
A1330 GLN327.67-Favored (2.67%)
General / -94.1,59.4
Favored (17.4%) mm110
chi angles: 303.1,305,140.5
0.03Å---
A1331 PHE255.68-Favored (22.44%)
Pre-Pro / -161.1,162.2
Favored (6.8%) m-80
chi angles: 271,301.8
0.03Å---
A1332 PRO258.25-Favored (23.65%)
Trans-Pro / -72.6,135.2
Favored (61.3%) Cg_endo
chi angles: 26.6,327,25.9
0.03Å---
A1333 GLY289.15-Favored (12.9%)
Glycine / 86.1,-134.9
-----
A1334 LYS327.67-Allowed (0.82%)
General / -131.7,-63.6
Favored (73.1%) mttt
chi angles: 278,188.9,176,182.5
0.02Å---
A1335 LEU279.45-Favored (4.29%)
General / -132.6,19.9
Favored (45%) mt
chi angles: 291.9,162.5
0.04Å---
A1336 ASP292.44-Favored (36.75%)
General / -104.0,8.9
Favored (10.3%) m-30
chi angles: 311.1,325.2
0.02Å---
A1337 PHE259.15-Favored (39.19%)
General / -74.0,130.1
Favored (57.8%) t80
chi angles: 176,64.5
0.01Å---
A1338 VAL267.8-Favored (34.12%)
Ile or Val / -80.8,121.3
Favored (62.8%) t
chi angles: 179.6
0.01Å---
A1339 LEU293.85-Favored (5.76%)
General / -79.5,81.2
Favored (53.9%) mt
chi angles: 289.1,163.4
0.03Å---
A1340 VAL290.17-Favored (4.29%)
Ile or Val / -79.3,160.8
Favored (16.8%) m
chi angles: 303.7
0.07Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1341 ASP319.1-Favored (18.28%)
General / 59.3,28.8
Favored (51.3%) m-30
chi angles: 304,319.5
0.08Å---
A1342 GLY294.18-Favored (96.62%)
Glycine / 65.0,39.7
-----
A1343 GLY307.08-Favored (5.91%)
Glycine / 70.3,58.6
-----
A1344 CYS303.59-Favored (45.59%)
General / -75.5,-44.0
Favored (30.3%) p
chi angles: 60.3
0.01Å---
A1345 VAL310.6-Favored (86.27%)
Ile or Val / -63.0,-39.7
Favored (25.7%) m
chi angles: 299.5
0.09Å---
A1346 LEU303.13-Favored (34.5%)
General / -78.3,129.0
Favored (62.3%) mt
chi angles: 300,170.2
0.02Å---
A1347 SER290.63-Favored (7.18%)
General / -83.1,-178.7
Favored (97.6%) p
chi angles: 65.8
0.03Å---
A1348 HIS303.12-Favored (36.83%)
General / -58.8,-55.3
Favored (60.1%) m-70
chi angles: 289.2,261.9
0.02Å---
A1349 GLY310.63-Favored (23.38%)
Glycine / -49.1,-37.6
-----
A1350 HIS309.02-Favored (73.25%)
General / -70.8,-39.0
Favored (44%) m90
chi angles: 298.4,105.7
0.02Å---
A1351 LYS313.7-Favored (75.19%)
General / -65.4,-33.1
Favored (86.2%) mttt
chi angles: 293.3,168.2,186,180.2
0.05Å---
A1352 GLN320.23-Favored (88.42%)
General / -65.5,-44.0
Favored (38.2%) mm-40
chi angles: 307.2,318.8,313.3
0.05Å---
A1353 LEU288.28-Favored (86.38%)
General / -66.5,-38.0
Favored (67.5%) mt
chi angles: 292,165.2
0.02Å---
A1354 MET327.67-Favored (70%)
General / -66.3,-48.5
Favored (10.8%) tpt
chi angles: 194.4,73.5,184.4
0.01Å---
A1355 CYS327.67-Favored (76.16%)
General / -62.2,-34.2
Favored (42.1%) t
chi angles: 186.3
0.00Å---
A1356 LEU327.67-Favored (17.94%)
General / -65.2,-55.6
Favored (14.4%) tp
chi angles: 170.6,53.2
0.01Å---
A1357 ALA327.670.48Å
HB2 with A1322 VAL HG21
Favored (72.61%)
General / -55.2,-41.9
-0.02Å---
A1358 ARG327.67-Favored (72.75%)
General / -55.6,-40.9
Favored (47.7%) ttm170
chi angles: 190.9,174,289.9,168.5
0.03Å---
A1359 SER310.68-Favored (60.84%)
General / -73.7,-42.7
Favored (6.8%) m
chi angles: 309.7
0.02Å---
A1360 VAL291.7-Favored (92.22%)
Ile or Val / -63.2,-41.3
Favored (59.8%) t
chi angles: 170.8
0.06Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1361 LEU269.76-Favored (67.74%)
General / -64.3,-24.7
Favored (26%) tp
chi angles: 186.7,55.1
0.03Å---
A1362 SER296.25-Favored (36.58%)
General / -82.8,1.9
Favored (4%) m
chi angles: 312.5
0.02Å---
A1363 LYS291.56-Favored (6.03%)
General / 43.4,49.6
Favored (53%) pttt
chi angles: 59.3,175.2,173,182.9
0.17Å---
A1364 ALA285.49-Favored (48.42%)
General / -72.1,139.5
-0.01Å---
A1365 LYS274.46-Favored (7.57%)
General / -79.2,-52.9
Favored (20.8%) mmtp
chi angles: 297.7,284.9,183.6,65.9
0.01Å---
A1366 ILE273.21-Favored (25.63%)
Ile or Val / -111.7,141.9
Favored (40.4%) mt
chi angles: 302.5,159.8
0.04Å---
A1367 LEU296.52-Favored (51.21%)
General / -127.2,143.7
Favored (2.3%) mp
chi angles: 290.3,95.9
0.02Å---
A1368 LEU323.87-Favored (33.54%)
General / -115.7,118.6
Favored (69.5%) mt
chi angles: 298.9,170.3
0.04Å---
A1369 LEU327.67-Favored (38.46%)
General / -108.7,119.1
Favored (7.1%) mp
chi angles: 279,67
0.01Å---
A1370 ASP327.67-Favored (6.48%)
General / -115.6,98.0
Favored (31.5%) t70
chi angles: 188.1,53.9
0.02Å---
A1371 GLU327.67-Allowed (0.69%)
Pre-Pro / 56.5,74.4
Favored (13.8%) mt-10
chi angles: 298.2,201.5,55.4
0.08Å---
A1372 PRO325.37-Allowed (0.14%)
Trans-Pro / -76.6,-47.9
Favored (39.4%) Cg_endo
chi angles: 23.2,333.4,19
0.03Å---
A1373 SER327.67-Favored (60.58%)
General / -75.0,-16.9
Favored (76.6%) p
chi angles: 60.2
0.03Å---
A1374 ALA327.67-Favored (3.3%)
General / -70.0,-58.9
-0.02Å---
A1375 HIS327.67-Favored (49.49%)
General / -76.5,-40.8
Favored (57%) m-70
chi angles: 293.2,258
0.02Å---
A1376 LEU316.91-Favored (19.76%)
General / -76.7,168.6
Favored (51.1%) mt
chi angles: 304.4,173
0.02Å---
A1377 ASP317.71-Favored (45.09%)
Pre-Pro / -112.7,153.4
Favored (15.8%) p0
chi angles: 58.4,310.1
0.03Å---
A1378 PRO315.88-Favored (6.91%)
Trans-Pro / -42.2,-41.1
Favored (67.9%) Cg_exo
chi angles: 328.7,34.3,336.8
0.04Å---
A1379 VAL308.060.41Å
HG12 with A1383 ILE HD12
Favored (86.9%)
Ile or Val / -65.5,-47.3
Favored (91.1%) t
chi angles: 174.3
0.04Å---
A1380 THR291.26-Favored (91.89%)
General / -64.9,-43.8
Favored (41.9%) m
chi angles: 304.9
0.01Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1381 TYR284.68-Favored (85.17%)
General / -58.5,-41.3
Favored (62.4%) t80
chi angles: 187.7,79.4
0.01Å---
A1382 GLN304.05-Favored (67.66%)
General / -69.2,-46.4
Favored (36.7%) tt0
chi angles: 192.6,186.8,314.6
0.02Å---
A1383 ILE309.680.41Å
HD12 with A1379 VAL HG12
Favored (79.57%)
Ile or Val / -60.0,-39.2
Favored (36.8%) mt
chi angles: 288.3,157.4
0.11Å---
A1384 ILE323.76-Favored (10.05%)
Ile or Val / -69.5,-56.9
Favored (11.3%) mm
chi angles: 293.9,284.7
0.03Å---
A1385 ARG327.67-Favored (76.81%)
General / -64.0,-33.9
Favored (14.6%) tpt-90
chi angles: 189.5,59.1,166.4,284
0.04Å---
A1386 ARG327.67-Favored (61.4%)
General / -73.3,-15.1
Favored (33.4%) ttt180
chi angles: 200.5,165.9,193.3,177.9
0.06Å---
A1387 THR309.08-Favored (12.18%)
General / -106.2,-25.0
Favored (8.7%) t
chi angles: 193
0.11Å---
A1388 LEU298.93-Favored (93.04%)
General / -65.5,-40.5
Favored (27.5%) tp
chi angles: 187.3,66.8
0.01Å---
A1389 LYS298.67-Favored (82.33%)
General / -67.3,-43.2
Favored (54.8%) mtmt
chi angles: 293.4,195,289.2,184
0.06Å---
A1390 GLN291.6-Favored (63.31%)
General / -72.5,-29.1
Favored (14.7%) pm20
chi angles: 55.4,265.1,37.6
0.10Å---
A1391 ALA289.71-Favored (79.93%)
General / -66.8,-35.4
-0.04Å---
A1392 PHE278.15-Allowed (1.33%)
General / -123.6,53.7
Favored (29.5%) m-80
chi angles: 303.7,307.6
0.01Å---
A1393 ALA288.46-Favored (70.34%)
General / -69.0,-45.5
-0.02Å---
A1394 ASP279.3-Allowed (0.69%)
General / -110.9,54.0
Favored (18.5%) t70
chi angles: 197.4,52.5
0.05Å---
A1395 CYS262.73-Favored (40.14%)
General / -145.4,152.6
Favored (67%) m
chi angles: 286.7
0.02Å---
A1396 THR280.09-Favored (40.5%)
General / -75.6,135.6
Favored (7.6%) m
chi angles: 313.2
0.02Å---
A1397 VAL295.33-Favored (52.3%)
Ile or Val / -133.7,137.7
Favored (41.5%) t
chi angles: 183.1
0.03Å---
A1398 ILE298.38-Favored (13.94%)
Ile or Val / -125.5,104.8
Favored (71.9%) mt
chi angles: 297.8,163.5
0.02Å---
A1399 LEU306.04-Favored (43.52%)
General / -100.2,134.2
Favored (64%) tp
chi angles: 179.4,58.9
0.03Å---
A1400 CYS327.67-Favored (42.7%)
General / -118.2,122.3
Favored (22.8%) t
chi angles: 190.4
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1401 GLU327.67-Favored (43%)
General / -141.4,150.9
Favored (22.5%) mm-30
chi angles: 282.7,281.8,8.8
0.03Å---
A1402 HIS321.6-Favored (34.7%)
General / -79.4,-38.4
Favored (94.2%) m-70
chi angles: 295.8,279.4
0.01Å---
A1403 ARG327.67-Favored (34.55%)
General / -79.8,129.5
Favored (27.7%) mmt90
chi angles: 303.5,289.1,175.6,76.8
0.04Å---
A1404 ILE311.71-Favored (61.24%)
Ile or Val / -71.5,-36.7
Favored (3.8%) tp
chi angles: 199.5,76.2
0.11Å---
A1405 GLU327.67-Favored (63.89%)
General / -69.2,-23.6
Favored (6.6%) mp0
chi angles: 274.7,70.6,49.2
0.06Å---
A1406 ALA327.67-Favored (66.85%)
General / -65.1,-21.9
-0.04Å---
A1407 MET327.67-Allowed (1.21%)
General / -114.5,47.7
Favored (10.4%) ptp
chi angles: 53.7,166.8,63.2
0.06Å---
A1408 LEU327.67-Favored (65.37%)
General / -73.2,-39.6
Favored (5.4%) tt
chi angles: 187.1,142.5
0.01Å---
A1409 GLU327.67-Favored (64.99%)
General / -68.1,-24.2
Favored (61.9%) mm-30
chi angles: 295.2,290.3,314.8
0.03Å---
A1410 CYS327.67-Favored (8.06%)
General / -65.8,117.3
Favored (80.1%) m
chi angles: 296.1
0.01Å---
A1411 GLN326.83-Favored (12.95%)
General / -72.0,-53.5
Favored (30.4%) mm110
chi angles: 293.7,289.7,117.4
0.08Å---
A1412 GLN318.94-Favored (21.15%)
General / -86.5,154.4
Favored (3.8%) tt0
chi angles: 195.3,166.8,211.5
0.02Å---
A1413 PHE293.350.51Å
HE1 with A1427 ILE HG12
Favored (50.99%)
General / -132.7,153.6
Favored (91.4%) m-80
chi angles: 291.3,90.8
0.15Å- OUTLIER(S)
worst is CA-CB-CG: 4.2 σ
-
A1414 LEU323.07-Favored (24.83%)
General / -133.9,123.5
Favored (86.8%) mt
chi angles: 297.2,171.6
0.03Å---
A1415 VAL319.04-Favored (54.69%)
Ile or Val / -102.3,128.7
Favored (60.7%) t
chi angles: 170.9
0.02Å---
A1416 ILE319.91-Favored (44.2%)
Ile or Val / -113.1,138.0
Favored (11.8%) mt
chi angles: 306.7,155
0.03Å---
A1417 GLU294.9-Favored (15.58%)
General / -162.2,172.6
Favored (6.9%) pt0
chi angles: 54.8,189.7,323.5
0.06Å---
A1418 GLU327.67-Allowed (0.88%)
General / -56.6,111.0
Favored (53%) tp30
chi angles: 188,63,31.3
0.02Å---
A1419 ASN327.67-Favored (15.2%)
General / 63.3,26.8
Favored (8.6%) m110
chi angles: 310.2,136.1
0.09Å---
A1420 LYS327.67-Favored (7.47%)
General / -162.2,137.9
Favored (77.2%) tttt
chi angles: 194.2,175.4,178.3,183.2
0.02Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1421 VAL327.67-Favored (56.05%)
Ile or Val / -133.9,134.2
Favored (93.2%) t
chi angles: 174.6
0.02Å---
A1422 ARG327.67-Favored (42.79%)
General / -136.9,143.3
Favored (49.4%) ttt90
chi angles: 183.9,164.5,177.5,77.2
0.01Å---
A1423 GLN327.67-Favored (24.25%)
General / -99.8,112.0
Favored (8.5%) tm-30
chi angles: 181.1,264,307.3
0.04Å---
A1424 TYR327.67-Favored (35.73%)
General / -90.5,125.9
Favored (38.3%) m-80
chi angles: 284.4,74.2
0.10Å---
A1425 ASP327.67-Favored (75.48%)
General / -67.7,-45.3
Favored (85.3%) m-30
chi angles: 289.3,335.3
0.12Å---
A1426 SER327.67-Favored (28.66%)
General / -109.9,150.3
Favored (68.3%) m
chi angles: 296.7
0.10Å---
A1427 ILE327.670.51Å
HG12 with A1413 PHE HE1
Favored (84.52%)
Ile or Val / -67.6,-45.6
Favored (60.3%) mt
chi angles: 303.8,168
0.08Å---
A1428 GLN327.67-Favored (88.82%)
General / -66.5,-39.6
Favored (83.5%) mt0
chi angles: 295.9,178.2,356.6
0.13Å---
A1429 LYS319.26-Favored (70%)
General / -65.0,-29.1
Favored (8%) ttmm
chi angles: 196.6,164.2,292.8,297.1
0.05Å---
A1430 LEU327.670.41Å
HD21 with A1243 LEU CD1
Favored (67.45%)
General / -64.6,-50.4
Favored (56.7%) tp
chi angles: 179.9,64.7
0.10Å---
A1431 LEU327.67-Favored (71.05%)
General / -65.2,-49.1
Favored (55.5%) tp
chi angles: 180,64.9
0.06Å---
A1432 ASN327.67-Favored (72.86%)
General / -68.7,-32.8
Favored (42%) p0
chi angles: 69.4,350.2
0.11Å---
A1433 GLU327.670.95Å
HA with A1437 PHE HD2
Favored (60.33%)
General / -69.4,-48.7
Favored (31.7%) tt0
chi angles: 191.8,173.1,311.8
0.03Å---
A1434 ARG327.67-Favored (43.53%)
General / -76.2,-43.2
Favored (48.4%) ttp80
chi angles: 197.5,200.4,66.1,75.5
0.00Å---
A1435 SER276.130.42Å
O with A1439 GLN HG2
Allowed (1.99%)
General / -73.4,-61.0
Favored (3.5%) t
chi angles: 197.8
0.03Å---
A1436 LEU267.7-Favored (31.64%)
General / -91.3,-14.0
Favored (15%) mt
chi angles: 312,172.2
0.02Å- OUTLIER(S)
worst is C-N-CA: 8.3 σ
-
A1437 PHE6.190.95Å
HD2 with A1433 GLU HA
Favored (43.83%)
General / -79.2,-30.9
Favored (41.5%) m-80
chi angles: 280.6,273.4
0.30Å- OUTLIER(S)
worst is N-CA-CB: 5.0 σ
-
A1438 ARG5.82-Favored (43.6%)
General / -72.1,-48.4
Favored (69.6%) mtt180
chi angles: 290.5,180.1,192.1,155.3
0.18Å---
A1439 GLN5.980.42Å
HG2 with A1435 SER O
Favored (42.63%)
General / -98.9,133.8
Favored (2.2%) pt0
chi angles: 72.9,204.8,118.3
0.05Å---
A1440 ALA7.24-Favored (23.39%)
General / -133.7,122.5
-0.08Å---
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1441 ILE7.76-Favored (30.99%)
Ile or Val / -122.5,111.6
Allowed (1.4%) mp
chi angles: 296.1,80.6
0.11Å---
A1442 SER7.73-OUTLIER (0)%)
Pre-Pro / 109.7,150.8
Favored (9.3%) p
chi angles: 82.6
0.30Å- OUTLIER(S)
worst is C-CA-CB: 5.1 σ
-
A1443 PRO6.84-Favored (8.92%)
Trans-Pro / -73.1,123.5
Favored (99.2%) Cg_exo
chi angles: 332.6,28.4,340.4
0.13Å---
A1444 SER8.220.49Å
HB3 with A1446 ARG HH22
Allowed (0.16%)
General / 76.6,155.3
Favored (3%) t
chi angles: 159.9
0.09Å---
A1445 ASP9.27-Favored (26.21%)
General / -79.6,161.0
Favored (2.6%) m-30
chi angles: 290.6,28.6
0.17Å---
A1446 ARG9.410.82Å
HH11 with A1450 PHE HB2
Allowed (1.07%)
General / -150.8,72.4
Allowed (0.9%) tpp-160
chi angles: 201.3,84.3,45.9,237.6
0.15Å---
A1447 VAL8.760.40Å
HG12 with A1448 LYS HG3
Favored (2.15%)
Ile or Val / -139.2,104.3
Favored (81.3%) t
chi angles: 176.5
0.08Å---
A1448 LYS9.380.40Å
HG3 with A1447 VAL HG12
Favored (4.84%)
General / 51.6,28.5
OUTLIER (0.3%)
chi angles: 46.9,76.4,201.1,158.8
0.25Å- OUTLIER(S)
worst is C-N-CA: 4.2 σ
-
A1449 LEU9.9-OUTLIER (0.02)%)
General / 170.1,133.9
Allowed (1.3%) tm
chi angles: 187.7,284.6
0.12Å---
A1450 PHE11.110.82Å
HB2 with A1446 ARG HH11
Favored (19.18%)
Pre-Pro / -140.2,138.3
Favored (46.4%) p90
chi angles: 69.4,275.9
0.17Å- OUTLIER(S)
worst is CA-CB-CG: 5.5 σ
-
A1451 PRO12.47-Favored (23.19%)
Trans-Pro / -80.2,157.7
Favored (69.6%) Cg_exo
chi angles: 335.4,28.9,336.9
0.06Å---
A1452 HIS13.560.42Å
CG with A1452 HIS O
Favored (2.83%)
General / -99.2,83.2
Favored (44.2%) p-80
chi angles: 61.7,293.7
0.03Å- OUTLIER(S)
worst is CD2-NE2-CE1: 4.4 σ
-
A1453 ARG15.07-Allowed (1.04%)
General / -155.5,82.3
OUTLIER (0.1%)
chi angles: 55.1,261.6,319,130.9
0.22Å- OUTLIER(S)
worst is N-CA-CB: 4.2 σ
-
A1454 ASN16.41-Allowed (0.3%)
General / 175.2,170.2
Favored (8.1%) p0
chi angles: 49.8,295.6
0.10Å---
A1455 SER17.78-Favored (5.29%)
General / -66.1,-58.5
Favored (80.3%) p
chi angles: 61.4
0.05Å---
A1456 SER18.83-Allowed (0.09%)
General / 78.6,-175.9
Favored (49.4%) p
chi angles: 74.6
0.16Å---
A1457 LYS19.720.48Å
O with A1458 CYS HB3
Favored (17.52%)
General / -93.4,155.2
OUTLIER (0%)
chi angles: 284.9,293.9,267.7,70.3
0.17Å---
A1458 CYS20.940.48Å
HB3 with A1457 LYS O
Allowed (0.07%)
General / 72.2,-116.4
Favored (41%) t
chi angles: 186.7
0.06Å---
A1459 LYS22.080.42Å
HE3 with A1463 GLN HG2
Favored (47.91%)
General / -125.4,149.7
Favored (6.8%) tptt
chi angles: 201.6,79,170.3,152.7
0.16Å---
A1460 SER23.16-Favored (66.6%)
General / -63.0,-22.1
Favored (63.9%) p
chi angles: 58.2
0.08Å- OUTLIER(S)
worst is C-N-CA: 4.8 σ
-
#AltResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengthsBond anglesCis Peptides
Avg: 236.83Clashscore: 6.3Outliers: 17 of 1478Poor rotamers: 18 of 1313Outliers: 23 of 1396Outliers: 8 of 1480Outliers: 98 of 1480Non-Trans: 0 of 1479
A1461 LYS24.46-OUTLIER (0)%)
Pre-Pro / 82.7,-1.9
OUTLIER (0.1%)
chi angles: 271.2,72.9,225.7,158.7
0.24Å- OUTLIER(S)
worst is CA-C-N: 9.7 σ
-
A1462 PRO25.66-Favored (16.93%)
Trans-Pro / -74.6,-21.4
Favored (95.9%) Cg_exo
chi angles: 331.5,30,338.5
0.18Å---
A1463 GLN24.80.43Å
HG2 with A1463 GLN O
Favored (22.21%)
General / -128.7,118.0
OUTLIER (0%)
chi angles: 65.1,301.1,128.6
0.10Å- OUTLIER(S)
worst is C-N-CA: 4.4 σ
-
A1464 ILE24.350.51Å
O with A1464 ILE HG23
Favored (24.82%)
Ile or Val / -118.0,108.6
Favored (17.2%) tt
chi angles: 193.7,163.3
0.14Å---
A1465 ALA25.88-Favored (20.83%)
General / -160.2,152.6
-0.13Å---
A1466 ALA26.59-Favored (6.5%)
General / -81.9,91.0
-0.09Å---
A1467 LEU25.19-Favored (43.88%)
General / -141.9,158.4
Favored (5.8%) mp
chi angles: 277,70.9
0.19Å---
A1468 LYS25.69-Favored (34.58%)
General / -83.1,136.1
Favored (67.5%) mmtt
chi angles: 293.3,292.4,185.5,172.3
0.13Å---
A1469 GLU25.6-Favored (2.44%)
General / -72.6,99.0
Favored (2%) mm-30
chi angles: 307.9,272.6,45.1
0.14Å---
A1470 GLU25.460.69Å
HG3 with A1479 ARG HH22
Allowed (0.07%)
General / -165.5,-143.9
Allowed (0.6%) pt0
chi angles: 52,146.7,335.1
0.14Å- OUTLIER(S)
worst is C-N-CA: 4.5 σ
-
A1471 THR26.37-Allowed (0.15%)
General / -44.9,109.3
Favored (26.5%) m
chi angles: 307.4
0.14Å---
A1472 GLU27.11-Favored (31.46%)
General / -90.9,138.6
Favored (55.3%) tt0
chi angles: 189,191.4,357.7
0.12Å- OUTLIER(S)
worst is C-N-CA: 4.2 σ
-
A1473 GLU25.74-Allowed (0.07%)
General / 78.4,103.6
Favored (63.8%) mt-10
chi angles: 292.4,159.4,12
0.14Å---
A1474 GLU25.64-Favored (3.72%)
General / -142.8,-172.7
Favored (13%) mt-10
chi angles: 283.1,158,44.3
0.06Å---
A1475 VAL27.20.48Å
O with A1475 VAL HG13
Favored (2.1%)
Ile or Val / -51.7,121.9
Favored (8.7%) p
chi angles: 66.9
0.05Å---
A1476 GLN27.16-Favored (19.04%)
General / 55.0,33.0
Allowed (0.4%) tm130
chi angles: 171.4,260.8,138.1
0.07Å- OUTLIER(S)
worst is CB-CG-CD: 4.1 σ
-
A1477 ASP26.62-Favored (17.42%)
General / 49.7,39.3
Favored (15.9%) m-30
chi angles: 298.6,1.3
0.10Å---
A1478 THR27.450.47Å
HG22 with A1479 ARG N
Favored (13.15%)
General / -166.6,158.2
Favored (31.6%) m
chi angles: 306.6
0.15Å---
A1479 ARG28.010.69Å
HH22 with A1470 GLU HG3
Favored (68.37%)
General / -72.1,-40.1
Favored (5.9%) mmt180
chi angles: 296.5,302.1,169.4,138
0.05Å---
A1480 LEU28.64--Favored (67.7%) mt
chi angles: 293.2,180.1
0.11Å---